Revised Report
Prepared for Public Health Agency of Canada
Supplier Name: Environics Research
Contract Number: CW2334642
Contract Value: $249,871.25 (including HST)
Award Date: October 19, 2023
Delivery Date: March 22, 2024
Registration Number: 074-23
For more information on this report, please contact Public Health Agency of Canada at: cpab_por-rop_dgcap@hc-sc.gc.ca
Ce rapport est aussi disponible en Français
Understanding Canadian Health Professionals' Knowledge, Attitudes, Opinions, and Perceptions Towards Zoonotic Infectious Diseases: Survey and Interviews 2023-2024 – Executive Summary
Prepared for Public Health Agency of Canada by Environics Research
March 2024
Revised November 2024 (Figure 9)
This public opinion research report presents the results of a quantitative and qualitative research study conducted by Environics Research on behalf of the Public Health Agency of Canada (PHAC). This study was reviewed and approved by the PHAC Research Ethics Board (Project File 2023-031P). The quantitative research consisted of an online survey of 1,023 Canadian health professionals in two groups: 526 physicians and 497 registered nurses/nurse practitioners. Participants were recruited through MDBriefCase, an organization providing accredited professional development education to medical professionals in Canada. This organization is in regular contact with more than 103,000 active health professionals. The survey was in field from December 5, 2023, to February 7, 2024. The qualitative research consisted of 38 interviews of 41 health professionals, conducted with 22 physicians and 19 nurses recruited from the same target population as the quantitative survey. 35 interviews were conducted individually while 3 interviews were conducted as diads with colleagues. 38 participants for interviews were recruited from the quantitative survey while 3 were referred by colleagues. The interviews were conducted from January 18 to February 6, 2024.
Permission to reproduce
This publication may be reproduced for non-commercial purposes only. Prior written permission must be obtained from the Public Health Agency of Canada. For more information on this report, please contact the Public Health Agency of Canada at: cpab_por-rop_dgcap@hc-sc.gc.ca
© His Majesty the King in Right of Canada, as represented by the Minister of Public Services and Procurement Canada, 2024
Cat. No. H14-625/2024E-PDF
ISBN 978-0-660-72391-4
Cette publication est aussi disponible en français sous le titre Comprendre les connaissances, les attitudes, les opinions et les perceptions des professionnels et professionnelles de la santé au Canada relativement aux maladies infectieuses zoonotiques: Sondage et entrevues, 2023-2024.
Cat. No. H14-625/2024F-PDF
ISBN 978-0-660-72392-1
Zoonotic infectious diseases (ZIDs) include a wide range of illnesses that pose a significant threat to human health. Currently, about 60 percent of known infectious diseases in humans and 75 percent of all emerging infectious diseases are zoonotic. 1 Furthermore, climate change has increasingly been found to act as a driving force behind the emergence and re-emergence of ZIDs. 2 Zoonotic events such as the 2002-2004 SARS outbreak, 2009 H1N1 pandemic, and the 2022 mpox outbreak have shown how ZIDs can impact the health of Canadians, the healthcare system, and the economy. 3 It is therefore critical for health professionals to have the capacity to identify, prevent, manage, and respond to ZIDs, to ensure preparedness and a coordinated response to address the latest zoonotic threats to the health and safety of the Canadian population.
PHAC has recognized this need for capacity building related to ZIDs among health professionals. Results from an extensive literature review conducted by PHAC showed the existence of literature on the general knowledge needs of health professionals, including knowledge needs related to infectious diseases. However, the available literature did not address the capacity-building needs of health professionals related to ZIDs specifically, despite the growing and evolving threat of these diseases to the health and safety of the Canadian population. Without an understanding of the capacity-building requirements of health professionals, it is challenging to address these needs. Therefore, it is important to identify the gaps in ZID knowledge, attitudes, opinions, and perceptions among health professionals in Canada through public opinion research (POR). This public opinion research project being led by the Zoonoses Health Professionals Guidance Team is part of a broader zoonoses program being advanced by the Zoonoses Division at PHAC.
The purpose of this research was to identify the knowledge, attitudes, opinions, and perceptions of Canadian human health professionals in relation to ZIDs to better understand their current public health and clinical practices as well as their knowledge and resource needs relating to ZIDs. The objectives of this research were to understand the current landscape in terms of knowledge and experience with ZIDs, identify barriers in providing ZID care, and ascertain information needs and learning preferences among health professionals where ZIDs are concerned.
The results of this research will inform guidance development and dissemination priorities related to ZIDs, in order to inform public health and primary care practice of health professionals in Canada, with consideration for the specific needs of key groups of healthcare professionals. By addressing the guidance needs identified through this research, this work will aim to ensure that health professionals are equipped to address ZID threats, and protect the health and safety of Canadians.
This research study consisted of two parts:
The survey sample came from MDBriefCase, an organization providing accredited professional development education to medical professionals in Canada. MDBriefCase's database provides access to more than 103,000 active health professionals. MDBriefCase was responsible for inviting and directing qualified respondents to the survey hosted by Environics. As this online survey used an opt-in list of health professionals, it is a non-probability survey. Thus, it cannot be assumed to be fully representative of the target population and no margin of sampling error is calculated. Results in this report are described as based on those responding and not representative of the population of doctors and nurses.
Environics achieved the following regional distribution among survey participants; final data were weighted to reflect regional distribution within each group based on Canadian Health Institute for Health Information (CIHI) data from 2020. 4
Occupation | Canada | Atlantic | Quebec | Ontario | MB/SK | Alberta | BC + Terr |
---|---|---|---|---|---|---|---|
Physicians/GPs | 526 | 29 | 57 | 270 | 32 | 61 | 77 |
Nurses/nurse practitioners | 497 | 58 | 44 | 171 | 77 | 85 | 62 |
Respondents were offered an incentive of $35 for their participation. MDBriefCase was responsible for providing incentives to their panellists through gift cards. Respondents had the choice to complete the survey in English or French; 953 surveys were completed in English and 70 in French.
The qualitative research is based on 38 semi-structured interviews with doctors, registered nurses, and nurse practitioners. Interviews were mainly conducted through a Canadian, privacy-authorized online web-based platform called Recollective, but some were conducted via Zoom or by telephone to accommodate participants who were not able to use Recollective.
Participants were recruited from the survey, which contained a short qualitative screener that asked respondents if they wished to opt-in for the qualitative research. Invitations were deployed to survey respondents from the opt-in list; to ensure a diverse mix of interview participants, some respondents in the list were prioritized for invitations based on location and specific practice experience. Participants were also given the option to invite colleagues with relevant expertise or delegated responsibilities; only 3 participants pursued this option, resulting in a total of 41 interview participants in 38 interviews.
Qualitative interview participants could choose to do their interview in English or French; 33 interviews were conducted in English and 5 in French. Participants comprised a mix of ages, gender, years of experience, clinical specialization, prior knowledge of zoonotic diseases, region, and experience with Indigenous populations. Interviews lasted 30 to 45 minutes. Participants were offered an incentive of $320 for their participation, paid by e-transfer from Environics Research.
Qualitative research provides insight into the range of opinions held within a population, rather than the weights of the opinions held, as measured in a quantitative survey. The results of the qualitative research should be viewed as indicative rather than projectable to the population.
The contract value was $249,871.25 (including HST).
The report begins with an executive summary outlining key findings and conclusions, followed by a detailed analysis of the quantitative survey data and qualitative interviews.
Quantitative results were analyzed by sub-groups including practitioner type, practice area or specialty, practice setting, region, and other key demographic and experience metrics to illuminate the findings where relevant. Statistical differences between sub-groups are noted in the report where they are interpreted to be important and relevant to the analysis. Differences between gender groups were omitted, due to the distinct differences in gender composition between doctors (52% women, 44% men) and nurses (89% women, 9% men). Put another way, 84% of all men who completed the study are doctors, and 62% of all women who completed the study are nurses. This difference means that statistically significant relationships between men and women in the study are likely to be spurious, and better explained by looking at their professional characteristics. Provided under a separate cover is a detailed set of "banner tables" presenting the results for all questions in the quantitative survey by population segments as defined by region, demographics, and practice details.
The qualitative findings in the main report were written based on the structure of the interview guide, with additional sections for themes and findings that emerged from the research. These results were used to further complement the findings from the quantitative survey on the barriers to accessing information and the information needs of physician and nurses in primary care and public health with respect to ZIDs. Quotations from the participants were included throughout the qualitative section to support the themes and findings.
Use of findings of the research. Data from this research will be used to identify and address the gaps in ZID knowledge, attitudes, opinions, and perceptions among health professionals in Canada for high priority diseases. This will aim to ensure health professionals have greater capacity to address zoonotic threats to the health and safety of the Canadian population.
Only 32% of health professionals report encountering zoonoses at least once a month among their patients, indicating that most do not encounter zoonoses frequently. When looking at specific diseases, Lyme disease is the disease encountered most by physicians and nurses in Canada; it is the only disease that was encountered by a majority of respondents. Other diseases among the list of 52 ZIDs included in the survey range from just 1% to 38% of health professionals saying they have encountered them in their practice. Diseases that are encountered more often tend to be those associated with well-known past outbreaks or epidemics (e.g., West Nile virus infection, rabies, Zika virus infection, mpox), common travel-related illnesses (e.g. chikungunya, cryptosporidiosis), and diseases that can be occupational hazards or risks for vulnerable patients (e.g., toxoplasmosis, bartonellosis, brucellosis). Most nurses and physicians did not mention other zoonoses of relevance to the scope of the zoonoses program work being led by the Zoonoses Health Professionals Guidance Team in the Zoonoses Division at PHAC.
The majority of doctors and nurses (89%) report having general, limited, or no knowledge on ZIDs. Very few rate their knowledge as expert or advanced (nurses 7%, physicians 15%). None of the nurses in the study rated their knowledge level as "expert."
A bivariate analysis shows there is a clear and positive correlation between encountering a disease, and self-reported confidence in managing it. Lyme disease stands out from others for being encountered most often, and with the highest ratings for confidence. A multivariate regression analysis shows that even in combination with other variables, like self-rated knowledge and various disease characteristics, encountering a disease is the strongest driver of confidence in managing diseases. This finding was echoed in the qualitative research, where participants often noted that their lack of confidence about managing ZIDs was specifically due to the rarity of these diseases in everyday practice.
For diseases that are more well-known, self-rated knowledge is also a key driver of self-reported confidence. Based on the quantitative and qualitative research, education about ZIDs is quite limited for most health professionals. From qualitative interviews, it appears that self-rated knowledge of specific ZIDs is largely built on information from sources such as public health bulletins, experience with patient cases, and articles in journals or magazines. This could explain why knowledge is often a more important driver of confidence for the more frequently encountered diseases than it is for others.
Physicians are more satisfied (52%) with the formal ZID education provided in the context of their academic program (e.g., medical school, residency, nursing school) than nurses (31%). Nearly one-quarter of nurses (23%) say they did not receive any education on ZIDs during their formal healthcare training on ZIDs, which was substantially more than the amount of doctors (7%) who say they did not receive such training. Satisfaction with formal education on ZIDs is higher for those practicing family medicine, those who see ZIDs more frequently (i.e. daily, weekly, or monthly), and those with experience practicing outside of Canada. In the multivariate regression analysis, satisfaction with formal education on ZIDs was a significant, albeit smaller, driver of self-reported confidence in managing ZIDs.
Physicians and nurses are equally satisfied with continuing education on ZIDs, when they have received it. Nearly half (46%) of physicians who received continuing education on ZIDs are satisfied with this education, just slightly lower than the proportion of physicians satisfied with their formal education (52%). In contrast to formal education satisfaction, nurses show an equal level of satisfaction with continuing education (47%) when compared to physicians.
A minority of health professionals indicate they are confident in providing specific ZID information or services; overall self-reported confidence is highest for public health reporting and lowest for patient management. Practice area seems to play a role here; those specializing in public health or working in public health settings are more confident about public health reporting, infection control, and contact tracing, while those in emergency and critical care say they are most confident about patient assessment, diagnosis, and patient management.
Results of the quantitative research indicated that federal, provincial and territorial government health websites and digital clinical support tools are the resources used most; information from the qualitative interviews indicated that digital tools, especially the clinical decision support resource, UpToDate, are the most preferred. Given that health professionals indicated in the survey that the biggest barrier to caring for ZID patients is keeping up with the latest information, it is not surprising that they also expressed a strong preference for a tool that includes this concept in its branding.
Almost all health professionals surveyed are at least somewhat interested in receiving more professional education on ZIDs. They rank treatment, prevention, and diagnosis as the topics they would most like to learn about. In terms of formats, self-directed online learning, interactive online courses, webinars and fact sheets are the top formats preferred by health professionals. Format preferences differ by sub-group in some instances, for example, fact sheets are preferred more often by nurses and those practicing in rural areas, while physicians are more inclined to pursue continuing medical education (CME) and read journal articles.
K-means analysis was used to cluster respondents accordingly to similarities in the diseases they encountered; this analysis partitioned respondents into four discrete clusters. Cluster 1 is experienced and confident with a wide range of ZIDs including those that are extremely rare; most are physicians in urban hospitals. They encounter patients with ZIDs more often than health professionals in the other clusters. Cluster 1 health professionals use a range of ZID resources often and are quite amenable to further training on the subject. Cluster 2 is experienced with some specific diseases, particularly respiratory diseases associated with livestock and wildlife, and hantavirus diseases associated with crowded living conditions, likely because they work in front-line settings where they are more likely to encounter patients at risk of specific ZIDs due to occupational or lifestyle risks. Cluster 2 health professionals have some interest in learning more about ZIDs, but time is a significant barrier and they are most interested in resources that are easy to use and available when they need them. Respondents in Cluster 3 are more likely to work in family practices and community care, sometimes in rural settings, where they rarely or never see ZIDs in patients. Their experience, confidence, and knowledge about ZIDs is limited, but the nature of their practices means that learning more about ZIDs is not a priority for them. Cluster 3 health professionals are most interested in resources that are short, easy to understand, and of demonstrable relevance to their practice. Health professionals in Cluster 4 have higher levels of experience with some specific diseases, in particular West Nile virus infection, and are the most likely among the four clusters to work in a public health or travel clinic setting (although most work in hospitals or family practice). They tend to have knowledge of ZIDs in a direct patient care context where patients may be diagnosed with ZIDs while seeking care for other reasons. Cluster 4 health professionals are more frequent users of ZID resources than Cluster 2, but like Cluster 2, time to look up symptoms for each patient is a critical barrier.
A principle components analysis was used to group the 52 diseases from the survey into groups (or factors) of diseases that tend to be seen by the same health professionals. Seven groups were defined by this analysis; additional research was used to identify shared characteristics of the diseases in each group. The seven groups can be broadly described as: rarely encountered, common endemic and travel diseases, outdoor and agricultural occupational risks, rare emerging and travel-related diseases, diseases related to crowded living conditions, respiratory diseases from livestock and wildlife, and rare encephalitic diseases.
The seven disease groups were analyzed to see which clusters, identified by the K-means analysis, were most associated with each disease group; this analysis can be used to inform strategic resource development to target resources to those health professionals for whom they are most relevant in practice. Cluster 1 is experienced in all seven groups. Cluster 2 is strongly associated with the respiratory diseases from livestock and wildlife group, and is also fairly experienced with common endemic and travel diseases, some diseases associated with outdoor and agricultural occupational risks, and the diseases related to crowding living conditions group (especially the hantaviruses in this group). Cluster 4 has specific experience with Lyme disease, mpox, West Nile virus infection (from the common endemic and travel diseases group) and bartonellosis (outdoor and agricultural occupational risks).
Primary care practitioners rarely identified ZID cases in their practices. Some said they provide counselling, vaccinations, or referrals for those with specific risk factors (animal exposure, recent travel, travel plans). In line with findings from the survey, Lyme disease was the most common ZID encountered in everyday practice, with health professionals across Canada often seeing patients with concerns about the risk. Participants located in Ontario, Quebec, and some parts of Atlantic Canada sometimes treated patients with Lyme disease, while those in other regions typically fielded questions about the disease but did not see active cases in patients.
Lack of experience with ZIDs drove low self-reported confidence in managing them. With most receiving limited training and continuing education on ZIDs, knowledge of specific diseases was very limited among physicians and nurses. Interview participants often pointed to this as a driver of low confidence in managing diseases. Additionally, due to the heavy demands of the job, ZIDs were simply not seen as a priority for learning unless they were directly relevant to their practice. Some health professionals had a higher degree of confidence in managing specific diseases like Lyme disease or rabies, but only when these were common in their practices.
UpToDate was the resource mentioned most often in interviews; PHAC and other Government of Canada resources were familiar, but generally not top-of-mind. UpToDate is a favourite resource for many nurses and physicians, who said it is easy to use, trustworthy, and up to date with recent research and recommendations. For infectious disease topics, the United States Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) were both frequently mentioned as good resources. Often, health professionals said they start with a Google search and look for reputable sources in the results, like Mayo Clinic and Johns Hopkins. Government of Canada resources were somewhat well-known, and many participants had used them intermittently, but they were often seen to be difficult to navigate, which limited their usefulness in situations where information was needed quickly.
An ideal resource would be a searchable web and app platform that is easy to use, with Canadian context. The relative rarity of most ZIDs in Canada meant they were not high on the priority list for deeper study or continuing education. Some interview participants pointed out that it was more important for them to know protocols for handling a potential case if it arises, rather than knowing specifics about individual diseases. Health professionals indicated that an ideal resource would be a user-friendly online database that they could access in an app or on a website, with different options for searching (e.g., by geography, symptom, patient risk factors, species involved, etc.). Canadian context was noted to be an important element, because different disease factors like endemicity, diagnostic tools, and treatment options can differ from country to country, and regionally within a country. Public health bulletins, infographics and articles were also seen as useful ways to drive familiarity with specific diseases, especially when there is imminent concern.
Five broad considerations for future resource development and capacity building were drawn from the research findings:
I hereby certify as senior officer of Environics that the deliverables fully comply with the Government of Canada political neutrality requirements outlined in the Communications Policy of the Government of Canada, and Procedures for Planning and Contracting Public Opinion Research. Specifically, the deliverables do not include information on electoral voting intentions, political party preferences, standings with the electorate, or ratings of the performance of a political party or its leaders.
Stephanie Coulter
Senior Research Associate, Corporate and Public Affairs
Environics Research Group
stephanie.coulter@environics.ca
Supplier name: Environics Research Group
PWGSC contract number: CW2334642
Original contract date: October 19, 2023
For more information, contact Public Health Agency of Canada at: cpab_por-rop_dgcap@hc-sc.gc.ca
Zoonotic infectious diseases (ZIDs) include a wide range of illnesses that pose a significant threat to human health. Currently, about 60 percent of known infectious diseases in humans and 75 percent of all emerging infectious diseases are zoonotic. 5 Furthermore, climate change has increasingly been found to act as a driving force behind the emergence and re-emergence of ZIDs. Altering climate patterns and ecological shifts can disrupt natural habitats, leading to shifts in the distribution and behaviour of vectors and reservoir hosts, and thereby facilitating the transmission of pathogens to human populations. 6 Zoonotic events such as the 2002-2004 SARS outbreak, 2009 H1N1 pandemic, and the 2022 mpox outbreak have shown how ZIDs can impact the health of Canadians, the healthcare system, and the economy. 7 These threats demonstrated the crucial role health professionals play on the frontlines when encountering ZIDs. It is therefore critical for health professionals to have the capacity to identify, prevent, manage, and respond to ZIDs, to ensure preparedness and a coordinated response to address the latest zoonotic threats to the health and safety of the Canadian population. PHAC has recognized this need for capacity building related to ZIDs among health professionals. This public opinion research project is part of a broader zoonoses program being advanced by the Zoonoses Division at PHAC. The Zoonoses Health Professionals Guidance Team within the Zoonoses Division has been conducting this project as part of a larger prioritization project that aims to identify high priority ZIDs for guidance/resource development and dissemination activities.
PHAC conducted an examination of the literature to gauge the extent of research on health professional capacity-building needs for ZIDs. It was a comprehensive review of the available literature related to health professionals' capacity-building needs, including their need for knowledge resources. This review included searches in academic databases, relevant journals, and reports. The intention was to cast a wide net to capture any relevant information.
Results showed the existence of literature on the general knowledge needs of health professionals, including knowledge needs related to infectious diseases. However, the available literature did not address the capacity-building needs of health professionals related to ZIDs specifically, despite the growing and evolving threat of these diseases to the health and safety of the Canadian population. Without an understanding of the capacity-building requirements of health professionals, it is challenging to address these needs. Therefore, it is important to identify the gaps in ZID knowledge, attitudes, opinions, and perceptions among health professionals in Canada through public opinion research (POR).
The purpose for this research was to identify the knowledge, attitudes, opinions, and perceptions of Canadian human health professionals in relation to ZIDs to better understand their current public health and clinical practices as well as their knowledge and resource needs relating to ZIDs. The objectives of this research were to:
Understand the current landscape:
Identify barriers in providing ZID care:
Ascertain information needs and learning preferences:
The results of this research will inform the guidance, development and dissemination priorities related to ZIDs, in order to inform public health and primary care practice of health professionals in Canada, with consideration for the specific needs of key groups of healthcare professionals. By addressing the guidance needs identified through this research, this work will aim to ensure that health professionals are equipped to address ZID threats, and protect the health and safety of Canadians.
This report begins with an executive summary outlining the key findings of the quantitative survey and qualitative interviews, followed by a detailed analysis and breakdown of the results. A detailed description of the survey methodology is presented in Appendix A and the qualitative methodology in Appendix B. The survey questionnaire is provided in Appendix C, the in-depth interview (IDI) discussion guide in Appendix D, and the screener is provided in Appendix E. As this online survey used an opt-in list of health professionals, it is a non-probability survey and cannot be assumed to be fully representative of the target population. Therefore, no margin of sampling error was calculated for this study.
Quantitative results are based on the entire sample and results are expressed as percentages unless otherwise noted. For results shown as graphs, results lower than 3% are not shown. Results may otherwise not add to 100% due to rounding (0.5 rounded up, <0.5 rounded down) or multiple responses. Provided under separate cover is a detailed set of "banner tables" presenting the results for all survey questions for the total and by sub-group segments. These tables are referenced by the survey question in the detailed analysis.
Differences between sub-groups are noted based on Z-test results at 95% probability for comparing proportions, and based on two-tailed T-test results at 95% probability for comparing means. Comparisons are based on differences between sub-groups, and not on differences compared to the total. In data charts in the report, bold and italicized text is used to note differences between sub-groups (i.e., higher results are bolded, lower are italicized). Note that sub-groups with less than 20 respondents (unweighted sample) are excluded from the analysis.
Differences between other sub-groups are called out where relevant. To ensure that differences noted in the report text are robust and meaningful to the analysis, when there are:
The following sub-groups were presented throughout this report:
When interpreting results, note that because this online survey used an opt-in panel, it is a non-probability survey and no margin of sampling error should be calculated. Reported percentages are not generalizable to any group other than the sample studied, and therefore no formal statistical inferences can be drawn between the sample results and the broader target population it may be intended to reflect.
Note that qualitative research provides insight into the range of opinions held within a population, rather than the weights of the opinions held, as measured in a quantitative survey. The results of the qualitative research should be viewed as indicative rather than projectable to the population.
Daily | At least once a week | At least once a month | At least once a year | Less than once a year | Never but is still part of my practice | |
---|---|---|---|---|---|---|
All respondents (n=1,023) | 3% | 9% | 20% | 31% | 24% | 13% |
Nurses / Nurse practitioners (n=497) | 3% | 5% | 17% | 27% | 27% | 21% |
Physicians (n=526) | 3% | 12% | 23% | 35% | 21% | 6% |
Only 32% of health professionals report encountering zoonoses at least once a month among their patients, indicating that most do not encounter zoonoses frequently; a small proportion see them on a frequent basis, i.e. daily or weekly (8% nurses, 15% physicians). One in five nurses (21%) and just 6% of physicians say that while they never encounter ZIDs, these diseases are still part of their practice – this could include health professionals who work in public health, counsel patients about risks, provide vaccines for at-risk groups and travellers, or prescribe other prophylactic measures.
Other sub-groups that are more likely to encounter ZIDs on a daily or weekly basis include:
Note, those who rate their ZIDs knowledge as limited or no knowledge are less likely to encounter ZIDs on a daily or weekly basis (3%).
Expert knowledge | Advanced knowledge | General knowledge | Limited knowledge | No knowledge | NET: Expert/Advanced | |
---|---|---|---|---|---|---|
All respondents (n=1,023) | 1% | 10% | 50% | 36% | 3% | 11% |
Nurses / Nurse practitioners (n=497) | 0% | 7% | 49% | 40% | 4% | 7% |
Physicians (n=526) | 2% | 13% | 51% | 32% | 1% | 15% |
When asked to rate their knowledge of ZIDs, a vast majority of nurses (89%) and physicians (83%) rate their knowledge as either general (nurses 49%, physicians 51%) or limited (40% nurses, 32% physicians). Very few rate their knowledge as expert or advanced (nurses 7%, physicians 15%) – in fact, none of the nurses in the study rated their knowledge as "expert."
Some sub-groups are more likely to rate their knowledge as expert or advanced:
One sub-group is notably less likely to rate their knowledge as expert or advanced:
Very satisfied | Somewhat satisfied | Somewhat dissatisfied | Very dissatisfied | Was not provided | NET: Satisfied | NET: Dissatisfied | NET: Satisfied ("Not provided" responses removed) | NET: Dissatisfied ("Not provided" responses removed) | |
---|---|---|---|---|---|---|---|---|---|
All respondents (n=1,023) | 4% | 32% | 35% | 13% | 15% | 36% | 48% | 43% | 57% |
Nurses / Nurse practitioners (n=497) | 2% | 22% | 34% | 19% | 23% | 24% | 53% | 31% | 69% |
Physicians (n=526) | 6% | 42% | 36% | 8% | 7% | 48% | 44% | 52% | 48% |
Physicians are notably more satisfied with the formal education they received about ZIDs, compared to nurses; with "not provided" cases removed, half (52%) of physicians say they are very or somewhat satisfied, compared to just one in three (31%) nurses. Two in three (69%) nurses say they are unsatisfied with their education on this topic. Based on what was heard during the qualitative interviews, nurses and nurse practitioners generally reported receiving little, if any, specific training about ZIDs or infectious diseases in general during nursing school, while physicians in this interviews often recalled receiving training in the form of a formal class, a clinical rotation, or other experience with patient cases during residency.
Looking at satisfaction with responses removed who did not receive formal education on ZIDs, sub-groups more likely to be satisfied (NET: very / somewhat satisfied) with their formal education on ZIDs include:
Sub-groups more likely to be dissatisfied (NET: very / somewhat dissatisfied) with their formal education on ZIDs include:
Very satisfied | Somewhat satisfied | Somewhat dissatisfied | Very dissatisfied | Did not receive training | NET: Satisfied | NET: Dissatisfied | NET: Satisfied ("Not provided" responses removed) | NET: Dissatisfied ("Not provided" responses removed) | |
---|---|---|---|---|---|---|---|---|---|
All respondents (n=1,023) | 4% | 31% | 30% | 11% | 24% | 35% | 41% | 47% | 53% |
Nurses / Nurse practitioners (n=497) | 3% | 29% | 23% | 13% | 31% | 32% | 36% | 47% | 53% |
Physicians (n=526) | 5% | 33% | 35% | 9% | 18% | 38% | 44% | 46% | 54% |
For physicians, when controlling for different uptakes in formal and continuing education, satisfaction levels for continuing education are similar to those for formal education. Excluding those who did not take any continuing professional education on ZIDs, 46% of physicians who received continuing education are satisfied. For continuing education, nurses show an equal level of satisfaction to physicians, in contrast to formal education, where their satisfaction is lower.
Sub-groups more likely to be satisfied (NET: very / somewhat satisfied) with continuing education include:
Sub-groups more likely to be dissatisfied (NET: very / somewhat dissatisfied) with continuing education include:
A vast majority of health professionals had encountered at least one disease from the list of 52 diseases presented in this survey. Lyme disease tops the list, encountered by three-quarters of nurses and almost nine in ten physicians.
Physicians and nurses were asked which of the 52 ZIDs they encountered in their practice. There was no specific definition of encountering in the questionnaire (i.e. respondents interpreted encountering in their own terms), which could extend to a variety of contexts. More precisely, participants in the qualitative interviews tended to refer to diagnosed cases, suspected cases, testing, differential considerations, patient questions, and public health alerts when recounting the ZIDs they had encountered in their practices.
Lyme disease stands alone as the only one that has been encountered by a majority; no other diseases come close. In total, 94% of survey respondents had encountered at least one disease from the list of 52. Shown in the table on the following page are the diseases encountered by 10% of respondents or more, broken down by practice setting. Looking at statistically significant differences between groups, several diseases are more common for health professionals in hospital settings, where patients may be coming in with acute symptoms, and those in public health settings.
Detailed topline results for this question can be found in Appendix K. The multivariate analysis, later in the report, contains extensive discussion of the relationships between different sub-groups and their likelihood of encountering diseases.
ZIDs encountered | Total (n=1,023) | Family / Walk-in / Urgent care / Long term care (n=466) | Hospital (n=263) | Community (n=126) | Public health / Travel (n=139) |
---|---|---|---|---|---|
NET: Any disease (of all 52) | 94% | 95% | 96% | 89% | 92% |
Lyme disease | 80% | 83% | 81% | 71% | 75% |
West Nile virus infection | 38% | 31% | 50% | 23% | 60% |
Rabies | 37% | 34% | 33% | 36% | 68% |
Toxoplasmosis | 37% | 35% | 48% | 29% | 30% |
Avian (zoonotic) influenza: H5N1 | 34% | 33% | 44% | 24% | 37% |
Dengue | 30% | 31% | 33% | 24% | 30% |
Zika virus infection | 30% | 32% | 35% | 10% | 38% |
MERS-CoV infection | 29% | 23% | 37% | 29% | 36% |
Bartonellosis (cat scratch disease) | 29% | 31% | 36% | 23% | 13% |
Avian (zoonotic) influenza: H7N9 | 19% | 15% | 28% | 14% | 18% |
Mpox (monkeypox) | 18% | 14% | 17% | 10% | 49% |
Chikungunya | 17% | 21% | 15% | 6% | 21% |
Tick-borne encephalitis | 17% | 12% | 25% | 13% | 23% |
Cryptosporidiosis | 17% | 15% | 21% | 12% | 22% |
Cutaneous larva migrans | 15% | 21% | 13% | 10% | 6% |
Rocky mountain spotted fever | 15% | 15% | 20% | 12% | 13% |
Yellow fever | 13% | 11% | 16% | 4% | 20% |
Q fever | 11% | 7% | 15% | 10% | 18% |
Brucellosis | 11% | 9% | 17% | 7% | 13% |
Bovine tuberculosis | 10% | 8% | 12% | 9% | 18% |
Leptospirosis | 10% | 9% | 15% | 8% | 7% |
Q10a/b. In the following grid, please indicate which diseases you have encountered in your practice, AND rate your level of confidence in managing each zoonotic infectious disease Note: Results for "Other" practice settings not shown due to small sample size (n=19). Some respondents did not provide their practice setting. |
For nearly all ZIDs, physicians self-rate their confidence higher than nurses. Notable exceptions are MERS-CoV infection and Ebola; these diseases were also encountered more frequently among nurses.
Physicians and nurses were asked to rate their confidence in managing each ZID in a list of 52. The question was asked without a specific definition for confidence, therefore respondents interpreted this in their own terms. Differences in interpretation were noted during the qualitative interviews, when participants discussed their own self-reported confidence; for some this specifically meant their ability to manage a patient with a ZID, but for others, confidence meant knowing where to access protocols and resources.
Mean self-reported confidence scores are based on a 4-point scale where 1 = "Not at all confident" and 4 = "Very confident." The mean ranges from 1 to 4 and includes all respondents, regardless of encounter. Shown on the following page are self-reported confidence scores for the top diseases with confidence ratings of 1.30 or higher. Complete results for this question can be found in Appendix K. A multivariate analysis discussed later in the report contains further discussion of the relationships between different sub-groups and their likelihood of encountering diseases.
All respondents (n=1,023) | Nurses / Nurse practitioners (n=497) | Physicians (n=526) | |
---|---|---|---|
Lyme disease | 2.20 | 2.01 | 2.38 |
Rabies | 1.96 | 1.96 | 1.96 |
Avian (zoonotic) influenza: H5N1 | 1.76 | 1.73 | 1.78 |
MERS-CoV infection | 1.66 | 1.74 | 1.59 |
Toxoplasmosis | 1.65 | 1.48 | 1.82 |
West Nile virus infection | 1.63 | 1.60 | 1.66 |
Zika virus infection | 1.60 | 1.50 | 1.71 |
Avian (zoonotic) influenza: H7N9 | 1.56 | 1.51 | 1.60 |
Dengue | 1.55 | 1.42 | 1.67 |
Bartonellosis (cat scratch disease) | 1.52 | 1.35 | 1.68 |
Mpox (monkeypox) | 1.50 | 1.52 | 1.48 |
Yellow fever | 1.42 | 1.41 | 1.42 |
Tick-borne encephalitis | 1.38 | 1.30 | 1.45 |
All respondents (n=1,023) | Nurses / Nurse practitioners (n=497) | Physicians (n=526) | |
---|---|---|---|
Rocky mountain spotted fever | 1.37 | 1.24 | 1.49 |
Chikungunya | 1.36 | 1.23 | 1.49 |
Cutaneous larva migrans | 1.34 | 1.11 | 1.55 |
Cryptosporidiosis | 1.32 | 1.20 | 1.43 |
Ebola disease | 1.31 | 1.35 | 1.27 |
Q fever | 1.29 | 1.26 | 1.33 |
Bovine tuberculosis | 1.27 | 1.21 | 1.33 |
Brucellosis | 1.27 | 1.14 | 1.39 |
Leptospirosis | 1.27 | 1.17 | 1.36 |
Japanese encephalitis virus | 1.26 | 1.22 | 1.30 |
Hantavirus – Hantavirus pulmonary syndrome | 1.26 | 1.23 | 1.28 |
Psittacosis | 1.23 | 1.13 | 1.33 |
Tularemia | 1.23 | 1.11 | 1.34 |
All respondents (n=1,023) | Nurses / Nurse practitioners (n=497) | Physicians (n=526) | |
---|---|---|---|
Plague | 1.22 | 1.16 | 1.27 |
Anthrax | 1.21 | 1.13 | 1.28 |
Hantavirus- Hemorrhagic fever with renal syndrome | 1.21 | 1.16 | 1.25 |
Babesiosis | 1.20 | 1.10 | 1.29 |
American trypanosomiasis (Chagas disease) | 1.20 | 1.10 | 1.28 |
Western equine encephalitis virus | 1.19 | 1.15 | 1.22 |
Ehrlichiosis | 1.17 | 1.11 | 1.22 |
Eastern equine encephalitis virus | 1.17 | 1.12 | 1.20 |
Cystic echinococcosis | 1.16 | 1.08 | 1.25 |
Human granulocytic anaplasmosis | 1.16 | 1.10 | 1.21 |
Murine typhus/ endemic typhus | 1.15 | 1.08 | 1.22 |
Toxocariasis | 1.15 | 1.08 | 1.21 |
California encephalitis | 1.14 | 1.10 | 1.17 |
All respondents (n=1,023) | Nurses / Nurse practitioners (n=497) | Physicians (n=526) | |
---|---|---|---|
Powassan virus disease | 1.13 | 1.09 | 1.17 |
Alveolar echinococcosis | 1.13 | 1.08 | 1.18 |
Rift Valley Fever | 1.13 | 1.09 | 1.17 |
La Crosse encephalitis | 1.13 | 1.11 | 1.14 |
St. Louis encephalitis | 1.13 | 1.08 | 1.17 |
Louse-borne relapsing fever | 1.12 | 1.10 | 1.15 |
Nipah virus disease | 1.12 | 1.11 | 1.14 |
Snowshoehareencephalitis | 1.12 | 1.09 | 1.15 |
Jamestown Canyon virus | 1.12 | 1.09 | 1.14 |
Lassa hemorrhagic fever | 1.12 | 1.09 | 1.14 |
Cache valley virus disease | 1.11 | 1.09 | 1.12 |
Marburg virus disease | 1.10 | 1.07 | 1.12 |
Crimean Congo hemorrhagic fever | 1.09 | 1.06 | 1.12 |
ZIDs in Practice | Encountered / Self-rated confidence (All diseases)
There is a clear, positive correlation between encountering a disease, and confidence in managing it.
The following page contains a graph that plots each disease by the proportion of health professionals in the survey who encountered it (X-axis) and its mean self-reported confidence rating among all respondents (Y-axis). In this graph, it is evident that there is a clear correlation between encountering a disease, and feeling confident about managing it. Diseases are also organized by colour according to their factors from the PCA analysis, which is discussed later in section D (Multivariate analysis)
Most of the 52 ZIDs on the list are infrequently encountered and survey respondents have low self-reported confidence in managing them. Lyme disease is the only disease in the list that was encountered by a majority of health professionals (80%) and with a mean confidence rating above 2 (2.20). Confidence ratings range from a low of 1.09 (Crimean Congo hemorrhagic fever) to a high of 2.20 (Lyme disease). Note that because the data is so tightly clustered, the axes use logarithmic scales to better highlight differences between diseases.
When those who did not encounter a disease are excluded from the analysis, the confidence ratings for each disease are in a fairly narrow range (1.80 to 2.59). Complete encountered and confidence data for all diseases can be found in Appendix K.
The later report section with multivariate analysis discusses disease encounters and self-reported confidence in detail, in terms of their relationship to each other and other variables.
Names | Encountered (logarithmic scale) | Confidence (logarithmic scale) | Factor Group | Encountered % (not visualised) | Mean Confidence (not visualised) |
---|---|---|---|---|---|
Lyme disease | -10% | 0.34 | Factor 2 | 80% | 2.20 |
Rabies | -43% | 0.29 | Factor 2 | 37% | 1.96 |
Avian (zoonotic) influenza: H5N1 | -46% | 0.24 | Factor 6 | 34% | 1.76 |
MERS-CoV infection | -53% | 0.22 | Factor 6 | 29% | 1.66 |
Toxoplasmosis | -43% | 0.22 | Factor 2 | 37% | 1.65 |
West Nile virus infection | -42% | 0.21 | Factor 2 | 38% | 1.63 |
Zika virus infection | -53% | 0.21 | Factor 2 | 30% | 1.60 |
Avian (zoonotic) influenza: H7N9 | -73% | 0.19 | Factor 6 | 19% | 1.56 |
Dengue | -52% | 0.19 | Factor 2 | 30% | 1.55 |
Bartonellosis (cat scratch disease) | -54% | 0.18 | Factor 3 | 29% | 1.52 |
Mpox (monkeypox) | -74% | 0.18 | Factor 2 | 18% | 1.50 |
Yellow fever | -89% | 0.15 | Factor 2 | 13% | 1.42 |
Tick-borne encephalitis | -77% | 0.14 | Factor 2 | 17% | 1.38 |
Rocky mountain spotted fever | -82% | 0.14 | Factor 3 | 15% | 1.37 |
Chikungunya | -77% | 0.13 | Factor 2 | 17% | 1.36 |
Cutaneous larva migrans | -82% | 0.13 | Factor 4 | 15% | 1.34 |
Cryptosporidiosis | -78% | 0.12 | Factor 3 | 17% | 1.32 |
Ebola disease | -113% | 0.12 | Factor 1 | 7% | 1.31 |
Q fever | -94% | 0.11 | Factor 3 | 11% | 1.29 |
Brucellosis | -94% | 0.10 | Factor 3 | 10% | 1.27 |
Bovine tuberculosis | -99% | 0.10 | Factor 6 | 10% | 1.27 |
Leptospirosis | -99% | 0.10 | Factor 3 | 11% | 1.27 |
Japanese encephalitis virus | -103% | 0.10 | Factor 2 | 9% | 1.26 |
Hantavirus – Hantavirus pulmonary syndrome | -106% | 0.10 | Factor 5 | 9% | 1.26 |
Psittacosis | -111% | 0.09 | Factor 3 | 8% | 1.23 |
Tularemia | -108% | 0.09 | Factor 3 | 8% | 1.23 |
Plague | -150% | 0.09 | Factor 1 | 3% | 1.22 |
Hantavirus- Hemorrhagic fever with renal syndrome | -108% | 0.08 | Factor 5 | 8% | 1.21 |
Anthrax | -143% | 0.08 | Factor 4 | 4% | 1.21 |
American trypanosomiasis (Chagas disease) | -123% | 0.08 | Factor 4 | 6% | 1.20 |
Babesiosis | -117% | 0.08 | Factor 3 | 7% | 1.20 |
Western equine encephalitis virus | -115% | 0.07 | Factor 1 | 7% | 1.19 |
Eastern equine encephalitis virus | -132% | 0.07 | Factor 1 | 5% | 1.17 |
Ehrlichiosis | -131% | 0.07 | Factor 3 | 5% | 1.17 |
Cystic echinococcosis | -125% | 0.07 | Factor 4 | 6% | 1.16 |
Human granulocytic anaplasmosis | -135% | 0.06 | Factor 3 | 4% | 1.16 |
Toxocariasis | -149% | 0.06 | Factor 4 | 3% | 1.15 |
Murine typhus / endemic typhus | -157% | 0.06 | Factor 4 | 3% | 1.15 |
California encephalitis | -148% | 0.06 | Factor 1 | 3% | 1.14 |
Alveolar echinococcosis | -159% | 0.05 | Factor 5 | 3% | 1.13 |
La Crosse encephalitis | -169% | 0.05 | Factor 1 | 2% | 1.13 |
Powassan virus disease | -167% | 0.05 | Factor 1 | 2% | 1.13 |
Rift Valley Fever | -177% | 0.05 | Factor 1 | 2% | 1.13 |
St. Louis encephalitis | -161% | 0.05 | Factor 1 | 2% | 1.13 |
Jamestown Canyon virus | -166% | 0.05 | Factor 7 | 2% | 1.12 |
Lassa hemorrhagic fever | -173% | 0.05 | Factor 1 | 2% | 1.12 |
Louse-borne relapsing fever | -168% | 0.05 | Factor 5 | 2% | 1.12 |
Nipah virus disease | -162% | 0.05 | Factor 1 | 2% | 1.12 |
Snowshoe hare encephalitis | -158% | 0.05 | Factor 7 | 3% | 1.12 |
Cache valley virus disease | -177% | 0.05 | Factor 1 | 2% | 1.11 |
Marburg virus disease | -170% | 0.04 | Factor 1 | 2% | 1.10 |
Crimean Congo hemorrhagic fever | -185% | 0.04 | Factor 1 | 1% | 1.09 |
Most nurses and physicians did not mention any other ZIDs of relevance to their practice.
After reviewing the 52 diseases in the survey list, respondents were asked to note any other zoonotic infectious diseases they felt were relevant in their practice. A large majority (88%) of health professionals indicated that they had nothing to add. Among those who responded to this open-ended question, some of the diseases mentioned were already in the main list, and most others did not meet the scope set out for this project. Parasitic diseases (4%) or bacterial infections (2%) were mentioned most often.
A minority of health professionals are confident in providing specific ZID information or services; self-reported confidence is highest for public health reporting and lowest for patient management.
Rating their confidence on seven aspects of ZID management, nurses and physicians are most confident about public health reporting, with four in ten saying they are confident or very confident (41% nurses, 38% physicians). While both groups share similar levels of self-reported confidence around patient assessment, patient education, and patient management, nurses are more confident about infection prevention and control (nurses 35%, physician 23%) and contact tracing (nurses 23%, physicians 14%), whereas physicians are more confident about diagnosis (nurses 18%, physicians 25%).
NET: Very confident/confident in providing ZIDs information or services | Total (n=1,023) | Nurses/NP (n=497) | Physicians (n=526) |
---|---|---|---|
Public Health Reporting: Reporting cases to local public health authorities per your jurisdictional requirements | 40% | 41% | 38% |
Infection prevention and control measures: Implementing infection control protocols to prevent healthcare-associated transmission, as appropriate. | 29% | 35% | 23% |
Patient assessment: Risk factors and physical assessment | 26% | 25% | 26% |
Patient education: Educating patients and their families about zoonotic diseases such as transmission, and preventive measures. | 22% | 24% | 21% |
Diagnosis: taking patient history, assessing patient's clinical presentation, ensuring appropriate tests are ordered, interpretation of results for laboratory diagnosis, understanding differential diagnoses | 22% | 18% | 25% |
Contact tracing: Identifying and monitoring individuals who may have been exposed to the ZID-infected patient. | 18% | 23% | 14% |
Patient management: Selecting the appropriate treatment plan and follow-up. | 15% | 13% | 17% |
Q12. Please rate your confidence at providing each of the following types of information or services related to the zoonotic infectious diseases you encounter as identified in this survey. Looking at results by practice setting, there are some differences in confidence on the aspects of management. |
Confidence rating | Total (n=1,023) | Family / Walk-in / Urgent care / Long term care (n=466) | Hospital (n=263) | Community (n=126) | Public health / Travel (n=139) |
---|---|---|---|---|---|
NET: Very confident / Confident | 40% | 39% | 34% | 34% | 61% |
Very confident | 12% | 10% | 10% | 10% | 25% |
Confident | 28% | 29% | 24% | 24% | 35% |
Somewhat confident | 38% | 39% | 37% | 47% | 26% |
Not at all confident | 20% | 20% | 25% | 17% | 8% |
Not applicable | 3% | 2% | 4% | 2% | 5% |
Q12. Please rate your confidence at providing each of the following types of information or services related to the zoonotic infectious diseases you encounter as identified in this survey. Note: Results for "Other" practice settings not shown due to small sample size (n=19). Some respondents did not provide their practice setting. |
Sub-groups more likely to be confident (NET: very confident/confident) about public health reporting include:
Confidence rating | Total (n=1,023) | Family / Walk-in / Urgent care / Long term care (n=466) | Hospital (n=263) | Community (n=126) | Public health / Travel (n=139) |
---|---|---|---|---|---|
NET: Very confident / Confident | 29% | 23% | 34% | 19% | 50% |
Very confident | 7% | 4% | 9% | 6% | 14% |
Confident | 22% | 19% | 25% | 14% | 36% |
Somewhat confident | 44% | 44% | 44% | 51% | 37% |
Not at all confident | 25% | 30% | 21% | 30% | 11% |
Not applicable | 2% | 2% | 1% | 0% | 2% |
Q12. Please rate your confidence at providing each of the following types of information or services related to the zoonotic infectious diseases you encounter as identified in this survey. Note: Results for "Other" practice settings not shown due to small sample size (n=19). Some respondents did not provide their practice setting. |
Sub-groups more confident (NET: very confident/confident) about infection prevention and control include:
Confidence rating | Total (n=1,023) | Family / Walk-in / Urgent care / Long term care (n=466) | Hospital (n=263) | Community (n=126) | Public health / Travel (n=139) |
---|---|---|---|---|---|
NET: Very confident / Confident | 26% | 25% | 29% | 17% | 34% |
Very confident | 5% | 4% | 8% | 3% | 4% |
Confident | 21% | 21% | 22% | 13% | 30% |
Somewhat confident | 48% | 47% | 45% | 61% | 43% |
Not at all confident | 24% | 27% | 25% | 21% | 14% |
Not applicable | 2% | 1% | 1% | 1% | 9% |
Q12. Please rate your confidence at providing each of the following types of information or services related to the zoonotic infectious diseases you encounter as identified in this survey. Note: Results for "Other" practice settings not shown due to small sample size (n=19). Some respondents did not provide their practice setting. |
Sub-groups more confident (NET: very confident/confident) about patient assessment include:
Confidence rating | Total (n=1,023) | Family / Walk-in / Urgent care / Long term care (n=466) | Hospital (n=263) | Community (n=126) | Public health / Travel (n=139) |
---|---|---|---|---|---|
NET: Very confident / Confident | 22% | 18% | 23% | 16% | 47% |
Very confident | 4% | 3% | 3% | 4% | 13% |
Confident | 18% | 16% | 20% | 12% | 34% |
Somewhat confident | 47% | 49% | 42% | 60% | 35% |
Not at all confident | 29% | 31% | 33% | 25% | 16% |
Not applicable | 2% | 1% | 2% | 0% | 2% |
Q12. Please rate your confidence at providing each of the following types of information or services related to the zoonotic infectious diseases you encounter as identified in this survey. Note: Results for "Other" practice settings not shown due to small sample size (n=19). Some respondents did not provide their practice setting. |
Sub-groups more confident (NET: very confident/confident) about patient education include:
Confidence rating | Total (n=1,023) | Family / Walk-in / Urgent care / Long term care (n=466) | Hospital (n=263) | Community (n=126) | Public health / Travel (n=139) |
---|---|---|---|---|---|
NET: Very confident / Confident | 22% | 22% | 23% | 9% | 31% |
Very confident | 4% | 5% | 5% | 2% | 5% |
Confident | 17% | 18% | 18% | 7% | 26% |
Somewhat confident | 42% | 43% | 44% | 52% | 27% |
Not at all confident | 31% | 33% | 27% | 33% | 26% |
Not applicable | 5% | 2% | 6% | 6% | 16% |
Q12. Please rate your confidence at providing each of the following types of information or services related to the zoonotic infectious diseases you encounter as identified in this survey. Note: Results for "Other" practice settings not shown due to small sample size (n=19). Some respondents did not provide their practice setting. |
Sub-groups more confident (NET: very confident / confident) about diagnosis include:
Confidence rating | Total (n=1,023) | Family / Walk-in / Urgent care / Long term care (n=466) | Hospital (n=263) | Community (n=126) | Public health / Travel (n=139) |
---|---|---|---|---|---|
NET: Very confident / Confident | 18% | 14% | 16% | 14% | 49% |
Very confident | 5% | 3% | 2% | 2% | 21% |
Confident | 14% | 11% | 14% | 11% | 28% |
Somewhat confident | 37% | 36% | 36% | 48% | 33% |
Not at all confident | 40% | 46% | 42% | 34% | 13% |
Not applicable | 5% | 4% | 7% | 4% | 5% |
Q12. Please rate your confidence at providing each of the following types of information or services related to the zoonotic infectious diseases you encounter as identified in this survey. Note: Results for "Other" practice settings not shown due to small sample size (n=19). Some respondents did not provide their practice setting. |
Sub-groups more confident (NET: very confident / confident) about contact tracing include:
Confidence rating | Total (n=1,023) | Family / Walk-in / Urgent care / Long term care (n=466) | Hospital (n=263) | Community (n=126) | Public health / Travel (n=139) |
---|---|---|---|---|---|
NET: Very confident / Confident | 15% | 15% | 15% | 13% | 18% |
Very confident | 2% | 2% | 3% | 1% | 2% |
Confident | 13% | 13% | 13% | 12% | 16% |
Somewhat confident | 39% | 40% | 39% | 40% | 37% |
Not at all confident | 40% | 43% | 39% | 42% | 27% |
Not applicable | 6% | 2% | 6% | 5% | 19% |
Q12. Please rate your confidence at providing each of the following types of information or services related to the zoonotic infectious diseases you encounter as identified in this survey. Note: Results for "Other" practice settings not shown due to small sample size (n=19). Some respondents did not provide their practice setting. |
Sub-groups more confident (NET: very confident / confident) about patient management include:
All respondents (n=1,023) | Nurses / Nurse practitioners (n=497) | Physicians (n=526) | |
---|---|---|---|
Government of Canada web pages for specific ZIDs | 59% | 64% | 54% |
Provincial and territorial health websites | 53% | 56% | 49% |
Digital clinical support tools (e.g., UpToDate, Medscape) | 52% | 41% | 62% |
Non-Canadian organizational websites (e.g., WHO, CDC) | 46% | 47% | 44% |
Colleague or expert consultation | 44% | 43% | 45% |
Medical academic journals and databases (e.g., NEJM, PubMed) | 25% | 19% | 30% |
Peer-rev. med. websites (e.g., Johns Hopkins, MayoClinic) | 23% | 27% | 20% |
Webinars and conferences and workshops/learning modules | 19% | 19% | 20% |
Advisory committee statements (e.g., CATMAT, NACI) | 18% | 17% | 19% |
Physical clinical support tools (e.g., medical textbooks) | 17% | 14% | 20% |
Canadian health prof. orgs (e.g., AMMI, CASN, CMA) | 14% | 9% | 18% |
Non-Canadian health prof. associations (e.g., AMA) | 9% | 5% | 13% |
Traditional media | 9% | 10% | 7% |
Social media | 5% | 7% | 3% |
Other | 4% | 3% | 4% |
None of the above | 5% | 4% | 5% |
The survey responses demonstrated some differences in terms of the resources that nurses and physicians have used where ZIDs are concerned. While both groups share the same top five resources overall, physicians most often use digital clinical support tools like UpToDate or Medscape (62%), while nurses most often use Government of Canada web pages for specific diseases (64%). Physicians are more likely to use academic journals (30%, compared to 19% of nurses) while nurses are more likely to access medical websites such as those offered by Johns Hopkins and the Mayo Clinic (27%, compared to 20% of physicians).
The qualitative interviews were generally well aligned with the quantitative results here, with some distinctions. UpToDate was the single resource mentioned most often in interviews, particularly among physicians. While most interview participants had some recall of Government of Canada resources, they were more of a secondary consideration after more popular resources like UpToDate and the CDC.
Looking at the top three sources, there were some sub-group differences.
For Government of Canada web pages, the following sub-groups were more likely to indicate they had used them:
Those with 5 years of experience or less are less likely to use Government of Canada web pages (49%) compared to those with more experience.
For provincial and territorial health websites, the following sub-groups were more likely to indicate they had used them:
For digital clinical support tools, including UpToDate, the following sub-groups were more likely to indicate they had used them:
Those in public health or travel settings are less likely to use these tools compared to all other practice settings (33%). Additionally, those who rate their ZID knowledge as limited or no knowledge are also less likely to use these tools (42%) than those with more experience.
Staying current with the latest information about diseases is the most common barrier to caring for ZIDs patients, mentioned by seven in ten health professionals.
From a provided list of possible barriers, a majority of nurses (70%) and physicians (71%) say that staying current with the latest information is a significant barrier to providing ZID care to their patients. The second biggest barrier, selected by 43 percent of nurses and physicians, is that information is not always relevant to their specific context (e.g., specialty, geographic region). Time is also a major barrier, particularly for physicians (37%). Most barriers are named by similar proportions of nurses and physicians; nurses are more likely to say that information is conflicting (nurses 15%, physicians 9%).
This topic was discussed in the qualitative interviews, where participants often explained that medical research and recommendations frequently evolve, and with heavy workloads it is difficult to find time for study and research, which leads them to prioritize the topics that are most pressing in their day-to-day practice. For most, ZIDs are perceived as an infrequent concern for patients, so the topic just does not rise to the top of the priority list.
Most significant information/resource-related barriers | Total (n=1,023) | Nurses/NP (n=497) | Physicians (n=526) |
---|---|---|---|
It is difficult to stay up-to-date on the latest information about a disease | 70% | 70% | 71% |
Information is not relevant to my specific context (e.g., specialty, geographic region) | 43% | 43% | 43% |
It takes too much time to look up specific symptoms for each patient | 32% | 26% | 37% |
It's too difficult to find relevant information | 23% | 22% | 24% |
There aren't enough trusted medical sources for information on zoonotic infectious diseases | 21% | 21% | 22% |
Information changes too frequently | 21% | 23% | 19% |
Information is not easy to access online | 20% | 21% | 20% |
Trusted sources are costly to access | 14% | 16% | 12% |
Available information is conflicting | 12% | 15% | 9% |
Q13. From the following list, select the three most significant information/resource-related barriers when it comes to providing care for patients with zoonotic infectious diseases in your own practice. |
Looking at sub-group differences, there are some distinctions where barriers are concerned:
Clinical manifestations and treatments are the most important ZIDs-related topic for health professionals practicing in Canada.
From a list of topics related to public health and clinical practice, the topic of clinical manifestations is the most important for both nurses (54%) and physicians (61%). For physicians, the second most important is diagnostics (58%), followed by treatment (57%). For nurses, prevention is second (51%), followed by treatment (46%). Differences between groups in terms of the relative importance of these topics is likely related to differences in their respective practice settings, and specific roles at work.
Clinical manifestations also seemed to be a high priority when discussing ZID topics in the qualitative interviews. Several qualitative interview participants felt that more guidance on symptoms and risk factors would help them to overcome their lack of awareness and self-reported confidence about managing most of the diseases on the survey list. They sometimes related recent examples of public health bulletins, posters, and information campaigns around diseases like Lyme disease and mpox. These types of resources were useful at equipping them to answer patient questions and recognize symptoms of these illnesses in patients.
Most important topics in relation to ZIDs | Total (n=1,023) | Nurses/NP (n=497) | Physicians (n=526) |
---|---|---|---|
Clinical manifestations | 57% | 54% | 61% |
Treatment | 52% | 46% | 57% |
Diagnostics | 46% | 33% | 58% |
Prevention | 36% | 51% | 23% |
Incidence in Canada | 33% | 30% | 36% |
Human to human transmission | 22% | 27% | 17% |
Zoonotic (animal to human, including via vector) transmission | 19% | 21% | 18% |
Disease trend | 14% | 14% | 14% |
Risk perception | 7% | 9% | 6% |
Current environmental climate | 6% | 6% | 6% |
Case fatality rate | 3% | 3% | 3% |
Q13B. From the following list, select up to three topics that are most important for you as a Canadian health professional to be informed on in relation to zoonotic infectious diseases? |
Clinical manifestations were mentioned more often by respondents in the follow sub-groups:
Clinical manifestations were mentioned less often by those working in public health and preventative medicine specialties (41%), those with 20 years of experience or more (53%), those working in public health or travel clinic settings (38%), and those with expert or advanced ZID knowledge (45%). This may reflect different roles within health care, with these types of health professionals less likely to see patients who are initially presenting with symptoms.
Treatment was mentioned more often by those in the following sub-groups:
Treatment was mentioned less often by those working in public health and preventative medicine (32%), those working in community settings (36%) and public health or travel clinic settings (32%), and those who never encounter ZIDs in patients (41%).
Diagnostics were mentioned as a priority topic more often by those in the following sub-groups:
Diagnostics were mentioned less often by those working in public health and preventative medicine (24%) and public health or travel clinic settings (17%).
Prevention was mentioned as a priority topic more often by those in the following sub-groups:
Prevention was mentioned less often by those working in family practices, walk-in clinics, urgent, or long-term care settings (27%), and those who see ZIDs monthly (27%).
Sub-groups were fairly uniform where incidence in Canada is concerned, with a couple of exceptions where interest was lower:
Human-to-human transmission was selected more often by:
Human-to-human transmission was selected less often as a priority topic by those working in family practices, walk-in clinics, urgent, or long-term care settings (15%).
Zoonotic transmission was statistically uniform across sub-groups.
Interest in disease trend was similar across most sub-groups except:
Risk perception is also relatively unvarying, but higher for those working in public health or travel clinic settings (16%).
Interest in current environmental climate and case fatality rate were similarly low across all sub-groups.
Almost all health professionals are at least somewhat interested in receiving more professional education on ZIDs.
Although the two groups differ in their background education on ZIDs, their experience with ZIDs in practice, and the resources they access to learn about ZIDs, nurses and physicians are equally interested in receiving additional education about ZIDs. About four in ten health professionals say they are very interested (nurses 38%, physicians 38%), and just over half say they are somewhat interested (nurses 56%, physicians 55%).
In the qualitative interviews, participants frequently said they wished they knew more about ZIDs or regretted not learning about them during their training, while readily admitting that it was difficult to find time to make this topic a priority. This duality of high interest, but lack of time, underscores the importance of accessible resources that meet health professionals where they are.
Interest in receiving more ZIDs professional education | Total (n=1,023) | Nurses/NP (n=497) | Physicians (n=526) |
---|---|---|---|
NET: Very/somewhat interested | 93% | 94% | 92% |
Very interested | 38% | 38% | 38% |
Somewhat interested | 55% | 56% | 55% |
Not interested | 7% | 6% | 8% |
Q14. How interested are you in receiving additional professional education on zoonotic infectious diseases? |
Net interest was high across most sub-groups, but looking specifically at those who said they were very interested, there are some groups who are particularly keen to learn more:
Some groups were less likely to be very interested:
Health professionals rank treatment, prevention, and diagnosis as the topics they would most like to learn about.
In an open-ended question to those interested in ZID education (n=947) about which specific topics they would like to learn about, the top topic overall is treatment (48%) followed by prevention (40%), however, nurses and physicians were different somewhat in their top choices. For physicians, treatment is the top topic (48%) followed by diagnosis (38%). For nurses, prevention comes out on top (53%) followed by treatment (47%). This likely reflects differing roles in patient care, as well as practice setting, between these two groups.
ZIDs Topics of Interest | Interested in receiving ZIDs education (n=947) | Family / Walk-in / Urgent care / Long term care (n=440) | Hospital (n=236) | Community (n=117) | Public health / Travel (n=129) |
---|---|---|---|---|---|
Treatment and management (NET) | 50% | 52% | 56% | 43% | 36% |
Prevention | 40% | 32% | 37% | 54% | 54% |
Epidemiology (NET) | 33% | 34% | 34% | 26% | 39% |
Diagnosis (NET) | 30% | 35% | 34% | 23% | 13% |
Clinical manifestations | 15% | 15% | 16% | 20% | 4% |
Interest in specific diseases | 6% | 5% | 7% | 7% | 7% |
Transmission (NET) | 5% | 4% | 5% | 12% | 8% |
Assessment/Risk Assessment | 5% | 4% | 5% | 6% | 8% |
Resources/information/updates | 5% | 5% | 5% | 4% | 3% |
Risk Perception | 5% | 6% | 4% | 6% | 2% |
Q15. If you were to learn more about zoonotic infectious diseases, what would you be interested in learning about? Note: Results for "Other" practice settings not shown due to small sample size (n=18). Some respondents did not provide their practice setting. |
Focusing on the top four topics mentioned most often by respondents, there are some notable differences between sub-groups:
Topics related to treatment and management are mentioned more often by:
Topics related to treatment and management are mentioned less often by:
Prevention is mentioned more often as a topic of interest to:
Prevention is mentioned less often as a topic of interest to:
Epidemiology topics are mentioned by similar proportions across all sub-groups of interest.
Diagnosis as a topic is of higher interest to:
Diagnosis as a topic is mentioned less by:
Self-directed online learning, interactive online courses, webinars and fact sheets are the top formats preferred by health professionals for additional ZID education.
Health professionals were shown a list of possible formats for additional professional education and resources on ZIDs and asked which they prefer. Self-directed online learning (54%) and interactive online courses (54%) are mentioned by a majority of health professionals, followed closely by webinars (47%) and fact sheets (45%). Online learning options and fact sheets were also highly preferred by participants in the qualitative interviews.
Preferred formats for additional ZIDs professional education and resources | Total (n=1,023) | Family / Walk-in / Urgent care / LTC (n=466) | Hospital (n=263) | Community (n=126) | Public health / Travel (n=139) |
---|---|---|---|---|---|
Self-directed learning online | 54% | 49% | 55% | 63% | 66% |
Interactive online courses | 54% | 47% | 58% | 64% | 64% |
Webinars | 47% | 41% | 47% | 56% | 63% |
Fact sheets | 45% | 40% | 42% | 54% | 65% |
Decisional algorithms | 38% | 37% | 36% | 43% | 32% |
Continued Medical Education programs in Canada | 35% | 42% | 35% | 30% | 20% |
Lecture based online courses | 31% | 31% | 27% | 36% | 36% |
Advisory pubs., e.g. Committee to Advise on Tropical Medicine and Travel (CATMAT) or CDC recs. | 30% | 30% | 28% | 32% | 39% |
Mobile applications (apps) | 30% | 29% | 36% | 25% | 22% |
Conferences | 30% | 33% | 24% | 35% | 29% |
Toolkits | 22% | 23% | 14% | 28% | 29% |
Workshop sessions | 19% | 15% | 23% | 18% | 31% |
Infographics | 17% | 16% | 17% | 13% | 27% |
Evidence briefs | 17% | 14% | 19% | 21% | 18% |
Interactive classroom courses | 12% | 14% | 12% | 10% | 12% |
Lecture based classroom courses | 9% | 11% | 8% | 6% | 6% |
Self-directed learning with physical resources (e.g., textbooks) | 8% | 7% | 10% | 8% | 9% |
Onsite educational outreach | 6% | 7% | 4% | 7% | 9% |
Postgraduate courses | 4% | 4% | 2% | 4% | 5% |
Other | <1% | <1% | 1% | <1% | 1% |
Q16. If you were to receive additional professional education and resources on zoonotic infectious diseases, in which formats would you prefer to receive the information? Note: Results for "Other" practice settings not shown due to small sample size (n=18). Some respondents did not provide their practice setting. |
In general, across sub-groups, the top four formats are highly ranked, though some sub-groups are more likely to prefer certain formats than others:
Self-directed learning online is preferred more by:
Self-directed online learning was preferred less by:
Interactive online courses are preferred less by:
Webinars are preferred more by:
Webinars are preferred less by:
Fact sheets are preferred more by:
Fact sheets are preferred less by:
Overall, 42% of the variance in self-reported confidence (for all diseases) is explained by the independent variables included in the Shapley Value Regression analysis.
A multivariate analysis, using Shapley Value Regression, was conducted to better understand the key drivers of self-reported confidence in managing zoonotic infectious diseases overall. In addition to data from the survey, external data provided by PHAC was included in the analysis. Details on how this external data was coded for analysis are included in Appendix I. The analysis was conducted using tools created in R, a free software environment for statistical computing and graphics.
The Shapley Value Regression is an analysis that quantifies the relative impact of each independent variable in a linear regression. This type of analytical technique is used to resolve a common weakness of linear regression for explanatory purpose, which is that it is not reliable when independent predictors are moderately to highly correlated (as is the case, for example, with encountering a disease and confidence in managing it).
The Shapley Value Regression consists of running multiple regression models with all possible combinations of independent variables being included or excluded out of the model, and then averaging the standardized beta scores of each independent variable across the models on which it is included. This computationally expansive technique then allows for a relative comparison across the independent variables, all while moderating the concern of multicollinearity.
This analysis was run across the 52 ZIDs listed in the survey as one "block" of data. The output of the analysis includes two main components:
The analysis included the following variables:
Dependent variables: Self-rated confidence in managing each disease (Q10B series)
Independent variables from Survey:
Independent variables based on Criteria provided by PHAC (see Appendix F):
Looking at the overall key drivers of confidence for all 52 diseases in the survey, the results from this analysis show that these variables have an adjusted R-squared value of 0.42, indicating that 42% of the variance in confidence (across all diseases) is explained by the independent variables included in the analysis.
The relative share of impact for the dependent variables shows that above all else, encountering a disease in practice is the most important driver of self-reported confidence in managing that disease, with a 68% share of impact. The second biggest driver is self-reported knowledge of ZIDs in general, at 12%. Years of practice internationally and the level of risk related to the ZIDs as perceived by the general public in Canada are tied for third place with a 3% share of impact. All other variables account for 2% or less each.
Variable | Share of impact (%) |
---|---|
Encountered disease (Survey Q10A) | 68% |
Self-reported knowledge of zoonotic infectious diseases (Survey Q6) | 12% |
Years of practice internationally (Q17C) | 3% |
Risk perception (External data) | 3% |
Infectious disease specialty / practice area (Q4) | 2% |
Mode of transmission: animal-to-human (External data) | 2% |
Incidence (External data) | 2% |
Satisfaction with education received during formal healthcare training (Q7) | 1% |
Province or territory (Q1B) | 1% |
Profession type (Q2) | 1% |
Preventability (External data) | 1% |
Treatability (External data) | 1% |
Severity of illness (External data) | 1% |
All other independent variables from external data | 1% |
All other independent variables from survey | 1% |
At the disease level, encountering disease is still the most important driver of self-reported confidence for most diseases. For Lyme disease, self-reported knowledge is a bigger driver than encountering the disease.
A simplified Shapley Value Regression analysis was conducted at the individual disease level to identify key drivers of self-reported confidence in managing specific diseases. Because this analysis was conducted at the individual disease level rather than comparing across all diseases, the disease-specific external data was not applicable.
Dependent Variables: Self-rated confidence in managing each disease (Q10B series)
Independent Variables from Survey:
The adjusted R-squared values for all 52 diseases ranged from 21% (Plague) to 54% (Q Fever), with a mean of 36%. Complete results for all 52 diseases are provided in Appendix I. Results for the top five diseases (i.e. those encountered most often in Q10A) are shown below.
Lyme disease | West Nile virus | Rabies | Toxoplasmosis | H5N1 | |
---|---|---|---|---|---|
Adjusted R-squared | 32% | 39% | 32% | 36% | 43% |
Variable share of impact | Lyme disease | West Nile virus | Rabies | Toxoplasmosis | H5N1 |
---|---|---|---|---|---|
Encountered disease (Survey Q10A) | 24% | 56% | 49% | 51% | 76% |
Self-reported knowledge of zoonotic infectious diseases (Survey Q6) | 32% | 20% | 18% | 22% | 10% |
Region (Q1B) | 11% | 6% | 3% | 4% | 1% |
Profession (Q2) | 6% | 0% | 1% | 5% | 0% |
Family medicine specialty / practice area (Q4) | 2% | 0% | 0% | 0% | 0% |
Satisfaction with education (Q7) | 3% | 2% | 2% | 2% | 1% |
Community health specialty / practice area (Q4) | 2% | 1% | 1% | 1% | 0% |
Family medicine practice setting (Q22) | 2% | 1% | 1% | 0% | 0% |
Years of practice (Q17A) | 2% | 0% | 1% | 0% | 0% |
Years of practice internationally (Q17C) | 2% | 0% | 2% | 4% | 0% |
Infectious disease specialty / practice area (Q4) | 1% | 3% | 1% | 1% | 2% |
Public health and preventive medicine specialty / practice area (Q4) | 1% | 1% | 4% | 1% | 0% |
Obstetrics/Gynecology specialty / practice area (Q4) | 1% | 2% | 1% | 0% | 0% |
Emergency medicine/critical care specialty / practice area (Q4) | 1% | 1% | 3% | 0% | 3% |
Internal medicine specialty / practice area (Q4) | 1% | 1% | 2% | 0% | 0% |
Surgery specialty / practice area (Q4) | 1% | 0% | 1% | 0% | 0% |
Hospital practice setting (Q22) | 1% | 1% | 0% | 2% | 2% |
Community health centre practice setting (Q22) | 1% | 0% | 0% | 0% | 0% |
Public health clinic practice setting (Q22) | 1% | 1% | 5% | 0% | 0% |
Variable share of impact | Lyme disease | West Nile virus | Rabies | Toxoplasmosis | H5N1 |
---|---|---|---|---|---|
Confidence in patient assessment (Q12) | 0% | 0% | 0% | 0% | 0% |
Confidence in diagnosis (Q12) | 0% | 0% | 0% | 0% | 0% |
Confidence in infection prevention and control measures (Q12) | 0% | 1% | 2% | 0% | 0% |
Confidence in patient management (Q12) | 0% | 0% | 0% | 0% | 0% |
Confidence in patient education (Q12) | 0% | 0% | 0% | 0% | 0% |
Confidence in contact tracing (Q12) | 0% | 0% | 0% | 0% | 0% |
Confidence in public health reporting (Q12) | 0% | 0% | 0% | 0% | 1% |
Urban vs Rural setting | 0% | 1% | 0% | 0% | 0% |
Pediatrics specialty / practice area (Q4) | 0% | 0% | 0% | 0% | 0% |
Walk-in clinic or urgent care practice setting (Q22) | 0% | 0% | 0% | 0% | 0% |
Specialized travel health centre/clinic practice setting (Q22) | 0% | 0% | 0% | 0% | 0% |
Long-term care residence practice setting (Q22) | 0% | 0% | 0% | 0% | 0% |
Northern experience (Q1B and Q20) | 0% | 0% | 1% | 1% | 0% |
Indigenous experience (Q26) | 0% | 1% | 1% | 2% | 0% |
Lyme disease
As discussed previously, Lyme disease is the disease encountered most often and with the highest self-rated confidence ratings. In this analysis, its below-average adjusted R-squared value of 32% indicates that variance in confidence is less influenced by the independent variables in the model, than it is for most other diseases. This means there are other factors influencing confidence that are not accounted for in this set of independent variables.
Looking at the share of impact for the independent variables, Lyme disease is the only of the top five (and in fact, one of only three) diseases from the full list of 52 where self-reported knowledge has a higher share of impact than encountering the disease. Lyme disease is the disease most influenced by region (11%), with health professionals in eastern provinces where the disease is more prevalent8 (i.e. Ontario, Quebec, Atlantic) showing higher levels of confidence about the disease. Confidence in managing Lyme disease is also influenced by being a physician (6%) and working in family medicine (5%); this lines up with other findings from the quantitative and qualitative research indicating that family physicians field many patient inquiries about this disease.
Confidence in managing Lyme disease may be increased by other factors not measured in the survey such as exposure to general information about the diseases, discussion with colleagues, and questions from patients. Based on what was heard during the qualitative interviews, information specific to Lyme disease accounts for a large proportion of the information health professionals receive about ZIDs from public health bulletins, continuing education opportunities, and patient cases and queries. This means that relative to the other diseases, health professionals are more likely to be educated about Lyme disease even if they have not encountered it with a patient, and this likely makes them feel more confident about managing it.
West Nile virus infection
The adjusted R-squared value for West Nile virus is above average at 39%, meaning the variables in the regression account for more of the variance in confidence, compared to most other diseases in the survey list. Encountering the disease has an above-average share of impact of 56%, with self-reported knowledge close to the average at 20%. Region also has a notable influence at 6%.
Findings from the qualitative research suggest that health professionals do not usually look for West Nile virus (or any other specific diseases) in patients with mild flu-like symptoms. Though they do receive public health bulletins about its presence in the community, they do not receive much information about managing patients with the virus unless they have a seriously ill patient who tests positive. The share of impact results also suggest that while knowledge plays a role in confidence, encounters with the disease is a stronger element.
Rabies
Over one in three survey respondents say they have encountered rabies in practice, and it is the disease with the second highest self-reported confidence rating, after Lyme disease. Similar to Lyme disease, its low adjusted R-squared value of 32% indicates that variance in confidence is less influenced by the independent variables in the model.
Unlike Lyme, however, encountering the disease has a higher share of impact at 49%, with self-reported knowledge at 18%. This means that encountering the disease is a stronger influence on confidence in managing rabies, than self-reported knowledge. These values are close to the average across all 52 diseases. Working in a public health setting (5%) or having public health as a specialty (4%) are also notably important for rabies in comparison with other diseases. Having an emergency medicine specialty also has a notable influence at 3%.
In the qualitative research, health professionals with rabies experience typically gained it as a matter of course while working with a patient base at risk for the disease, but also received bulletins about rabies and had access to public health resources when needed.
Toxoplasmosis
The adjusted R-squared value for toxoplasmosis is 36%, which is about average among the 52 diseases from the survey. Encountering toxoplasmosis has a share of impact at 51%, and self-reported knowledge at 22%; these values are also close to average for the 52 survey diseases. Other variables that have a notable influence on confidence in managing this disease are profession (5%), region (4%), and years of practice internationally (4%).
Relative to most diseases in the list, toxoplasmosis was mentioned somewhat often by participants in the qualitative interviews, who usually noted it as a disease of concern for pregnant patients. Knowledge beyond simple awareness of the disease and the risk profile seemed to be limited.
Avian influenza A(H5N1)
The adjusted R-squared value for avian influenza A(H5N1) is 43%, which is quite high relative to most diseases in the survey. Encountering the disease has a very high share of impact at 76%, while the share for self-reported knowledge is 10% and having an emergency medicine specialty is also notable at 3%. This suggests that encountering avian influenza A(H5N1) in practice is an even more important component in self-reported confidence for this disease than it is for most of the others.
Respondents were segmented into four broad groups based on the diseases they encountered; the analysis shows four distinct groups of health professionals with different degrees of ZID experience and expertise closely linked to practice setting.
Assigning the segments
A segmentation analysis was applied to all respondents in the study, based on K-Means analysis of diseases encountered; data for all 52 diseases was included in the segmentation. This analysis looks at similarities between respondents based on the inputs used (in this case, diseases encountered) and groups similar respondents into discrete categories (i.e., segments or clusters).
Segmentation can be applied using any variables in a dataset; often segmentation is done using demographic variables, to group respondents with shared characteristics. For this analysis, segmentation was applied using the diseases encountered variables, for several reasons:
For this analysis, four different solutions, arriving at three to six clusters, were initially analyzed to determine which solution was most useful for the study objectives. After comparing the different cluster solutions, by looking at the profile of respondents in each cluster including their demographics, practice setting, specialization, and experience, the four-cluster solution was selected for discussion in the report, illustrated below. Complete results for the four clusters are provided under separate cover with the banner tables for the study.
As a starting point to understand the clusters, the table below shows the proportion of respondents in each cluster who had encountered a selection of key diseases from the list. Looking at the proportions within each cluster who had encountered these diseases, the four clusters have some different characteristics:
Cluster 1 | Cluster 2 | Cluster 3 | Cluster 4 | Total | |
---|---|---|---|---|---|
Cluster size (unweighted N) | N=76 | N=227 | N=499 | N=221 | N = 1,023 |
% encountered any disease | 100% | 100% | 88% | 100% | 94% |
Mean # diseases encountered | 24.5 | 9.9 | 2.6 | 6.3 | 6.5 |
Lyme disease | 100% | 95% | 65% | 94% | 80% |
West Nile Virus | 90% | 54% | 1% | 96% | 38% |
Rabies | 75% | 62% | 20% | 41% | 37% |
MERS-CoV | 47% | 69% | 18% | 7% | 29% |
Bartonellosis | 77% | 34% | 18% | 33% | 29% |
Bovine tuberculosis | 46% | 16% | 4% | 6% | 10% |
Chagas disease | 51% | 6% | 1% | 2% | 6% |
Crimean Congo hemorrhagic fever | 13% | 2% | 0% | 1% | 1% |
Q10a/b. In the following grid, please indicate which diseases you have encountered in your practice, AND rate your level of confidence in managing each zoonotic infectious disease |
The next table shows the mean self-reported confidence for the same set of diseases, by cluster. Cluster 1 exhibits significantly higher levels of confidence for each disease, while cluster 3 has lower confidence across the board. Cluster 2 has notably higher confidence about some specific diseases, while cluster 4 is specifically more confident about West Nile virus.
Cluster 1 | Cluster 2 | Cluster 3 | Cluster 4 | Total | |
---|---|---|---|---|---|
Cluster size (unweighted N) | N=76 | N=227 | N=499 | N=221 | N = 1,023 |
Mean confidence (all diseases) | 2.04 | 1.35 | 1.20 | 1.28 | 1.31 |
Lyme disease | 2.89 | 2.32 | 2.03 | 2.27 | 2.20 |
West Nile virus | 2.53 | 1.80 | 1.31 | 1.94 | 1.63 |
Rabies | 2.54 | 2.17 | 1.78 | 1.98 | 1.96 |
MERS-CoV | 2.30 | 2.10 | 1.48 | 1.43 | 1.66 |
Bartonellosis | 2.44 | 1.53 | 1.40 | 1.50 | 1.52 |
Bovine tuberculosis | 2.07 | 1.31 | 1.17 | 1.20 | 1.27 |
Chagas disease | 2.02 | 1.15 | 1.13 | 1.13 | 1.20 |
Crimean Congo hemorrhagic fever | 1.52 | 1.07 | 1.04 | 1.08 | 1.09 |
Q10a/b. In the following grid, please indicate which diseases you have encountered in your practice, AND rate your level of confidence in managing each zoonotic infectious disease |
The diseases encountered by each cluster are discussed in more detail in the later section on Principal Components (PCA) factor analysis.
Practice settings by cluster
Looking at results by practice setting highlights some key differences between the clusters.
Cluster 1 | Cluster 2 | Cluster 3 | Cluster 4 | Total | |
---|---|---|---|---|---|
Cluster size (unweighted N) | N=76 | N=227 | N=499 | N=221 | N = 1,023 |
Family practice / walk-in / urgent / LTC | 37% | 44% | 51% | 39% | 46% |
Hospital | 44% | 32% | 19% | 30% | 26% |
Community | 8% | 7% | 18% | 7% | 11% |
Public health / Travel | 11% | 13% | 7% | 18% | 11% |
Other | 0% | 2% | <1% | 2% | 1% |
Q22. What type of setting describes your Practice setting? |
Experience and knowledge
Looking at overall experience with ZIDs, self-rated knowledge, and satisfaction with education, the segments differ again. Cluster 1 members see ZIDs in practice often, with more than half seeing them daily or weekly. They rate themselves to be very knowledgeable about ZIDs, and are highly satisfied with the education they have received about this subject matter. The other clusters are generally similar to the total average for these characteristics, except that cluster 3 has a higher proportion who never encounter ZIDs in patients, despite indicating that they are part of their practice, and are less likely to rate their knowledge as advanced or expert.
Cluster 1 | Cluster 2 | Cluster 3 | Cluster 4 | Total | |
---|---|---|---|---|---|
Cluster size (unweighted N) | N=76 | N=227 | N=499 | N=221 | N = 1,023 |
% encounter ZIDs daily or weekly | 51% | 13% | 7% | 8% | 12% |
% encounter ZIDs never | 2% | 11% | 18% | 8% | 13% |
% expert or advanced knowledge | 59% | 10% | 5% | 12% | 11% |
% satisfied with formal ZIDs education* | 61% | 38% | 44% | 39% | 43% |
% satisfied with continuing education on ZIDs | 64% | 43% | 45% | 48% | 47% |
% encountered any disease from list | 100% | 100% | 88% | 100% | 94% |
Mean confidence (all diseases in list) | 2.04 | 1.35 | 1.20 | 1.28 | 1.31 |
*Excludes those who said they did not receive such education. |
Self-rated confidence in ZID management
The segments also differ by their confidence in providing various types of information or services related to ZIDs, with cluster 1 notably more confident and cluster 3 less confident than other segments.
NET: Very/somewhat confident in providing ZID information or services | Cluster 1 | Cluster 2 | Cluster 3 | Cluster 4 | Total |
---|---|---|---|---|---|
Cluster size (unweighted N) | N=76 | N=227 | N=499 | N=221 | N = 1,023 |
Public health reporting | 57% | 41% | 34% | 45% | 40% |
Infection prevention and control measures | 50% | 32% | 20% | 38% | 29% |
Patient assessment | 60% | 30% | 19% | 28% | 26% |
Patient education | 54% | 24% | 14% | 30% | 22% |
Diagnosis | 55% | 24% | 15% | 24% | 22% |
Contact tracing | 37% | 24% | 11% | 23% | 18% |
Patient management | 46% | 15% | 12% | 15% | 15% |
Q12. Please rate your confidence at providing each of the following types of information or services related to the zoonotic infectious diseases you encounter as identified in this survey. |
Other characteristics of segments
The segments also show some differences in demographic and experience characteristics.
Cluster 1 | Cluster 2 | Cluster 3 | Cluster 4 | Total | |
---|---|---|---|---|---|
Cluster size (unweighted N) | N=76 | N=227 | N=499 | N=221 | N = 1,023 |
% Nurse / Nurse practitioner | 15% | 50% | 51% | 51% | 49% |
% Physician | 85% | 50% | 49% | 49% | 51% |
Mean years practicing | 24.05 | 19.83 | 19.51 | 21.70 | 20.32 |
% with experience outside Canada | 44% | 21% | 17% | 21% | 21% |
% with urban primary practice | 94% | 87% | 80% | 84% | 83% |
Indigenous experience | 35% | 20% | 18% | 19% | 20% |
Summary of segment characteristics
Cluster 1 contains health professionals who have a high degree of ZID expertise relative to other health professionals. They are experienced with a wide range of ZIDs including those that are rarely encountered by most, knowledgeable about the subject overall, and confident about their ability to manage these diseases when they come up in practice, even when the disease is very rare. Most, but not all, are physicians in urban settings.
Cluster 2 comprises health professionals with a solid working knowledge of some ZIDs. In many ways they are average, in terms of their responses to survey questions, but they have experience with some specific diseases, particularly respiratory diseases associated with livestock and wildlife, and the hantavirus diseases. This is discussed in more detail in the following section describing results from the PCA factor analysis.
Health professionals in cluster 3 are less experienced with ZIDs, and have lower self-reported confidence about managing them. They are more likely to work in family practices and community care, sometimes in rural settings, where they may rarely or never see ZIDs in patients. This cluster also contains health professionals with fewer years of experience on average, so they may not have had exposure to a broad range of patient cases at this stage in their career.
Overall, cluster 4 is similar to cluster 2, with differences in the diseases they have encountered. They tend to work in settings where they are likely to encounter patients with suspected or confirmed cases of ZIDs that require management. Directionally, they are more likely to work in a public health or hospital setting, and are somewhat more confident about public health reporting and infection control.
Information sources and barriers
Respondents in cluster 1 are more likely to report using provincial or territorial websites, non-Canadian sites (e.g. WHO or CDC), medical journals, advisory committee statements, and Canadian health professional organizations. Directionally, their information barriers look somewhat different than other clusters; they are most likely to say there aren't enough trusted medical sources for information on ZIDs, that information changes too frequently, it's not easy to access online, trusted sources are costly to access, or that available information is conflicting. Since this group generally has more expertise about ZIDs, they are likely more familiar with a range of resources and have more to critique.
Cluster 2 is similar to the average in terms of the information sources they recall using for ZIDs. When it comes to barriers, cluster 2 respondents say they find it more difficult to stay up to date, and that looking up symptoms for each patient is time-consuming. This is in keeping with other cluster characteristics since cluster 2 largely comprises nurses and physicians in busy, front-line settings where they see ZIDs on an occasional basis, meaning that they do not prioritize learning about the topic.
Compared to the other clusters, those in cluster 3 are significantly or directionally less likely to use any of the listed resources (except for traditional media). Cluster 3 is the least experienced and engaged with ZIDs overall, so it follows that their use of resources is more limited. Where barriers to information are concerned, cluster 3 is similar to the average, perhaps reflecting a lack of specific experience with the topic in general.
Cluster 4 is directionally above average for their use of most resources. Where barriers are concerned, they are more likely to find that it takes too much time to look up symptoms for each patient, but less likely to have difficulty finding relevant information. While not as well-versed in ZIDs as cluster 1, cluster 4 does exhibit a degree of ZIDs experience and expertise in a public health context, which likely influences them to use resources somewhat more frequently (compared to clusters 2 and 3) and leads them to have more specific critiques of the information resources they use.
ZID resources used | Cluster 1 | Cluster 2 | Cluster 3 | Cluster 4 | Total |
---|---|---|---|---|---|
Cluster size (unweighted N) | N=76 | N=227 | N=499 | N=221 | N = 1,023 |
Government of Canada (canada.ca) web pages for specific ZIDs | 75% | 64% | 51% | 68% | 59% |
Provincial and territorial health websites | 67% | 53% | 48% | 59% | 53% |
Digital clinical support tools (e.g., UpToDate, Medscape, etc.) | 56% | 56% | 48% | 56% | 52% |
Non-Canadian organizational websites (e.g., WHO, CDC) | 61% | 47% | 41% | 49% | 46% |
Colleague or expert consultation | 55% | 46% | 39% | 50% | 44% |
Medical academic journals and databases (e.g., NEJM, PubMed) | 60% | 30% | 18% | 25% | 25% |
Peer-reviewed medical websites (e.g., Johns Hopkins, MayoClinic) | 34% | 23% | 19% | 31% | 23% |
Webinars and conferences and workshops/learning modules | 31% | 19% | 15% | 26% | 19% |
Advisory committee statements (e.g., CATMAT, NACI) | 39% | 16% | 13% | 26% | 18% |
Physical clinical support tools (e.g., medical textbooks) | 29% | 17% | 15% | 21% | 17% |
Canadian health professional organizations (e.g., AMMI, CASN, CMA) | 38% | 13% | 9% | 17% | 14% |
Non-Canadian health professional associations (e.g., AMA) | 17% | 10% | 6% | 12% | 9% |
Traditional media | 10% | 4% | 10% | 10% | 9% |
Social media | 8% | 6% | 4% | 6% | 5% |
Other | 9% | 4% | 4% | 1% | 4% |
None of the above | 3% | 2% | 6% | 4% | 5% |
Q9. Please indicate if you have used any of the following resources to inform your practice regarding zoonotic infectious diseases. |
Barriers to resources | Cluster 1 | Cluster 2 | Cluster 3 | Cluster 4 | Total |
---|---|---|---|---|---|
Cluster size (unweighted N) | N=76 | N=227 | N=499 | N=221 | N = 1,023 |
It is difficult to stay up-to-date on the latest information about a disease | 56% | 77% | 69% | 72% | 70% |
Information is not relevant to my specific context (e.g., specialty, geographic region) | 32% | 40% | 45% | 44% | 43% |
It takes too much time to look up specific symptoms for each patient | 25% | 38% | 28% | 37% | 32% |
It's too difficult to find relevant information | 27% | 26% | 25% | 14% | 23% |
There aren't enough trusted medical sources for information on zoonotic infectious diseases | 28% | 22% | 20% | 21% | 21% |
Information changes too frequently | 24% | 21% | 18% | 26% | 21% |
Information is not easy to access online | 20% | 17% | 21% | 23% | 20% |
Trusted sources are costly to access | 20% | 14% | 13% | 15% | 14% |
Available information is conflicting | 16% | 11% | 12% | 11% | 12% |
Other | 10% | 5% | 8% | 4% | 6% |
Q13. From the following list, select the three most significant information/resource-related barriers when it comes to providing care for patients with zoonotic infectious diseases in your own practice. |
Interest in receiving professional education and topics of interest
Where information and education are concerned, cluster 1 is most likely to be very interested in receiving additional professional education. This aligns with other findings that suggest health professionals prioritize topics that are relevant to their practice.
The segments are similar in their specific topics of interest, except that cluster 3 is more interested in prevention and clinical manifestations. This likely relates to their practice settings (see Table 22 above), where they may be counselling patients on risks rather than identifying active disease.
There were few notable differences between segments as far as preferred formats were concerned. Cluster 1 members were far more interested in CMEs, advisory publications, evidence briefs, and interactive classroom courses compared to the other clusters. This points to a more academic style of learning as far as ZIDs are concerned, that is in line with the general composition of the cluster; that is to say, these health professionals encounter ZIDs regularly, and are thus more likely to devote time to learning about them in depth.
Interest in receiving more ZIDs professional education | Cluster 1 | Cluster 2 | Cluster 3 | Cluster 4 | Total |
---|---|---|---|---|---|
Cluster size (unweighted N) | N=76 | N=227 | N=499 | N=221 | N = 1,023 |
NET: Very/somewhat interested | 96% | 94% | 93% | 92% | 93% |
Very interested | 65% | 41% | 33% | 39% | 38% |
Somewhat interested | 31% | 53% | 60% | 54% | 55% |
Not interested | 4% | 6% | 7% | 8% | 7% |
Q14. How interested are you in receiving additional professional education on zoonotic infectious diseases? |
Interest in receiving more ZIDs professional education | Cluster 1 | Cluster 2 | Cluster 3 | Cluster 4 | Total (Interested in additional education) |
---|---|---|---|---|---|
Cluster size (unweighted N) | N=74 | N=213 | N=458 | N=202 | N = 947 |
Treatment | 55% | 50% | 45% | 47% | 48% |
Prevention | 26% | 37% | 45% | 35% | 40% |
Diagnosis | 30% | 32% | 28% | 35% | 30% |
Outbreaks | 25% | 25% | 23% | 27% | 25% |
Clinical manifestations | 8% | 12% | 18% | 11% | 15% |
Q15. If you were to learn more about zoonotic infectious diseases, what would you be interested in learning about? |
Interest in receiving more ZIDs professional education | Cluster 1 | Cluster 2 | Cluster 3 | Cluster 4 | Total |
---|---|---|---|---|---|
Cluster size (unweighted N) | N=76 | N=227 | N=499 | N=221 | N = 1,023 |
Self-directed learning online | 48% | 56% | 53% | 56% | 54% |
Interactive online courses | 60% | 52% | 52% | 59% | 54% |
Webinars | 42% | 45% | 47% | 52% | 47% |
Fact sheets | 36% | 45% | 44% | 51% | 45% |
Decisional algorithms | 38% | 30% | 39% | 43% | 38% |
Continued Medical Education programs in Canada | 58% | 31% | 32% | 40% | 35% |
Lecture based online courses | 23% | 27% | 32% | 34% | 31% |
Advisory publications such as CATMAT or CDC recommendations | 44% | 27% | 27% | 37% | 30% |
Mobile applications (apps) | 27% | 37% | 27% | 31% | 30% |
Conferences | 33% | 27% | 30% | 32% | 30% |
Toolkits | 22% | 19% | 23% | 24% | 22% |
Workshop sessions | 19% | 21% | 15% | 24% | 19% |
Infographics | 18% | 21% | 16% | 17% | 17% |
Evidence briefs | 29% | 16% | 15% | 18% | 17% |
Interactive classroom courses | 23% | 10% | 11% | 14% | 12% |
Lecture based classroom courses | 18% | 7% | 9% | 7% | 9% |
Self-directed learning with physical resources (e.g., textbooks) | 8% | 7% | 8% | 10% | 8% |
Onsite educational outreach | 13% | 7% | 5% | 5% | 6% |
Postgraduate courses | 6% | 3% | 4% | 3% | 4% |
Other | 3% | <1% | <1% | <1% | <1% |
Q16. If you were to receive additional professional education and resources on zoonotic infectious diseases, in which formats would you prefer to receive the information? |
Applying the cluster analysis to communication
Cluster analysis groups respondents who are similar to each other in the way they respond to survey questions. The cluster analysis shows that some clusters are associated with certain types of professionals, areas of specialty, and practice settings. Looking at the composition of other sub-groups by cluster can therefore be useful for application.
Shown below are clusters by practice setting. For family practice and community settings, a majority of health professionals land in cluster 3; knowing that cluster 3 is less experienced with ZIDs and not likely to prioritize learning about them, resources directed to these settings should be developed with these characteristics in mind. While this cluster reports high interest in all of the top four resource formats in question 16, resources they can access quickly, like fact sheets, or education that requires little commitment, like short webinars, will likely be more effective than longer courses.
In hospital and public health settings, there is a higher concentration of cluster 2 and cluster 4 health professionals than in other settings. Therefore, these are the best settings to prioritize for communication towards cluster 2 and cluster 4 with more strategic resources that suit their relatively higher levels of expertise with ZIDs.
Cluster 1 is most prevalent in hospitals. Understanding that these health professionals are primarily physicians and they have more experience with ZIDs than other clusters, CMEs, academic resources and detailed clinical information about rarer diseases will find more of an audience in the hospital setting, particularly if it is aimed at those with specialties and practice areas that are more engaged with ZIDs patients. It cannot be understated, however, that cluster 1 also had the same general preference for the top four information formats as all other clusters.
Clusters | Total (n=1,023) | Family / Walk-in / Urgent care / LTC (n=466) | Hospital (n=263) | Community (n=126) | Public health / Travel (n=139) |
---|---|---|---|---|---|
Cluster 1 | 7% | 6% | 12% | 4% | 7% |
Cluster 2 | 22% | 21% | 27% | 11% | 27% |
Cluster 3 | 51% | 57% | 38% | 69% | 33% |
Cluster 4 | 20% | 17% | 23% | 16% | 32% |
Note: Results for "Other" practice settings not shown due to small sample size (n=19). Some respondents did not provide their practice setting. |
The following section discusses the findings from a PCA analysis that provides more insight into the specific diseases and disease types that are most relevant to the different clusters.
A principal components analysis was used to group diseases into seven categories, or factors: rarely encountered, common endemic and travel diseases, outdoor and agricultural occupational risks, rarer emerging and travel-related diseases, diseases related to crowded living conditions, respiratory diseases from livestock and wildlife, and rare encephalitic diseases.
To better understand how ZIDs coalesce on the incidence of health professionals encountering the diseases, a Principal Components Analysis (PCA) was applied on Q10A. This analysis provides the opportunity to explore whether there are any themes that emerge across groups of ZIDs, i.e., to identify groups of ZIDs that are seen more frequently by similar groups of survey respondents.
What this means is that diseases within each group tend to be encountered by the same health professionals, which is a reflection of the patient population or community being served by those health professionals. These are largely discrete groups; some diseases were strongly associated with more than one group, in these cases they were assigned to their strongest group, and noted in their second strongest group in the analysis with an asterisk.
It is also important to note that there was no specific definition of encounter in the questionnaire, i.e. respondents interpreted encounter in their own terms, which could extend to a variety of contexts such as diagnosed cases, suspected cases, testing, differential considerations, patient questions, and public health alerts.
Seven factors emerged using the "elbow" method in the scree plot – that is, the visible break at which an additional factor component explains a notably lower amount to the variability in the data than the previous factor component. Note that one of the groups simply consists of the diseases that were most commonly encountered in the survey, and another group consists of those least encountered, while the other five groups appear to share more specific characteristics in terms of the populations at risk.
In application, these broad groups of diseases could be considered as higher priorities for communication among the health professionals who would be serving patients at higher risk for them. In some cases it may be appropriate to strategize about resource development at a group level.
The seven factors, or disease groups, can be broadly defined as follows:
Complete numerical outputs for the PCA analysis are appended to the report in Appendix G.
The seven factors, or groups of diseases, are described in more detail below. Diseases are assigned to the factor for which they have the highest weight. In some instances, diseases are included in a second group where they also had a high weight; these diseases are noted in their second-highest factor in italics with an asterisk.
Disease | Factor weight |
---|---|
Rift Valley Fever | 0.656 |
Marburg virus disease | 0.650 |
La Crosse encephalitis | 0.643 |
Lassa hemorrhagic fever | 0.600 |
Plague | 0.581 |
California encephalitis | 0.557 |
St. Louis encephalitis | 0.524 |
Nipah virus disease | 0.478 |
Powassan virus disease | 0.459 |
Crimean Congo hemorrhagic fever | 0.452 |
Ebola disease | 0.391 |
Western equine encephalitis virus | 0.373 |
Eastern equine encephalitis virus | 0.370 |
Cache valley virus disease | 0.310 |
Ehrlichiosis* | 0.346 |
Bovine tuberculosis* | 0.277 |
Factor 1 is the largest factor. Looking at the characteristics of the diseases in this list, the trait they really have in common are that they are rarely encountered – most are near the bottom of the list in terms of the proportion of participants who said they had encountered them in practice. In application, these diseases can be considered a low priority for communication among most health professionals, as they are likely only encountered by those with a specific specialty or interest in rare diseases.
Despite being rarely encountered overall, they tend to be familiar to those in cluster 1. Ebola disease specifically is familiar to cluster 2.
Disease | Factor weight |
---|---|
Dengue | 0.634 |
Zika virus infection | 0.628 |
West Nile virus infection | 0.558 |
Chikungunya | 0.547 |
Yellow fever | 0.508 |
Rabies | 0.475 |
Japanese encephalitis virus | 0.427 |
Lyme disease | 0.426 |
Toxoplasmosis | 0.423 |
Tickborne encephalitis | 0.412 |
Mpox (monkeypox) | 0.372 |
Rocky mountain spotted fever* | 0.400 |
Ebola disease* | 0.298 |
Leptospirosis* | 0.262 |
Q fever* | 0.234 |
In contrast to Factor 1, the diseases in Factor 2 are encountered frequently relative to other diseases in the survey list. These diseases tend to reside near the top of the list by proportion of respondents who encountered them. Also, most of the diseases that were mentioned often in qualitative interviews are in this group. It contains a mix of diseases that are well-known endemic risks in Canada, diseases that are common concerns for travellers, and diseases that have been in the public eye due to outbreaks and epidemics. These are the ZIDs that would come up most often in general family practices, emergency rooms, urgent care, and community clinics, and they should be considered a high priority for communication among most health professionals seeing patients in any primary care setting.
These diseases are highly familiar to those in cluster 1 and cluster 2. Lyme disease, mpox, and West Nile virus are specifically encountered frequently by cluster 4 as well.
Disease | Factor weight |
---|---|
Babesiosis | 0.605 |
Brucellosis | 0.522 |
Cryptosporidiosis | 0.511 |
Human granulocytic anaplasmosis | 0.471 |
Tularemia | 0.463 |
Psittacosis | 0.447 |
Rocky mountain spotted fever | 0.411 |
Ehrlichiosis | 0.382 |
Bartonellosis (cat scratch disease) | 0.367 |
Leptospirosis | 0.347 |
Q fever | 0.289 |
Toxoplasmosis* | 0.402 |
Cystic echinococcosis* | 0.380 |
Western equine encephalitis virus* | 0.327 |
Bovine tuberculosis* | 0.245 |
Factor 3 diseases are a mix of diseases that are mainly bacterial. Several are transmitted by ticks, and some are transmitted by close contact with affected species. Many of the diseases in this list would be most familiar to physicians or nurses working in rural or remote areas with patients who spend a lot of time outdoors or who work with animals. Resources for managing these diseases should be communicated to health professionals who serve rural and remote areas.
All of the diseases in factor 3 are known to those in cluster 1, and some are known to cluster 2, namely bartonellosis, Q fever, and Rocky Mountain spotted fever. Bartonellosis is specifically encountered frequently by cluster 4.
Disease | Factor weight |
---|---|
American trypanosomiasis (Chagas disease) | 0.558 |
Murine typhus / endemic typhus | 0.529 |
Anthrax | 0.494 |
Cystic echinococcosis | 0.470 |
Cutaneous larva migrans | 0.453 |
Toxocariasis | 0.446 |
Alveolar echinococcosis* | 0.368 |
Eastern equine encephalitis virus* | 0.341 |
Factor 4 diseases are rare emerging and travel-related diseases. In general, most of these diseases are contracted by travellers and possibly newcomers to Canada from further south in the Americas, including southern portions of the United States. Many of these diseases also have relevant vectors, hosts, and reservoirs already established in Canada, with some diseases, such as echinococcosis, emerging in the country. Communication strategies about Factor 4 diseases should be aimed at health professionals with highly travelled patient bases, mainly those in urban settings and affluent areas, those who serve significant newcomer populations. Cluster 1 respondents are familiar with this group.
Disease | Factor weight |
---|---|
Hantavirus – Hemorrhagic fever with renal syndrome | 0.583 |
Hantavirus – Hantavirus pulmonary syndrome | 0.525 |
Alveolar echinococcosis | 0.455 |
Louse-borne relapsing fever | 0.452 |
The four diseases in factor 5 are often associated with crowded living conditions. Some of these diseases tend to be found in patients who are new immigrants or refugees from impoverished regions and places affected by conflict. 9 Hantavirus pulmonary syndrome and alveolar echinococcosis can occur in Canada, and may impact those living in crowded conditions with prolonged close contact with animals such as rodents and dogs, and can be a public health concern specifically in remote Indigenous communities. Resources for managing these diseases should be communicated specifically to those working with these highly vulnerable populations. These diseases are familiar to cluster 1; the two hantavirus diseases are also somewhat familiar to those in cluster 2.
Disease | Factor weight |
---|---|
Avian (zoonotic) influenza H7N9 | 0.726 |
Avian (zoonotic) influenza H5N1 | 0.703 |
MERS-CoV infection | 0.552 |
Bovine tuberculosis | 0.286 |
The diseases in factor 6 are respiratory diseases associated with livestock and wildlife, and usually initially present with generalized respiratory symptoms in humans. These diseases would likely be diagnosed only in patients with more serious symptoms, presenting with a risk profile that leads to specific testing that would detect them. Communication about this group of diseases should be aimed at health professionals in agricultural communities, especially those who employ temporary foreign workers as well as health professionals with significant newcomer populations in general. These diseases, like all the others, are familiar to cluster 1, but are even more familiar to those in cluster 2.
Disease | Factor weight |
---|---|
Jamestown Canyon virus | 0.743 |
Snowshoe hare encephalitis | 0.737 |
Nipah virus disease* | 0.422 |
Cache Valley virus disease* | 0.285 |
Factor 7 is the smallest group, with two main diseases that belong to the same serogroup of viruses, and are often conflated with each other: Jamestown Canyon virus and snowshoe hare encephalitis. Nipah virus and Cache Valley virus, both part of factor 1, are marginal for factor 7. The trait these four diseases have in common is that they can all cause encephalitis. This suggests that the physicians and nurses who have experience with this group of diseases likely work with encephalitis patients, and these diseases come up during investigation and diagnosis. These diseases are most familiar to those in cluster 1.
Applying the factor analysis to communication
The research findings indicate that health professionals generally do not prioritize learning about ZIDs unless they are specifically relevant to their practice. The factor analysis can be applied to strategic resource development and dissemination that targets health professionals with resources about the ZIDs that are most likely to apply to their practices. These groupings need not be considered concrete; it can be used as a starting point for making this large list of diseases more digestible for health professionals. For example, a resource aimed at those serving agricultural communities could provide information about diseases from group 3 and group 6, along with select other diseases from other factors that are also thematically, if not mathematically, related.
The following table shows the profile of participants in the study (data are weighted).
Characteristic | Total (n = 1,023) | Nurses/NP (n = 497) | Physicians (n = 526) |
---|---|---|---|
Primary profession | |||
Registered Nurse or Nurse Practitioner | 49% | 100% | - |
Physician/Resident | 51% | - | 100% |
Area of practice | |||
Family medicine | 54% | 37% | 70% |
Community health and palliative care/pain management | 18% | 33% | 3% |
Public health | 15% | 26% | 5% |
Emergency medicine/critical care, urgent care/acute care | 12% | 12% | 11% |
Internal medicine and mental health/psychiatry/psychology/addiction | 8% | 8% | 7% |
Other | 5% | 6% | 3% |
Practice setting | |||
Family medicine clinic/ private practice/ specialist clinic | 46% | 26% | 65% |
Hospital setting | 26% | 29% | 23% |
Community health centre and home or community setting/palliative care and mental health and addictions | 13% | 21% | 6% |
Public health clinic/setting | 10% | 17% | 3% |
Specialized travel health centre/clinic | 1% | 1% | 1% |
Other | 2% | 4% | 1% |
Indigenous health experience | |||
Yes | 20% | 25% | 15% |
No | 74% | 70% | 77% |
Not sure | 4% | 4% | 5% |
Northern health experience | |||
---|---|---|---|
Yes | 6% | 7% | 5% |
No | 94% | 93% | 95% |
Years of experience in Canada | |||
5 years or less | 8% | 7% | 9% |
6 to 10 years | 17% | 18% | 17% |
11 to 20 years | 36% | 43% | 29% |
>20 years | 37% | 31% | 42% |
Practice outside Canada | |||
Yes | 21% | 13% | 28% |
No | 75% | 84% | 66% |
Prefer not to answer | 4% | 3% | 6% |
Regions practiced in (of those who practiced outside Canada) | |||
United States | 24% | 31% | 21% |
Europe | 21% | 23% | 20% |
Africa | 18% | 12% | 20% |
Asia | 17% | 21% | 16% |
Middle East | 10% | 7% | 12% |
Australia or New Zealand | 10% | 6% | 12% |
South America or Central America | 5% | 7% | 5% |
Caribbean/Mexico | 4% | 4% | 4% |
Age | |||
---|---|---|---|
Under 35 | 11% | 17% | 5% |
35-44 | 31% | 36% | 26% |
45-54 | 25% | 24% | 26% |
55-64 | 20% | 17% | 23% |
65+ | 10% | 4% | 16% |
Gender | |||
Woman | 70% | 89% | 52% |
Man | 27% | 9% | 44% |
Gender diverse/other | <1% | <1% | 0% |
Prefer not to say | 3% | 1% | 4% |
Region | |||
British Columbia | 12% | 10% | 14% |
Alberta | 12% | 12% | 12% |
Saskatchewan | 3% | 3% | 3% |
Manitoba | 4% | 5% | 3% |
Ontario | 37% | 36% | 37% |
Quebec | 24% | 23% | 24% |
Atlantic | 8% | 8% | 7% |
Territories | 1% | 3% | <1% |
Community size | |||
Urban | 83% | 78% | 88% |
Rural primary | 9% | 14% | 5% |
Rural any | 11% | 16% | 6% |
None of the above | 7% | 7% | 7% |
In total, 41 health professionals participated in interviews for this study. The most common practice settings for interview participants were family medicine or walk-in clinics in large or medium cities. Other settings included hospitals (large cities and smaller towns), virtual care, public health clinics, and specialist practices.
Most participants had some experience with ZIDs, but on a very infrequent basis. The specific diseases they had experience with depended on the nature of their practice, but Lyme disease, rabies, and travel-acquired illnesses in general were mentioned most often.
When asked to discuss their practices and what experiences they had with ZIDs at work, many health professionals talked about the characteristics of their patients and the communities they serve, though they were not asked about this directly. The patient base served by interview participants also varied and largely mirrored the quantitative survey sample characteristics; most were in general practice with patients who reflected the population in the community they served. For those in urban centres, newcomers to Canada and travellers were a notable proportion of their patient population that they perceived to be at a higher risk for zoonotic infections. Zika virus infection and toxoplasmosis counselling was often mentioned by those serving patients who were pregnant, or planning to become pregnant.
Health professionals in cities tended to refer ZID cases to the emergency room, infectious disease specialists, or public health units, depending on the severity of the patient's symptoms and the suspected cause. The main exceptions to this were those working in practices that specifically offered travel health services, like vaccination, travel consultation, and travel-related disease testing and treatment.
"Most often it's malaria and Zika virus, we do counselling on. We have a lot of people going to Eastern Europe, so we do vaccines for tick-borne encephalitis. We screen for dengue, depending on where our patients came from."
"Most of the time, it's like someone came back from a trip somewhere … They're suddenly unwell, and we're just trying to figure out if they caught something from another country... It's mostly just a workup for it."
"I would say almost all the time that there's a potential zoonotic infection, the patient gets referred to infectious diseases."
Those working in smaller towns and rural areas noted that their patients who were most at risk for ZIDs were those involved in agriculture (e.g., farmers, veterinarians), those who worked outdoors, and those with outdoor recreational pursuits (e.g., hunting, hiking). These participants often saw patients at a heightened risk of rabies exposure from incidents like dog bites or wildlife encounters, though no interview participants noted seeing a lab-confirmed rabies diagnosis in Canada, where prevention measures for rabies are highly available. Health professionals in smaller communities also tended to be more aware of livestock and wildlife-related illnesses like avian influenza, brucellosis and bovine tuberculosis. Small community participants were often more involved with investigation, diagnosis, and treatment, since they and their patients had limited access to amenities like specialists and testing facilities.
Participants with experience working in extremely remote or far northern communities noted some specific risk factors that were fairly unique to this community type, including a much higher likelihood of contact with wildlife or feral domestic animals, and a general lack of precautions during outdoor activities. In addition to rabies, hantavirus and tick-borne diseases were issues of heightened concern for these health professionals though these diseases were rarely seen in patients.
Several interview participants were nurses and nurse practitioners with public health experience. There were also some physicians who had worked in or received training in public health. Those working directly in public health often had experience following up with patients with potential rabies exposure, or confirmed cases of Lyme disease. Nurses and physicians with public health experience or education tended to demonstrate more knowledge of ZIDs in general, and had higher awareness of specific diseases like Lyme disease, rabies, Zika virus infection, mpox, West Nile virus infection, and avian influenza.
"Even with something like Lyme disease it's unusual enough that the average doc doesn't know much about guidelines. I know a little more because my public health involvement and it was a public health issue across Canada."
For physicians and nurses working in urgent care or emergency room settings, containment and PPE were high priorities; several interview participants noted that they were concerned about infections spreading within the workplace and to staff households. For those in urgent or emergency care, a typical approach was to focus on stabilizing the patient before referring them to an infectious disease specialist, a public health unit, or a family doctor for further investigation and follow-up care. Whether or not an infectious disease was specifically zoonotic was not a major concern in this type of setting, where there are standard policies and protocols to follow for patients with infectious diseases in general.
For most doctors and nurses who participated in interviews, knowledge of the ZIDs on the list (52 key diseases from survey) was limited. Interview participants often recalled feeling surprised or overwhelmed by the number of zoonotic diseases that were unfamiliar to them. Another common impression of the list overall was that many of the diseases were rare or foreign (i.e. not endemic to their region, or to Canada overall).
"This is a very extensive list of infectious diseases; I think a lot of primary care providers are probably not very well versed."
"There's a lot of concern about zoonotic disease… we do see waves of patient concern, but we really haven't seen waves of disease."
Even when referring directly to the list (which was offered to participants as a downloadable PDF file), most interview participants had only passing familiarity with a few diseases on the list. A handful of diseases were mentioned somewhat more often.
Lyme disease was mentioned most often in interviews as a disease that was relevant to participants' practice. This aligns with findings from the survey research, where Lyme disease is the disease encountered most, and with the highest ratings for self-reported confidence among survey respondents. Physicians and nurses in areas where Lyme is more common (Ontario, Quebec, Atlantic provinces) generally had some experience diagnosing and treating it, and frequently encountered patients who were concerned about contracting it. Elsewhere in Canada, most doctors and nurses had some experience discussing it with patients, but usually they had not seen any confirmed cases. Several interview participants commented on the increasing prevalence of Lyme disease in some regions of Canada in recent years, and some had received some form of public health communication or continuing education about it.
"Living here in Alberta I guess the main zoonotic thing that I would be asked about in my day-to-day work was always Lyme. That's the main thing that people worry about."
"I have certainly a lot of people who come in wanting screening for Lyme disease or have a tick that had to be removed or other stuff, and some who actually test Lyme positive and require treatment."
Rabies was mentioned often in interviews as an endemic disease posing a risk to particular populations. Several doctors and nurses, mostly in rural areas, had managed cases where rabies exposure was a risk (i.e., animal bites, picking up dead animals, wildlife encounters, etc.) but nobody recalled a positive case in a patient, or a positive test result from an animal in Canada. Some interview participants, especially those in rural settings and those working in public health, had experience administering rabies vaccines and prophylactic immunoglobulin treatments to at-risk individuals. In urban areas, these patients were usually referred to public health. One doctor had seen fatal cases of rabies in two patients while working abroad.
Rural health professionals also counselled high risk patients, such as veterinarians, farmers, and outdoor enthusiasts, on risk reduction and procedures to follow for suspected exposure (e.g., seek treatment immediately, if possible try to contain the animal without killing it so it can be observed).
"Rabies is a big one … in the isolated communities, there are no veterinarian services. So, we have a lot of dogs that are unimmunized... There's a lot of fear around it with clients."
"I've never had an actual rabies case, but I've worked in places where people have been bitten by dogs or wild animals. It's something that we keep aware of and treat seriously."
Many interview participants recalled seeing public health alerts about mpox in the past couple of years, but very few had seen confirmed or suspected cases. Some physicians and nurses working in urban settings had referred patients for vaccines based on their risk profile. Those who had seen mpox cases noted that the materials they received, like public health bulletins and information posters, helped them to recognize the disease in patients.
West Nile virus infection was mentioned frequently as a disease that participants were generally aware of, but few had any detailed understanding of its current status in Canada. Some recalled instances of confirmed infections in patients who had severe symptoms, but in general, it was viewed as a disease that is known to be endemic but is rarely a consideration for testing in patients.
"West Nile virus… I don't hear so much about that right now, but it is still very present in the community."
Several participants were aware of these specific strains of influenza, and some physicians recalled requisitioning tests that covered them (along with other viruses). However, most interview participants who mentioned these diseases said they generally did not differentiate between different strains of influenza and typically treated patients for flu-like symptoms unless there was a more severe illness requiring further investigation.
Zika virus infection was mentioned several times as a topic discussed with pregnant patients. Several interview participants recalled hearing about Zika virus during the outbreak in 2015 and 2016, and there were some mentions of positive Zika virus cases in travellers.
"I do see some pregnant women as well. So especially those who travel to tropical climates, there are concerns there, in particular for Zika virus and prevention and travel advice."
There were limited mentions of some other diseases from the list:
"Oftentimes they're like mosquito-borne ones (in the emergency room). That's pretty typical from where people are returning back from, especially if they have fevers… Chikungunya is something they look at."
"We don't actually see a lot of tick-related diseases… we do talk about it in training and whatnot. We've always talked about Rocky Mountain spotted fever, Lyme disease and things like that, but haven't actually seen those."
Most of the other diseases on the list were unfamiliar or unknown to the vast majority of interview participants. While discussing their experiences with specific ZIDs, some participants mentioned diseases that were not part of the survey list; often, the diseases mentioned were vector-borne or mainly human-to-human diseases that are sometimes associated with animals. Malaria, salmonella, giardia, ringworm, and COVID-19 are examples of diseases that were mentioned repeatedly, but were not part of the survey list.
Participants were told that survey results showed very low confidence among health professionals when it comes to managing the diseases on the list. None of the participants were surprised to hear this, and they almost unanimously rated their own confidence at managing ZIDs as low. A few participants, who had some experience with ZIDs in their practices, suggested they were somewhat more confident at managing the diseases that were familiar.
"Pretty low confidence. Because even though we deal with it at least a few times a week, we don't deal with it a few times a day… that's where I feel like you really kind of solidify your knowledge."
Physicians and nurses alike attributed low confidence among health professionals to a lack of direct experience, and a lack of education about individual diseases or infectious diseases in general. Very few had taken anything more than a single, general course on infectious diseases during their medical training, and continuing education on any topics related to ZIDs was very rare. For those participants who had encountered any of the diseases on the list, experience with confirmed cases was often limited to one or two across an entire career.
"Lack of education in the area and the infrequency of how often we see these types of infections come up in BC are the drivers of low confidence."
"My own differential diagnosis is still very limited about the things I could only possibly see here in Canada … there's so much overlap in some of the symptoms. I might have even seen some of these conditions but not identified them as such because they are so rare and so infrequent."
When discussing resources, it is important to note that most health professionals interviewed did not strongly differentiate between ZIDs, and infectious diseases in general. With little experience, they often spoke more in hypothetical terms about the resources they would consult. Real experience with these resources was usually in the context of other diseases not mentioned in the survey list.
A few key resources were mentioned frequently:
This popular online resource was mentioned by nearly all physicians interviewed, and many nurses as well. One key advantage of this resource, as the name suggests, is that it is up to date with current research. It was also seen as trustworthy, easy to use, and relevant, with information presented in a useful format. This resource was popular both among participants who liked looking up information on a phone, and those who preferred to use a computer. The only significant drawback for UpToDate was that it is not a Canadian resource, therefore tests and treatments discussed may not be relevant for Canadian practices. As a subscription service, the fees have potential to be a barrier, but most participants had their subscriptions paid for by their employers.
"There are different things like calculators, drug interactions, but there's a search bar within UpToDate which can tell you what to do when you look up certain infections… I can look up zoonoses for cats and then it can talk about some of the different infections."
The CDC was seen as a trustworthy source of information about diseases in general, and was mentioned frequently in interviews. Occasionally, it was mentioned in contrast to Government of Canada resources, with interview participants suggesting that the CDC's website was easier and more effective for them to use when researching a disease. Like UpToDate, the lack of Canadian-specific context was a potential drawback.
The WHO was also mentioned as a trustworthy source of information about medical topics in general, and as a potential source of information about the diseases on the list, particularly those of concern for travellers and immigrants. Again, not reflecting Canadian-specific context was a minor limitation.
Health professionals often mentioned resources from their own province or territory, or other Canadian provinces. BCCDC resources were mentioned by health professionals located in BC and other western provinces as a reliable resource for ZIDs, infectious diseases in general, and other public health topics. This provincial government resource was seen as well researched, and the Canadian context was helpful. It was also noted to be easy to use, and often preferred over resources from other provinces. Quebec resources like those produced by the Institut national de santé publique du Québec (INSPQ) and Institut national d'excellence en santé et services sociaux (INESSS) were well-regarded by Quebec-based health professionals, but were not mentioned by participants outside of Quebec.
Spontaneous mentions of Government of Canada resources were not uncommon among participants, but were rarely noted as major resources. Most often, Government of Canada information was noted to be useful in the context of travel advisories, or the risk of diseases endemic in other countries. When asked directly about Government of Canada resources, most observed that while they felt government resources were thorough and trustworthy, website navigation was difficult due to the number of links they would have to click through to reach relevant web pages, and inconsistent formatting across different pages and resources. These issues meant that Government of Canada resources were not viewed as a streamlined reference to be accessed in a hurry, because it took too much reading to find clinically relevant information. Some indicated that Government of Canada resources could be worthwhile when there was time for a deeper read. In some instances, interview participants did not differentiate between provincial government resources and those offered by the Government of Canada.
"I also get asked questions from patients asking what kind of vaccines to get, what to avoid. I often direct them to the government travel advisory website."
"I find it is very hard to navigate. You search for a specific topic, and you get tons of links that often are not relevant… Going through all this information to find what you need is very laborious."
Several interview participants talked about popular reference books for their fields, such as the American Academy of Pediatrics (AAP) "Red Book" for pediatric cases, the U.S. Food and Drug Administration (FDA) "Orange Book" on medications, and the CDC's "Yellow Book" for travel health concerns. In discussion, some interview participants suggested that resources like these were expensive, became quickly outdated, and also lacked Canadian context.
Other health professionals were seen as an important source of information and guidance in both informal and formal contexts. Many interview participants said that when faced with a difficult case or an unfamiliar disease, they would consult colleagues with different experience or training backgrounds. Local health units and local specialists were a good option, where these were accessible. E-consultation services, providing access to specialists, were also popular; interestingly, both urban and rural participants mentioned using e-consultation. Some participants also mentioned that after referring patients to an infectious disease specialist, reading the specialist's report about the case was an excellent way to enhance their knowledge.
"I use the e-consult service a lot, because it's all covered under OHIP, and I can get a response usually right away."
"Because most of my experiences in Quebec have been up north... I just call the MUHC, and I see who's on call for infectious diseases."
When health professionals are looking for information on ZIDs, they often start with a simple Google search, and from the results, look for information from reputable sources like universities, the CDC, Mayo Clinic, or Johns Hopkins. Some noted that it was important to be aware of what their patients might also be seeing in general internet searches, so they could be better equipped to have productive conversations about patient concerns.
Knowledge gaps
Most interview participants agreed that there are knowledge gaps within their field when it comes to ZIDs in general. Though they struggled to come up with concrete reasons for this knowledge gap, a few themes emerged:
Rarity
Most zoonotic diseases, including those on the survey list, are seen as rare or foreign. In the context of primary care, this means that actual patient cases are limited or non-existent in regular practice. Because they are so rare, most of these diseases are not even considered by physicians in their differential diagnoses.
Related to this is that the symptoms of many ZIDs are similar to more common illnesses; health professionals will consider many other conditions first in a patient presenting with signs and symptoms like fever, headache, and diarrhea. Several participants related the medical adage "When you hear hoofbeats, think of horses, not zebras" in describing this perspective. Ultimately, the importance of maintaining knowledge about ZIDs is simply dwarfed by the necessity of knowing about more common conditions that affect their patients, like diabetes, heart disease, and cancer.
"If you don't see them often, then you don't end up being able to treat them, and you don't know how to treat them."
"If you look at the symptom constellation for things like Lyme disease or West Nile, they tend to blend into other things that we see commonly … for every person who has Lyme disease, I'm probably going to see a few hundred with flu so it's a bit of a needle in a haystack."
"[Mpox] is not such an exotic infection… there was a big, a large campaign of awareness from the local public health, the provincial public health and federally as well, on understanding the signs, symptoms, risk factors, et cetera, for that illness. So, a little bit more confidence in that."
"When you see it recurrently, you get your comfort level there. You can go through training in specific infectious diseases or conditions, but then if you don't see them frequently enough, you forget."
"It's very hard to keep up with things you're not really seeing."
Not covered in formal medical education
Most interview participants noted that infectious diseases in general, and ZIDs more specifically, were not a main focus during their formal education in medical or nursing school. Physicians could usually recall being taught about infectious diseases at a high level during medical school, and some had seen patient cases during their residencies. Most nurses in the interviews did not recall receiving any specific formal education about ZIDs. Beyond that, very few health professionals had attended continuing education courses or conferences that touched on ZIDs (or infectious diseases in general).
When choosing CMEs and other training options, participants often said they typically pursued topics that were more immediately relevant to their daily practice. Some mentioned that they could not recall seeing many opportunities to receive continuing education about ZIDs, or infectious diseases in general. Another factor was that pharmaceutical companies often drive awareness of medical topics; some interview participants suggested that there is little pharmaceutical industry attention given to infectious diseases and related topics.
"Unless you're working in a like a health authority funded position where this was the specialty clinic, and they were willing to train an NP on that. That's the only way you're going to get the education. Even self-study is hard because where do we even start that? We can go and review resources, but there isn't really a great program or course that's really tailored to zoonotic infections and primary care."
"I think there's not very much ongoing training on these illnesses, unlike many other topics of clinical interest... There's not very much pharmaceutical industry sponsorship of those kinds of infectious diseases."
Information overload
Interview participants did not generally perceive there to be a lack of adequate resources about ZIDs available to them. However, this perception should be interpreted with the understanding that most health professionals had low overall awareness and few encounters with the 52 ZIDs in the study list, and therefore little experience trying to find resources or information about them. The challenge they perceived with resources was more a matter of information overload where all medical topics are concerned, which makes it difficult to focus on a given topic, or to stay abreast of new developments. This poses a risk where resources that are too specific have the potential to be overlooked.
"There're all these different electronic medical records all over the place… all these different access points. How many pages do I need to have open on a given day to provide the care that I need to provide at this moment in time?"
"There's constant reminders of things coming at you. So, it's this bleep and that bleep and your email, your phone is on, and you've got all this stuff."
"I don't think there's any lack of resources... The problem is that there are almost too many resources now and you're often left not knowing which ones to trust."
Perceived as low priority
While most health professionals interviewed agreed that there was a knowledge gap about ZIDs among their industry colleagues, this was not necessarily seen as an issue requiring their immediate action. Many participants felt that in a high information environment where health professionals must maintain knowledge on many complex topics, the relative infrequency of ZIDs (as discussed earlier) means they are not high on their priority list for learning. Most were confident that they do have ready access to support resources and infectious disease specialists when a case comes up. Some practitioners also indicated that detailed knowledge about specific diseases is not necessary even when they encounter a case – it's more critical to know where to find information such as:
"As a busy family physician, most of the things we do are on the go… we have a case, we learn, we study, we consult, but not necessarily specifically for zoonotics."
"Especially as a family physician, there's a lot of breadth of things we need to know but we definitely do not know the nitty gritty details of this zoonotic disease and I will never pretend I do … it's not uncommon for us to actually pick up the phone and call our infectious disease colleagues for advice on testing, on treatment because it's not that straightforward."
"It would be nice to know what the risks are... I know a lot of my colleagues are quite concerned about taking it home to their children or just taking it home to any potentially immunocompromised people."
"I don't know when in my day I would ever find time to sit down and just think about something that I don't see a lot of, but I'm interested to learn… I think that's how everybody in health care feels right now."
Staying current with medical knowledge in general is a major challenge for health professionals, who frequently mentioned how much effort it takes for them to be up to date on research, practice methods, medications, and emerging threats. Many health professionals talked about how they try to prioritize what they spend time on, and what forms of information tend to get their attention. Where ZIDs are concerned, there were some information sources that seemed to break through better than others.
In general, health professionals take public health issues very seriously, so public health bulletins or alerts are effective. Most interview participants could recall seeing public health information about specific diseases (e.g., mpox, avian influenza, West Nile virus infection). This puts a specific disease on their radar, so to speak, which seems to boost their confidence about counselling at-risk patients or spotting symptoms, and helps them know where to look if they need more information.
"If you think of mpox, for instance, we'll be getting a lot more sort of information from public health… I think that has been helpful, but I don't see the same kind of information uploads for other conditions."
"I get updates constantly from Ottawa Public Health… that's where I usually get the information from, because public health will send reminders and bulletins about what's out there."
Articles and columns about emerging trends or diseases of concern in Canada are effective for some. Physicians in particular often indicated that they browse industry-specific magazines and journals. While they may not have time to read complete peer-reviewed studies about all topics, shorter articles that summarize key information are useful for introducing a topic and generating a baseline level of awareness about a specific disease.
"Every month when I get these journals, I do actually try my best to go through the interesting cases, especially for topics I don't know about or don't see very often."
When asked to describe an ideal resource for learning about ZIDs, physicians and nurses provided a variety of suggestions. There was a broad appetite among participants to have access to a web-based resource with the following characteristics:
"Dovetailing it into an app instead of us having to pay for these infectious disease apps."
"Why reinvent the wheel? Like, the Canadian STI guideline, it's a great resource. It's easy to access… why couldn't there be a resource like that? Like, the Canadian Zoonotic Infectious Diseases Guidelines and set up in a very similar way."
"Maybe a website that's password protected, with our license number, for example. Then we log in and we type in the condition. For example, yellow fever, and it would pop up with the signs and symptoms and the diagnostic test required was the latest up -to-date treatment that's evidence -based."
"The ideal format would be a website… with up-to-date factual information, including clinical presentations, diagnosis, management, treatment, and emerging epidemiology of the different diseases."
"It would be something that was good for both diagnosis and management… how the disease is going to present, which countries are more likely to have that type of infection, what tests to do to diagnose it and what the management would be."
"A Canadian lens would be more helpful, because a lot of the information is American. Whether the values are different for labs or the medications aren't available in Canada, it can sometimes be frustrating."
In addition to a comprehensive web-based resource, participants mentioned a variety of other types of resources they would find helpful. Some common themes for other resources included:
"What I could use is almost like a triage thing. Family doctors are very practical, so walking me through the steps of what should be done would be very helpful."
"I wish they had maybe an online course … like yearly refreshers on what's new and in travel medicine."
"I kind of like a one pager of what should be done about it, how it can be maybe prevented, and then maybe what could be the treatment for it, or where to go for more information."
"I think if you're a subspecialist… the opportunities for CME are quite abundant… I could understand how a general practitioner or somebody specializing in another area would not necessarily get exposure to that type of CME."
When it comes to the authors or distributors of information on ZIDs, interview participants were generally agnostic about resources as long as they come from organizations who are trustworthy, current, and evidence-based. When asked to specify who they saw as trustworthy, health professionals named a wide variety of entities and organizations, such as provincial health ministries, local public health units, infectious disease specialists, CDC, WHO, and reputable universities (in Canada or elsewhere). The Government of Canada was widely seen as trustworthy overall, but many health professionals expect to receive information from the provinces, rather than the federal government. Some participants also referred back to the sources they had discussed earlier in the interview, reiterating that trust was a reason they relied on online resources like UpToDate and MayoClinic. Several doctors specifically mentioned being somewhat wary of resources provided by or funded by pharmaceutical companies, not because they believe the information is incorrect, but because they expect it to serve a commercial agenda that may not align with patient needs.
"Something coming from a … large Canadian University that would be trustworthy because I know it's not going to be biased through pharmaceutical companies. Things that are paid and sponsored through pharmaceuticals even though they mean well, they often will distort the information."
The quantitative and qualitative results of this research point to several key findings that could inform future efforts to develop resources and build capacity where ZIDs expertise is concerned:
The executive summary at the beginning of this report provides additional discussion of the key findings.
Here are some considerations, stemming from the key findings, that may be employed to ensure that health professionals are equipped to manage ZID cases when the need arises.
Resources should be relevant and realistic:
Resources are most useful if they are broad in scope, accessible, and easy to use:
Health professionals know what resources have worked for them in the past:
Resources can be designed to be very strategic to increase their relevance and uptake:
Collaboration and consultation with colleagues can grow capacity:
This assignment involved quantitative research, consisting of an online panel-based survey of 1,000 health professionals in Canada in two groups: general practitioners/physicians, and nurses/nurse practitioners. The survey was administered in English and French depending on the respondent's preference.
The survey sample was obtained from a proprietary panel of health professionals, MDBriefCase. MDBriefCase was responsible for inviting and directing qualified respondents to the survey hosted by Environics. With an opt-in membership of more than 103,000 pre-profiled healthcare professionals, broken out by occupation, with whom MDBriefCase regularly interacts, this panel provides a cost-effective mechanism to engage HCPs in a timely manner. As this online survey utilized an opt-in list of health professionals, it is a non-probability survey. Thus, it cannot be assumed to be fully representative of the target population and no margin of sampling error is calculated. Results in this report were described as based on those responding and not representative of the population of doctors and nurses.
Environics achieved the following regional distribution based on CIHI population data 10; final data were weighted to reflect regional distribution within each group.
Occupation | Canada | Atlantic | Quebec | Ontario | MB/SK | Alberta | BC + Terr |
---|---|---|---|---|---|---|---|
Physicians/GPs | 526 | 29 | 57 | 270 | 32 | 61 | 77 |
Nurses/nurse practitioners | 497 | 58 | 44 | 171 | 77 | 85 | 62 |
Respondents were offered an incentive of $35 for their participation. MdBriefCase was responsible for providing incentives to their panellists through gift cards. 953 surveys were administrated in English and 70 in French depending on the respondent's preference.
Environics worked with the Public Health Agency of Canada to develop a questionnaire that ensured the research objectives were met and all questions were appropriately worded, and that they adhered to federal government standards for public opinion research. Upon approval from the Public Health Agency of Canada, the questionnaire was translated into French. The final questionnaire is included in Appendix C.
Prior to the launch of the survey, Environics provided test links to the Public Health Agency of Canada for both language versions of the survey and changes were made based on their comments. Environics arranged to conduct pretests in both official languages. For the pretests MDBriefcase issues invitations to a limited number of records and conducted a "soft launch" in each language. These preliminary surveys included standard Government of Canada pretest probing questions at the end, to ascertain the survey length and language was appropriate. The pretest took place on December 5, 2023, and achieved 17 completes in English. No changes were required as a result of the pretests. The pretest responses were retained in the data set. Because no French participants responded to the pre-test, early French completions were monitored carefully to ensure accuracy. No changes were required as a result of this monitoring.
The online survey was conducted from December 5, 2023, to February 7, 2024. The final average survey length was 15 minutes.
The surveys were conducted by Environics using a secure, fully featured web-based survey environment. Environics' data analysts programmed the questionnaires then performed thorough testing to ensure accuracy in set-up and data collection. This validation ensured the data entry process conformed to the survey's basic logic. The data collection system handles sampling invitations, quotas and questionnaire completion (skip patterns, branching, and valid ranges).
Environics assumed overall responsibility for all aspects of the survey fieldwork. The survey was conducted according to the following steps:
All respondents were offered the opportunity to complete the surveys in their official language of choice. All survey respondents were informed of Government of Canada's sponsorship of the research, that their participation was voluntary, and that information collected was protected under the authority of privacy legislation.
All research work was conducted according to best practices in the industry, such as the Standards for the Conduct of Government of Canada Public Opinion Research – Online Surveys (http://www.tpsgc-pwgsc.gc.ca/rop-por/enligne-online-eng.html) as well as applicable federal legislation (Personal Information Protection and Electronic Documents Act, or PIPEDA). Environics is a founding member of the Canadian Research Insights Council (CRIC) and registered the survey with CRIC's Research Verification System, which permits the public to verify a survey call, inform themselves about the industry and/or register a complaint. For more information about CRIC: https://www.canadianresearchinsightscouncil.ca/
Following data collection and prior to analysis, data analysts performed a data-cleaning and validation process, in accordance with the highest industry standards. Open-ended question data were coded and Environics designed banner tables in consultation with the project authority. Data tables were submitted in CSV format.
Differences between sub-groups are noted based on Z-test results at 95% probability for comparing proportions, and based on two-tailed T-test results at 95% probability for comparing means. Comparisons are based on differences between exclusive sub-groups, and not on differences compared to the total in overlapping groups.
Non-response bias analysis
The following table compares the survey respondents to the closest professional categories available in CIHI data for 2020 therefore the non-response bias analysis is limited to what can be ascertained from this data; the survey somewhat over-represents older physicians and under-represents younger nurses, but otherwise is close to the distribution of health professionals in Canada as far as it can be quantified by the CIHI data.
Proportions by profession (read across) | CIHI 2020 | ZID Survey | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Gender | Age | Gender | Age | |||||||
Male | Female | <30 | 30-59 | 60 | Male | Female | <30 | 30-59 | 60+ | |
Physicians | 60 | 40 | 4 | 73 | 23 | 47 | 53 | 3 | 70 | 27 |
Regulated nurses | 9 | 91 | 17 | 72 | 11 | 9 | 91 | 9 | 78 | 13 |
Notes: CIHI gender: excludes PEI and Quebec (no data available for 2020) Survey gender: excludes those preferring not to respond and other gender identification to correspond to CIHI gender categories CIHI age: excludes PEI, Quebec and Manitoba (no data available for 2020) Survey age: categories in survey did not align with CIHI statistics; results in two categories were divided by two to align with CIHI age categories (i.e. 25 to 34 and 55 to 64) |
Self-report / recall bias
Research that relies on self-reporting, including surveys like this one, can be subject to bias due to poor recall, the influence of social desirability, and other factors that may influence respondents to provide responses that are incorrect or dishonest. This bias should be taken into consideration while interpreting results. For this study, several steps were taken to minimize the impact of this type of bias. These measures include:
Sampling bias
Sampling bias is when some members of a target population (in this case, health professionals) have a higher or lower likelihood of being included in the sample. This type of bias can be a result of flaws in the sampling methodology or the sources available for sampling. As discussed in the sampling section above, the sample source for this study is a large database of medical professionals working in Canada (i.e., MDBriefCase). This source was used specifically because it is considered to be a high quality and extensive list of such individuals. There is a risk that some members of the target population could be excluded from this sampling technique, mainly those who are not subscribed to MDBriefcase, or those who have low engagement with the company. Because this sample source is, for all intents and purposes, an opt-in panel, it is considered a non-probability sample.
The completion results for survey are presented in the following table.
Disposition | N |
---|---|
Total invitations (c) | 49,398 |
Total completes (d) | 1,023 |
Qualified break-offs (e) | 538 |
Disqualified (f) | 356 |
Not responded (g) | 47,189 |
Quota filled (h) | 292 |
Contact rate = (d+e+f+h)/c | 4.47 |
Participation rate = (d+f+h)/c | 3.38 |
The qualitative interviews were conducted between January 18 and February 6, 2024. The objective of the qualitative research was to further explore the barriers to accessing information and the information needs of physician and nurses in primary care and public health with respect to ZIDs.
IDI participants were selected from the survey respondents, as screening for the IDIs first took place within the quantitative survey instrument. The screener is attached to this report at the end of the questionnaire in Appendix C.
A total of 38 interviews were conducted with 41 participants in total, 34 in English and 5 in French. Interviews were conducted with 22 doctors and 19 nurses. An incentive of $320 per participant was paid to all those who completed the exercise.
Interview participants were mainly recruited via the online survey. To broaden the pool of potential interview participants and hear perspectives reflecting different roles in clinical settings, interview participants were permitted to invite a colleague to participate in the interview with them; just three pursued this option. To recruit participants, the quantitative survey included a qualitative screener which invited participants to the interviews. The recruitment was aimed at including members of specific groups, including:
The screener was designed with standard questions to ensure participants were qualified to participate in the qualitative research in accordance with Government of Canada requirements, specifically:
Data from survey respondents who qualified and opted-in to the qualitative research were extracted into a data file containing information, basic demographics, and answers to key survey questions to determine quit attempts, and screener responses. This file was used by the Environics research team to recruit qualified participants to interviews.
Using the file extracted from the initial survey, qualified respondents were invited by email to participate in an interview. Invitations were sent directly from Environics Research. Invitation wording included critical details about the study to help overcome hesitance, and assurances that confidentiality will be preserved.
Respondents were invited on a priority basis, based on target quotas for region, language and experience. Ultimately, 115 survey respondents were invited to participate in interviews, 45 scheduled interviews, and 38 completed interviews (3 invited colleagues, bringing the total number of participants to 41).
The qualitative interviews were conducted between January 18 and February 6, 2024. Interviews were scheduled to be 45 minutes; completed interviews ranged from 25 minutes to over an hour in length, averaging around 35 minutes.
Environics drafted a discussion guide for review and approval by the Public Health Agency of Canada. Participants were mainly interviewed in an online platform called Recollective, where they could schedule their own interviews at times that were convenient for them. However, some opted for interviews on Zoom or by telephone. Interviews were offered in both English and French.
At the outset of each interview, the facilitator confirmed the participant's consent to proceed and verified the participant's identity and qualification to participate. Sessions were recorded with participants' consent, and transcribed automatically by the Recollective or Zoom platforms; interviews conducted by telephone were not recorded. All resulting data were stored securely on servers located in Canada. Immediately following each session, the recordings were transcribed; recordings were deleted upon completion of the report. Transcriptions have been provided to the Public Health Agency of Canada with personally identifying details removed.
Public Health Agency of Canada/Agence de la santé publique du Canada
Zoonotic Infectious Diseases – Health professionals
Final Questionnaire
Subject line: The Public Health Agency of Canada wants to hear from you about zoonotic infectious diseases.
Dear [CONTACT],
You are invited to participate in an online survey about zoonotic infectious diseases, which are infections that are transmissible between animals and humans, including via vectors. These are important issues facing health care professionals given global health developments and our experience of the COVID-19 pandemic. The survey is being conducted by Environics Research, an independent research company, on behalf of the Public Health Agency of Canada.
Participants who qualify and complete the survey will receive a $35 (CAD) Virtual Visa electronic Gift card!
The survey will take about 15 minutes to complete, and is best viewed on a desktop or laptop computer, rather than a mobile device. You will be asked about your experiences with, and opinions about, zoonotic infectious diseases in the context of patient care. The aim of this project is to build capacity for health professionals related to zoonotic infectious diseases. This research will gather the existing knowledge/resource gaps and needs of Canadian health professionals for zoonotic infectious diseases. The findings will inform the development and dissemination of resources for Canadian health professionals, which will ensure that they can support the health and safety of individuals and communities affected by zoonotic infectious diseases. The survey is voluntary. Your decision on whether or not to participate will not affect any interactions you may have with the Government of Canada.
By default, your responses will not be attributed to you. Please do NOT include personal information or information about specific cases in your answers to the survey questions.
We are additionally conducting qualitative interviews as part of this research. At the end of the survey, you may be asked if you are interested in participating in this component of the research. In that case, with your explicit, informed consent, we will ask if you wish to provide contact information. This contact information and some survey data would be used solely for the purpose of contacting you for an interview. Your survey data will never be linked with your contact details in the analysis, and your identity will never be shared with the Government of Canada.
If you don't have time to complete the survey in one sitting, you can return to it by clicking on the link below again. Once the survey period closes on [DATE], if you do not complete the entire survey, your answers will not be retained. Your answers will be deleted from Environics Research's system and not included for analysis in the survey data. Only those who complete the survey will be compensated.
If you have any questions about the survey, please contact Stephanie Coulter of Environics Research by phone 437-990-2393) or email (stephanie.coulter@environics.ca).
This study has been registered with the Canadian Research Insights Council's Research Verification Service so that you may validate its authenticity. If you would like to enquire about the details of this research, you can visit CRIC's website www.canadianresearchinsightscouncil.ca and reference project code XXXXXXX.
Welcome and thank you for your interest in our survey / Bienvenue et merci de l'intérêt que vous portez à ce sondage.
Please select your preferred language for completing the survey / Veuillez choisir la langue dans laquelle vous préférez remplir le sondage
This study has been registered with the Canadian Research Insights Council's Research Verification Service so that you may validate its authenticity. If you would like to enquire about the details of this research, you can visit CRIC's website www.canadianresearchinsightscouncil.ca and reference project code XXXXXXX.
What about your personal information?
What happens after the survey?
What happens if I don't complete the survey?
If you have any questions about the survey, please contact Environics at stephanie.coulter@environics.ca
< PROGRAMMING NOTE: All questions are mandatory unless otherwise indicated.>
< PROGRAMMING NOTE: Add progress bar.>
Please provide the first 3 digits of the postal code of the location where you practice most often.
This information will be used to categorize your work location (i.e. province/territory and urban / rural / remote) for analysis purposes.
ENTER: X#X [CATEGORIZE INTO PROVINCE BASED ON FIRST LETTER, IF NOT VALID ASK 1B]
99 - Prefer not to say
1A) [IF VALID IN Q1] If you currently practice in more than one location, please provide the first 3 digits of this/these postal code(s): ENTER: X#X [CATEGORIZE INTO PROVINCE BASED ON FIRST LETTER]
1B. [IF PREFER NOT TO SAY OR NOT VALID IN Q1, OR NO POSTAL CODE IN 1A] In what province or territory do you currently practice? If you practice in more than one location, please select your Practice setting.
DROP DOWN LIST – SEE QUOTAS
1C) [IF 1-13 in Q1B] If you currently practice in more than one province or territory, please identify additional provinces or territories where you practice (select all that apply)[USE DROP DOWN LIST OF PROVINCES AND TERRITORIES]
[INCLUDE OPTIONS:
No other provinces or territories
Prefer not to answer]
2. What is your primary profession?
Select one only
THANK AND TERMINATE WHEN QUOTA ACHIEVED FOR PROFESSION
3. Which of the following categories best describes your current employment status as a health professional? Are you...
Select one only
4. What is your area of practice or clinical specialty?
Select all that apply
4B. [CHECK FOR INFECTIOUS DISEASE SPECIALIST QUOTA]
[IF PROFESSION = PHYSICIAN AND AREA OF PRACTICE IS ONLY INFECTIOUS DISEASE, ASK]
Are you an infectious disease specialist?
5. On average, how often do you encounter patients with zoonotic infectious diseases in your practice? [SHOW DEFINITION OF ZIDS AS POP-UP: An infection that is transmissible between animals and humans, including via vectors.]
Select the option that best describes your experience on average
This survey is about your experience with patient care as it pertains to zoonotic infectious diseases. Please answer the following questions as they reflect your current practice.
6. How would you characterize your level of knowledge regarding zoonotic infectious diseases in humans?
Select one only
7. How satisfied are you with the zoonotic infectious disease education provided during your formal healthcare training (e.g., medical school, residency, nursing school)?
8. How satisfied are you with the continuing professional education you have completed on zoonotic infectious disease after completing your formal healthcare training?
9. Please indicate if you have used any of the following resources to inform your practice regarding zoonotic infectious diseases.
Please select all that apply
For the next few questions you will be looking at a list of specific zoonotic infectious diseases. It is important to consider each one individually as you answer the questions.
You may notice that these diseases are organized into groups with shared characteristics. This is simply to make the survey easier to follow, and these groups are not meant to be discrete or definitive.
[PROGRAMMING – LIST OF DISEASE IS BELOW. LIST TO BE USED FOR Q10.]
[PROGRAMMING – DEFINE INSTRUCTIONS FOR RANDOMIZING DISEASE LIST – IF IT IS GROUPED BY TYPE, RANDOMIZE WITHIN TYPES]
[GROUP 1]
Encephalitides:
[GROUP 2]
Tick-borne and mosquito-borne diseases:
[GROUP 3]
Hemorrhagic fevers:
[GROUP 4]
Direct Zoonoses:
[GROUP 5]
Influenza, Influenza-like, and respiratory:
[GROUP 6]
Parasitic and other:
10. In the following grid, please indicate which diseases you have encountered in your practice, AND rate your level of confidence in managing each zoonotic infectious disease. [GRID, USE LIST]
Disease name | Encountered disease in your practice | Please rate your level of confidence in managing each zoonotic infectious disease (including patient assessment, diagnosis, infection prevention and control measures, patient management, patient education, contact tracing, public health reporting) | ||||
---|---|---|---|---|---|---|
1. Yes | 2. No | 1. Not at all confident | 2. Somewhat confident | 3. Confident | 4. Very confident | |
[Randomize disease names] |
[PROGRAMMING: PLEASE ADD A POP UP BOX WITH THE FOLLOWING TEXT:
11. The past few questions were about a list of specific diseases. Are there any zoonotic infectious diseases NOT in the list that you consider to be relevant in your practice for which you would like to have more resources? OPEN END
ADD OPTION: No other relevant diseases to add.
12. Please rate your confidence at providing each of the following types of information or services related to the zoonotic infectious diseases you encounter as identified in this survey.
RANDOMIZE ORDER
13. From the following list, select the three most significant information/resource-related barriers when it comes to providing care for patients with zoonotic infectious diseases in your own practice.
RANDOMIZE ORDER, ALLOW THEM TO SELECT LESS THAN THREE
13B. From the following list, select up to three topics that are most important for you as a Canadian health professional to be informed on in relation to zoonotic infectious diseases?
RANDOMIZE ORDER
[PROGRAMMING: OFFER POP-UP DEFINITIONS FOR EACH – SEE LIST BELOW]
14. How interested are you in receiving additional professional education on zoonotic infectious diseases?
15. [IF Q14 is 3 (Not interested) SKIP TO Q16] If you were to learn more about zoonotic infectious diseases, what would you be interested in learning about?
(e.g. outbreaks, infection prevention and control, latest treatment, etc.)
[OPEN QUESTION]
16. If you were to receive additional professional education and resources on zoonotic infectious diseases, in which formats would you prefer to receive the information?
Please select all that apply
17. The following are a few questions about you, for statistical purposes only. By default, your answers will not be attributed to you, and you may skip questions that you do not wish to answer.
<PROGRAMMING: Respondents should be able to skip ALL demographic questions without responding / leave them unanswered.>
Please indicate the number of years of experience that you have as a practicing health professional...
ENTER NUMBER 0 TO 75
A. Total years of experience | B. Years practicing in Canada | C. Years practicing outside of Canada* |
---|---|---|
## | ## | ## |
Prefer not to answer | Prefer not to answer | Prefer not to answer |
[SHOW BELOW TABLE] *As many zoonotic infectious diseases are not endemic in Canada, the purpose of asking for additional information about medical experience outside of Canada is to assess if there is a difference in zoonotic disease capacity amongst health professionals with domestic and international experience. |
18. [IF YEARS OUTSIDE OF CANADA>1 ASK] Please specify in which countries you have practiced (optional).
20. Do you have previous health professional experience working in the Canadian territories within the last 5 years? If yes, please indicate the Canadian territory or territories where you have experience (optional).
22. What type of setting best describes your Practice setting?
Select one only
23. Please indicate to which of the following age categories you belong?
24. What language(s) do you speak most often in the workplace?
Select all that apply
25. How do you identify yourself?
Select one only
26. Do you have significant experience (at least one year) of providing comprehensive health care services to Indigenous (First Nations, Inuit, Métis) populations in Canada?
Significant experience may be acquired through working in a health capacity with an Indigenous community and/or on a First Nations reserve.
If you are unsure that you have significant experience working in a health capacity with Indigenous population, please provide additional details (optional).
Select one only
Thank you for completing the survey!
We will be conducting follow-up qualitative research to better understand current practices around zoonotic infectious diseases in the medical context. This would involve a more in-depth one-on-one discussion for professionals like yourself. Participants will receive an honorarium of $320 as a thank you for your time.
The discussions would be conducted by Environics Research (https://environicsresearch.com/) on behalf of the Government of Canada.
The discussions will happen in January. Participation would involve an interview that would last for approximately 30-45 minutes. The interview will take place in an online platform. The interview will be conducted by a highly trained researcher from Environics Research who will ask questions about your practice and zoonotic infectious diseases.
All data gathered will be securely stored on Environics Research servers in Toronto for approximately 12 months for documentation and insight generation purposes only. Environics Research will take reasonable steps to retain Personal Information only for as long as needed to complete the research. For more information, please see Environics Research's privacy policy: https://environicsresearch.com/privacy-policy/
Taking part in these interviews is completely voluntary. If you are interested, you will need to provide your first name and email address. Please note that this information (name and email address) will only be used to invite you to participate, should you be selected, and will be kept separate from your responses in the interview.
Additionally, we may use some of your demographic and practice information from the survey to help us ensure that we include a diverse range of participants in our interviews. These details will only be used for the purposes of selecting and contacting interview participants and they will not be linked to your interview responses.
QUAL1. Understanding how your information will be used, are you interested in participating?
The information you provide during the interview will not be linked with your name on any written document or report. Environics may record the conversations to aid them in analyzing the results, so we ask that you do not disclose your last name and/or any identifiable information about yourself. We will provide instructions about securing your identity in advance of the session.
QUAL2. Do you agree to these terms of participation?
QUAL3. Please provide us with the following contact information so we can send you details about the interviews if you are selected to participate. Please note again that this information (first name and email address) will only be used to invite you to participate, should you be selected, and will be kept separate from your responses in the interview.
SHOW ALL: This completes the survey. The gift card is being administered by MDBriefcase; they will be contacting you. On behalf of the Public Health Agency of Canada, thank you for your valuable input. In the coming months, the results of this survey will be available on the Library and Archives Canada website.
ENG | FRE |
---|---|
Thank you for taking our survey. Your efforts are greatly appreciated! | Merci d'avoir répondu à notre sondage. Nous vous sommes reconnaissants de vos contributions. |
Public Health Agency of Canada
Individual In-depth Interviews with healthcare professionals (re: Zoonotic Infectious Diseases)
Interview Guide
December 18, 2023
Participant Name:
Date:
Interviewer:
Introduction (5 minutes)
Hello, my name is... from Environics Research. Thanks for joining me today.
We are conducting interviews on behalf of the Public Health Agency of Canada. This is a follow-up to a survey you recently completed about zoonotic infectious diseases.
The interview will take approximately 30 minutes to complete.
I would like to assure you that your responses will be only reported in aggregate with other respondents. Your name and identifying details will not be shared in the report or in any documents that are published or shared with the client.
This interview is voluntary. We are interested in learning about your experiences for research purposes and it's important to us that you feel comfortable and safe. If there is anything you don't wish to answer, that is okay. You can also choose to end the interview at any time.
Do you consent to proceeding with the interview? [CONTINUE IF YES]
I would like to record the interview for note-taking and quality control purposes. The recording files will not be sent to anyone outside of Environics, uploaded to any websites, or included in any reports.
We may play select AUDIO portions of some interviews for PHAC and Environics staff in a closed setting. Identifying details like your name and details about you or your practice will be removed if we do this.
Do I have your permission to record this interview? [CONTINUE WITHOUT RECORDING IF NO]
Do you have any questions before we begin?
Participant Introduction – Warm-up (3 minutes)
Before we get started talking about Zoonotic diseases, could you please tell me a little bit about your practice and your experience?
We are asking healthcare professionals about their experiences with zoonotic infectious diseases.
Theme 1: Zoonotic infectious disease questions from Topline Data
Preliminary results from the survey we conducted, identified that health professionals are not confident in managing many zoonotic infectious diseases, do you feel the same?
Health professionals have identified having low confidence in managing specific diseases and disease groups, can you provide suggestions on what you think the drivers of this low confidence are for these diseases:
[INSERT DISEASE NAMES/GROUPINGS]
Health professionals have identified having more confidence in managing specific diseases and disease groups, can you provide suggestions on what you think the drivers of this confidence are for these diseases:
[INSERT DISEASE NAMES/GROUPINGS]
Preliminary survey results demonstrate that many health professionals are dissatisfied with continuing education on zoonoses. Have you completed any continuing education related to zoonoses? Do you feel the same?
Theme 2: Resources they access (10 minutes) I would like to hear about your experience in accessing zoonotic infectious diseases resources.
In your practice, what sources of information and resources do you access for zoonotic infectious diseases?
[IF THE ANSWER IS TOO GENERAL, PROBE] Can you give me some specific examples? [This can include: Clinical tools, websites, webinars; please ask for specific names of resources, websites etc].
Now going back to talk more generally about zoonotic infectious disease resources that you access, do you have confidence in the resources you use when encountering or potentially encountering a patient with a zoonotic disease?
Do you use any Government of Canada online zoonotic infectious disease resources in your practice?
Theme 3: Resource Gaps
Next, let's talk about the amount and the quality of information available for you and other health professionals regarding zoonotic infectious diseases.
Next, let's talk about knowledge and resource gaps for health professionals related to zoonotic infectious disease care.
Theme 4: Ideal Resource (10 minutes)
What would your ideal information resource for zoonotic infectious diseases look like?
When it comes to finding resources on zoonotic infectious diseases, which of the following factors are a priority and why?
(Note to moderator: List all the following factors. Please use the prompts as necessary)
Conclusion
This research is being conducted on behalf of the Public Health Agency of Canada, to better understand educational needs about zoonotic infectious diseases. Is there anything you would like to expand on or that I've failed to ask?
Do you have any other comments about this topic in general?
Thank you for your valuable contribution and input into this project. The report for this project will be published by Library and Archives Canada in a few months.
Invitation Process
Invitations to be sent by email, with separate open links for French or English. See invitation documents.
Participants will create their own log in for Recollective, and join the study in the language of their choice.
Recollective Home Page
Items will be set up as "cards" on the home screen.
Welcome Card
[card visible for participants who have not completed the screener]
Welcome
Thank you for your interest in our research, conducted on behalf of the Public Health Agency of Canada (PHAC). To confirm your participation and schedule your interview, you will be asked to complete some simple questions.
Privacy Information Card
[card visible on home screen to all participants for duration of study, including those disqualified]
Privacy Information
Included below is some additional information about your privacy and your rights as a research participant:
Disqualified Thank You Card
[appears at top of home screen for disqualified respondents]
Thank you for your interest
At this time, you do not qualify for an interview. Thank you for your interest in this research. If you have any questions, please contact Stephanie Coulter, Senior Research Associate at Environics Research (stephanie.coulter@environics.ca).
Colleague / Diad Thank You Card
[appears at top of home screen for participants who are doing interviews with colleagues]
Thank you!
You may wish to add an email address to your profile so we can send you important information about your interview.
Single Interview Thank You Card
[appears at top of home screen for participants who scheduled a one-on-one interview without a colleague]
Thank you!
Don't forget to log back in for your interview.
You may wish to add an email address to your profile so we can send you important information.
Activity Title:
Tell us about you!
Tasks:
1. Prompt - ALL
Name:
Start
Text:
We have a few questions just to confirm that you qualify for the interview.
Button:
Continue
2. Poll - ALL
Name:
Respondent or colleague
Question:
Did you complete the survey, or were you invited by a colleague?
Choices:
I completed the survey Survey respondent stream
I was invited by a colleague Colleague stream
3. Poll – Survey respondent stream
Name:
Single or joint interview
Question:
In the invitation letter, you were given the option to include a colleague in your interview.
Are you planning to do your interview with a colleague?
Choices:
Yes Diad stream
No Single stream
4. Poll – All
Name:
Region
Question:
In what province or territory do you currently practice?
Choices:
5. Poll - All
Name:
Profession
Question:
What is your primary profession?
Choices:
6.Multimedia - All
Name:
Area or Specialty
Question:
What is your area of practice or clinical specialty?
[text box for response]
7. Poll - All
Name:
Question:
On average, how often do you encounter patients with zoonotic infectious diseases in your practice?
Select the option that best describes your experience on average.
Choices:
8. Prompt – Qualified Participants (Survey Respondents)
Name:
Scheduling
Text:
Thank you for your responses. Click on the link below to schedule an interview.
Button:
Schedule my interview
9. Prompt – Qualified Participants (Colleagues)
Name:
Colleague prompt
Text:
Thank you for your responses. Click on the link below to help us match you with the colleague who invited you.
Button:
Match me with my colleague
10. Prompt – Disqualified Participants
Name:
Thank you for your interest.
Text:
Thank you for your interest in this study. At this time, you do not qualify for an interview. If you have any questions, please contact Stephanie Coulter, Senior Research Associate at Environics Research (stephanie.coulter@environics.ca).
Button:
Return to home screen
Name: Colleague matching
Tasks:
1. Multimedia – Colleague stream
Name:
Colleague information
Question:
Please give us the email address of the colleague who invited you to participate in this interview. This will only be used to match you with your colleague for the interview.
[text box for response]
2. Prompt – Colleague stream
Name:
Thank you
Text:
Thank you for providing your details. You have qualified for the interview. We will be asking the colleague who invited you to provide us with your availability for an interview. Please coordinate with them so they can provide us with this information. You will receive a notification from us when the interview has been scheduled.
Button:
Return to home screen
Name:
Scheduling a one-on-one interview
[the module allows participants to choose an available time slot]
Meeting Invitation:
Schedule a one-on-one interview
Select an available date and time between January 9 and January 31.
Schedule Meeting
Name:
Scheduling an interview with a colleague
Tasks:
1. Grid – Survey respondents who are scheduling with a colleague
Name:
Availability
Text:
We would like to schedule an interview with you and your colleague. Please indicate some dates and times that you could be available for a 30 to 45 minute interview with your colleague. The times noted are start times for the interviews, and represent the Eastern time zone. Please note that interview timing is subject to availability. We will contact you to schedule an interview with you and your colleague.
Please confirm availability with your colleague before completing this form. You can return to the site later if you need more time to contact your colleague.
If your colleague is no longer available or interested, please contact Stephanie Coulter, Senior Research Associate, at stephanie.coulter@environics.ca if you would like to schedule a one-on-one interview.
2. Multimedia
Name
Colleague information
Question:
Please give us the email address of the colleague you invited to participate in this interview. This will only be used to match you with your colleague for the interview.
[text box for response]
3. Prompt
Name:
Thank you
Question:
Thank you for providing your availability. We will follow up with you and your colleague to confirm an interview.
Button:
Return to home screen
Name:
Final comments
Tasks:
1. Multimedia – All interview participants
Name:
Additional comments
Text:
Thank you for completing the interview. This research is being conducted on behalf of the Public Health Agency of Canada, to better understand educational needs about zoonotic infectious diseases. Do you have any other comments about this topic in general?
[text box for response]The Shapley regression analysis incorporated external data about each disease. This data was provided by PHAC. Definitions for these variables are outlined in this appendix.
Name | Label | RC1 | RC2 | RC3 | RC4 | RC5 | RC6 | RC7 | Factor |
---|---|---|---|---|---|---|---|---|---|
Q10A5r25 | Rift Valley Fever | 0.656 | 0.079 | 0.103 | 0.041 | -0.022 | 0.108 | -0.009 | 1 |
Q10A3r3 | Marburg virus disease | 0.650 | 0.144 | 0.149 | 0.192 | 0.059 | 0.079 | 0.075 | 1 |
Q10A1r24 | La Crosse encephalitis | 0.643 | 0.052 | -0.029 | 0.033 | 0.061 | 0.074 | 0.192 | 1 |
Q10A3r4 | Lassa hemorrhagic fever | 0.600 | 0.141 | 0.105 | 0.256 | -0.055 | 0.052 | 0.019 | 1 |
Q10A6r26 | Plague | 0.581 | 0.074 | 0.376 | 0.183 | 0.133 | 0.034 | -0.096 | 1 |
Q10A1r21 | California encephalitis | 0.557 | 0.170 | 0.102 | -0.023 | 0.094 | 0.142 | 0.355 | 1 |
Q10A2r13 | St. Louis encephalitis | 0.524 | 0.117 | 0.146 | 0.083 | 0.022 | 0.104 | 0.379 | 1 |
Q10A1r28 | Nipah virus disease | 0.478 | 0.083 | 0.162 | -0.054 | 0.113 | 0.105 | 0.422 | 1 |
Q10A2r4 | Powassan virus disease | 0.459 | -0.036 | 0.041 | 0.113 | 0.036 | 0.356 | 0.139 | 1 |
Q10A3r1 | Crimean Congo hemorrhagic fever | 0.452 | 0.140 | 0.065 | 0.379 | -0.139 | -0.092 | 0.202 | 1 |
Q10A3r2 | Ebola disease | 0.391 | 0.298 | 0.180 | 0.291 | 0.288 | -0.026 | -0.052 | 1 |
Q10A1r27 | Western equine encephalitis virus | 0.373 | 0.154 | 0.186 | -0.112 | 0.171 | 0.327 | 0.156 | 1 |
Q10A1r26 | Eastern equine encephalitis virus | 0.370 | 0.058 | 0.341 | -0.160 | 0.168 | 0.267 | 0.204 | 1 |
Q10A2r10 | Cache valley virus disease | 0.310 | -0.010 | -0.098 | 0.043 | 0.177 | 0.200 | 0.285 | 1 |
Q10A2r12 | Dengue | 0.103 | 0.634 | 0.221 | 0.036 | 0.000 | 0.112 | 0.046 | 2 |
Q10A2r16 | Zika virus infection | 0.055 | 0.628 | 0.026 | 0.102 | 0.088 | 0.146 | 0.036 | 2 |
Q10A2r14 | West Nile virus infection | 0.000 | 0.558 | 0.036 | 0.125 | 0.159 | 0.170 | 0.020 | 2 |
Q10A2r11 | Chikungunya | 0.090 | 0.547 | 0.268 | 0.015 | -0.185 | 0.100 | 0.141 | 2 |
Q10A2r15 | Yellow fever | 0.314 | 0.508 | 0.096 | 0.091 | 0.204 | 0.073 | 0.111 | 2 |
Q10A4r5 | Rabies | 0.179 | 0.475 | -0.023 | 0.061 | 0.201 | -0.056 | -0.028 | 2 |
Q10A1r23 | Japanese encephalitis virus | 0.273 | 0.427 | 0.161 | 0.160 | 0.091 | 0.126 | 0.040 | 2 |
Q10A2r3 | Lyme disease | -0.051 | 0.426 | 0.004 | -0.024 | 0.045 | 0.159 | 0.041 | 2 |
Q10A4r6 | Toxoplasmosis | 0.052 | 0.423 | 0.148 | -0.050 | 0.122 | 0.402 | -0.018 | 2 |
Q10A2r5 | Tickborne encephalitis | 0.246 | 0.412 | -0.030 | 0.107 | 0.206 | 0.298 | -0.065 | 2 |
Q10A6r29 | Mpox (monkeypox) | 0.029 | 0.372 | 0.163 | 0.354 | 0.107 | -0.036 | 0.089 | 2 |
Q10A2r1 | Babesiosis | 0.029 | 0.111 | -0.038 | 0.017 | 0.032 | 0.605 | 0.104 | 3 |
Q10A4r2 | Brucellosis | 0.096 | 0.191 | 0.272 | 0.182 | 0.103 | 0.522 | 0.066 | 3 |
Q10A4r3 | Cryptosporidiosis | 0.093 | 0.254 | 0.198 | 0.200 | -0.004 | 0.511 | -0.093 | 3 |
Q10A2r2 | Human granulocytic anaplasmosis | 0.103 | 0.049 | -0.124 | 0.337 | -0.056 | 0.471 | 0.207 | 3 |
Q10A2r6 | Tularemia | 0.159 | 0.199 | 0.290 | 0.102 | 0.075 | 0.463 | 0.249 | 3 |
Q10A5r27 | Psittacosis | 0.324 | 0.102 | 0.278 | 0.045 | 0.121 | 0.447 | -0.048 | 3 |
Q10A2r9 | Rocky mountain spotted fever | 0.184 | 0.400 | 0.018 | -0.072 | 0.127 | 0.411 | 0.095 | 3 |
Q10A2r7 | Ehrlichiosis | 0.346 | 0.153 | 0.040 | 0.026 | -0.040 | 0.382 | 0.136 | 3 |
Q10A6r28 | Bartonellosis (cat scratch disease) | -0.059 | 0.251 | 0.346 | -0.080 | -0.015 | 0.367 | -0.017 | 3 |
Q10A4r4 | Leptospirosis | 0.207 | 0.262 | 0.224 | 0.105 | 0.042 | 0.347 | 0.068 | 3 |
Q10A5r24 | Q fever | 0.115 | 0.234 | 0.266 | 0.129 | 0.169 | 0.289 | 0.172 | 3 |
Q10A6r23 | American trypanosomiasis (Chagas disease) | 0.210 | 0.271 | 0.558 | 0.046 | 0.098 | 0.127 | 0.153 | 4 |
Q10A6r30 | Murine typhus / endemic typhus | 0.306 | 0.144 | 0.529 | -0.006 | 0.126 | -0.053 | 0.122 | 4 |
Q10A6r27 | Anthrax | 0.303 | 0.076 | 0.494 | 0.125 | 0.222 | -0.019 | 0.029 | 4 |
Q10A6r22 | Cystic echinococcosis | -0.084 | -0.028 | 0.470 | 0.370 | -0.031 | 0.380 | 0.111 | 4 |
Q10A6r24 | Cutaneous larva migrans | -0.040 | 0.200 | 0.453 | 0.146 | -0.177 | 0.229 | 0.032 | 4 |
Q10A6r25 | Toxocariasis | 0.306 | 0.000 | 0.446 | 0.065 | 0.141 | 0.269 | 0.255 | 4 |
Q10A3r5 | Hantavirus – Hemorrhagic fever with renal syndrome | 0.226 | 0.279 | -0.020 | 0.583 | 0.168 | 0.159 | -0.041 | 5 |
Q10A5r23 | Hantavirus – Hantavirus pulmonary syndrome | 0.149 | 0.225 | 0.049 | 0.525 | 0.307 | 0.171 | 0.026 | 5 |
Q10A6r21 | Alveolar echinococcosis | 0.193 | 0.000 | 0.368 | 0.455 | -0.073 | 0.224 | 0.262 | 5 |
Q10A6r31 | Louse-borne relapsing fever | 0.296 | -0.080 | 0.305 | 0.452 | 0.034 | 0.138 | 0.120 | 5 |
Q10A5r22 | Avian (zoonotic) influenza H7N9 | 0.073 | 0.102 | 0.078 | 0.103 | 0.726 | 0.069 | 0.091 | 6 |
Q10A5r21 | Avian (zoonotic) influenza H5N1 | 0.011 | 0.156 | 0.040 | 0.015 | 0.703 | 0.144 | 0.032 | 6 |
Q10A5r26 | MERS-CoV infection | 0.026 | 0.217 | 0.059 | 0.047 | 0.552 | -0.040 | 0.089 | 6 |
Q10A4r1 | Bovine tuberculosis | 0.277 | 0.063 | 0.230 | 0.079 | 0.286 | 0.245 | -0.058 | 6 |
Q10A1r22 | Jamestown Canyon virus | 0.143 | 0.111 | 0.135 | 0.120 | 0.008 | 0.065 | 0.743 | 7 |
Q10A1r25 | Snowshoe hare encephalitis | 0.250 | 0.045 | 0.166 | 0.089 | 0.128 | 0.146 | 0.737 | 7 |
Factor | Cluster 1 | Cluster 2 | Cluster 3 | Cluster 4 | |
---|---|---|---|---|---|
Cache valley virus disease | 1 | 7% | 3% | 1% | 1% |
California encephalitis | 1 | 30% | 3% | <1% | 2% |
Crimean Congo hemorrhagic fever | 1 | 13% | 2% | 0% | 1% |
Eastern equine encephalitis virus | 1 | 34% | 6% | 1% | 3% |
Ebola disease | 1 | 38% | 14% | 2% | 4% |
La Crosse encephalitis | 1 | 16% | 2% | 1% | 1% |
Lassa hemorrhagic fever | 1 | 17% | 1% | <1% | 1% |
Marburg virus disease | 1 | 23% | 1% | 0% | 1% |
Nipah virus disease | 1 | 23% | 1% | 1% | 0% |
Plague | 1 | 26% | 4% | <1% | 2% |
Powassan virus disease | 1 | 20% | 1% | <1% | 2% |
Rift Valley Fever | 1 | 18% | 1% | <1% | 1% |
St. Louis encephalitis | 1 | 25% | 2% | <1% | <1% |
Western equine encephalitis virus | 1 | 47% | 8% | 1% | 8% |
Chikungunya | 2 | 68% | 25% | 7% | 17% |
Dengue | 2 | 94% | 54% | 12% | 29% |
Japanese encephalitis virus | 2 | 52% | 13% | 2% | 8% |
Lyme disease | 2 | 100% | 95% | 65% | 94% |
Mpox (monkeypox) | 2 | 53% | 30% | 6% | 22% |
Rabies | 2 | 75% | 62% | 20% | 41% |
Tick-borne encephalitis | 2 | 66% | 35% | 3% | 16% |
Toxoplasmosis | 2 | 97% | 68% | 16% | 35% |
West Nile virus infection | 2 | 90% | 54% | 1% | 96% |
Yellow fever | 2 | 67% | 22% | 2% | 11% |
Zika virus infection | 2 | 83% | 61% | 7% | 33% |
Babesiosis | 3 | 35% | 10% | 2% | 6% |
Bartonellosis (cat scratch disease) | 3 | 77% | 34% | 18% | 33% |
Brucellosis | 3 | 72% | 13% | 4% | 7% |
Cryptosporidiosis | 3 | 79% | 20% | 6% | 18% |
Ehrlichiosis | 3 | 36% | 5% | 2% | 2% |
Human granulocytic anaplasmosis | 3 | 28% | 5% | 2% | 2% |
Leptospirosis | 3 | 61% | 13% | 2% | 9% |
Psittacosis | 3 | 51% | 9% | 2% | 5% |
Q fever | 3 | 63% | 17% | 2% | 10% |
Rocky mountain spotted fever | 3 | 73% | 25% | 4% | 14% |
Tularemia | 3 | 66% | 7% | 2% | 6% |
American trypanosomiasis (Chagas disease) | 4 | 51% | 6% | 1% | 2% |
Anthrax | 4 | 27% | 2% | 1% | 5% |
Cutaneous larva migrans | 4 | 59% | 15% | 9% | 16% |
Cystic echinococcosis | 4 | 39% | 5% | 2% | 4% |
Murine typhus/ endemic typhus | 4 | 25% | 3% | 1% | 1% |
Toxocariasis | 4 | 30% | 3% | 1% | 1% |
Alveolar echinococcosis | 5 | 28% | 2% | <1% | 1% |
Hantavirus – Hantavirus pulmonary syndrome | 5 | 49% | 15% | 2% | 5% |
Hantavirus – Hemorrhagic fever with renal syndrome | 5 | 49% | 13% | 2% | 5% |
Louse-borne relapsing fever | 5 | 18% | <1% | 1% | 2% |
Avian (zoonotic) influenza: H5N1 | 6 | 69% | 72% | 18% | 23% |
Avian (zoonotic) influenza: H7N9 | 6 | 41% | 48% | 7% | 8% |
Bovine tuberculosis | 6 | 46% | 16% | 4% | 6% |
MERS-CoV infection | 6 | 47% | 69% | 18% | 7% |
Jamestown Canyon virus | 7 | 20% | 1% | 1% | <1% |
Snowshoe hare encephalitis | 7 | 25% | 2% | 1% | 0% |
Variable | Variable description | Alveolar Echinococcosis | Chagas disease | Anthrax | Avian influenza A(H5N1) | Avian influenza A - H7N9 | Babesiosis | Bartonellosis |
---|---|---|---|---|---|---|---|---|
R2 | R-squared value | 40% | 34% | 26% | 43% | 37% | 36% | 49% |
Q6 | Level of knowledge | 18% | 26% | 26% | 10% | 10% | 23% | 12% |
Q10A | Encountered disease | 55% | 39% | 33% | 76% | 72% | 52% | 69% |
Q1B | Province | 2% | 4% | 2% | 1% | 1% | 3% | 2% |
Q2 | Profession type | 2% | 4% | 4% | <1% | <1% | 4% | 3% |
Q4r2 | Specialty - Family medicine | 1% | 1% | 1% | <1% | <1% | <1% | <1% |
Q7 | Satisfaction with education | 3% | 3% | 6% | 1% | 2% | 3% | 2% |
Q4r6 | Specialty - Community Health | <1% | 1% | 1% | <1% | <1% | 1% | <1% |
Q22_1 | Practice setting - Family medicine clinic | 1% | 1% | 1% | <1% | 1% | 1% | 1% |
Q17Ar1 | Years of practice | <1% | <1% | <1% | <1% | 1% | <1% | <1% |
Q17Cr1 | Years of practice Internationally | 4% | 6% | 8% | <1% | 1% | 4% | 2% |
Q4r1 | Specialty - Infectious disease | 6% | 5% | 3% | 2% | 3% | 2% | <1% |
Q4r3 | Specialty - Public health and preventive medicine | <1% | <1% | <1% | <1% | <1% | 1% | 1% |
Q4r4 | Specialty - Obstetrics/Gynecology | <1% | <1% | 1% | <1% | <1% | 1% | 1% |
Q4r7 | Specialty - Emergency medicine/critical care | 1% | <1% | <1% | 3% | 2% | <1% | 1% |
Q4r8 | Specialty - Internal medicine | <1% | <1% | <1% | <1% | <1% | <1% | <1% |
Q4r91 | Specialty - Surgery | <1% | 1% | 1% | <1% | <1% | <1% | <1% |
Q22_2 | Practice setting - Hospital setting | 1% | 3% | 2% | 2% | 1% | 2% | 1% |
Q22_5 | Practice setting - Community health centre | <1% | <1% | 1% | <1% | <1% | <1% | <1% |
Q22_7 | Practice setting - Public health clinic/setting | 1% | 1% | 1% | <1% | <1% | <1% | 2% |
Q12r1 | Confidence - Patient assessment | <1% | <1% | <1% | <1% | <1% | <1% | <1% |
Q12r2 | Confidence - Diagnosis | <1% | <1% | <1% | <1% | <1% | <1% | <1% |
Q12r3 | Confidence - Infection prevention and control measures | <1% | <1% | 1% | <1% | 1% | <1% | <1% |
Q12r4 | Confidence - Patient management | <1% | <1% | <1% | <1% | <1% | <1% | <1% |
Q12r5 | Confidence - Patient education | <1% | <1% | <1% | <1% | <1% | <1% | <1% |
Q12r6 | Confidence - Contact tracing | <1% | <1% | <1% | <1% | <1% | 1% | <1% |
Q12r7 | Confidence - Public Health Reporting | <1% | <1% | 1% | 1% | 1% | <1% | <1% |
URBAN_RURAL | Urban vs Rural setting | <1% | 1% | <1% | <1% | <1% | <1% | <1% |
Q4r5 | Specialty - Pediatrics | <1% | <1% | <1% | <1% | <1% | <1% | <1% |
Q22_3 | Practice setting - Walk-in clinic or urgent care | <1% | <1% | <1% | <1% | <1% | <1% | <1% |
Q22_4 | Practice setting - Specialized travel health centre/clinic | <1% | <1% | <1% | <1% | <1% | <1% | <1% |
Q22_6 | Practice setting - Long-term care residence | <1% | <1% | 3% | <1% | 1% | <1% | <1% |
Q20 | Northern experience | 1% | 1% | 1% | <1% | <1% | <1% | <1% |
Q26 | Indigenous experience | <1% | 1% | 1% | <1% | 1% | 1% | <1% |
Variable | Variable description | Bovine tuberculosis | Brucellosis | Cache Valley virus | California encephalitis | Chikungunya | Crimean-Congo hem. fever |
---|---|---|---|---|---|---|---|
R2 | R-squared value | 42% | 46% | 24% | 31% | 40% | 26% |
Q6 | Level of knowledge | 14% | 20% | 23% | 26% | 16% | 19% |
Q10A | Encountered disease | 62% | 55% | 38% | 49% | 63% | 38% |
Q1B | Province | 1% | 2% | 2% | 2% | 4% | 6% |
Q2 | Profession type | 1% | 4% | <1% | 1% | 4% | 2% |
Q4r2 | Specialty - Family medicine | 1% | <1% | 1% | <1% | <1% | 1% |
Q7 | Satisfaction with education | 2% | 2% | 2% | 5% | 1% | 3% |
Q4r6 | Specialty - Community Health | <1% | <1% | <1% | <1% | 1% | <1% |
Q22_1 | Practice setting - Family medicine clinic | 1% | <1% | <1% | <1% | 1% | <1% |
Q17Ar1 | Years of practice | <1% | 1% | <1% | <1% | <1% | <1% |
Q17Cr1 | Years of practice Internationally | 5% | 6% | 15% | 6% | 3% | 9% |
Q4r1 | Specialty - Infectious disease | 2% | 3% | 6% | 2% | 2% | 9% |
Q4r3 | Specialty - Public health and preventive medicine | <1% | <1% | 1% | 1% | <1% | 1% |
Q4r4 | Specialty - Obstetrics/Gynecology | 1% | <1% | <1% | 1% | <1% | <1% |
Q4r7 | Specialty - Emergency medicine/critical care | <1% | <1% | 1% | <1% | <1% | <1% |
Q4r8 | Specialty - Internal medicine | <1% | 1% | <1% | <1% | <1% | <1% |
Q4r91 | Specialty - Surgery | <1% | <1% | <1% | <1% | <1% | <1% |
Q22_2 | Practice setting - Hospital setting | 1% | 1% | 1% | 1% | <1% | 2% |
Q22_5 | Practice setting - Community health centre | <1% | <1% | <1% | <1% | <1% | <1% |
Q22_7 | Practice setting - Public health clinic/setting | <1% | 1% | 1% | 1% | 1% | 1% |
Q12r1 | Confidence - Patient assessment | <1% | <1% | <1% | <1% | <1% | <1% |
Q12r2 | Confidence - Diagnosis | <1% | <1% | <1% | <1% | <1% | 1% |
Q12r3 | Confidence - Infection prevention and control measures | <1% | <1% | <1% | <1% | <1% | <1% |
Q12r4 | Confidence - Patient management | <1% | <1% | 1% | <1% | <1% | <1% |
Q12r5 | Confidence - Patient education | <1% | <1% | <1% | <1% | <1% | 1% |
Q12r6 | Confidence - Contact tracing | <1% | <1% | <1% | <1% | <1% | <1% |
Q12r7 | Confidence - Public Health Reporting | <1% | <1% | <1% | <1% | <1% | <1% |
URBAN_RURAL | Urban vs Rural setting | <1% | <1% | <1% | <1% | <1% | <1% |
Q4r5 | Specialty - Pediatrics | <1% | <1% | <1% | <1% | <1% | <1% |
Q22_3 | Practice setting - Walk-in clinic or urgent care | <1% | <1% | 1% | <1% | <1% | <1% |
Q22_4 | Practice setting - Specialized travel health centre/clinic | <1% | <1% | <1% | 1% | <1% | <1% |
Q22_6 | Practice setting - Long-term care residence | <1% | <1% | 1% | 1% | 1% | 1% |
Q20 | Northern experience | 4% | 1% | 2% | <1% | <1% | 2% |
Q26 | Indigenous experience | 2% | <1% | 1% | <1% | <1% | 1% |
Variable | Variable description | Cryptosporidiosis | Cutaneous Larva Migrans | Cystic Echinococcosis | Dengue virus | E. equine encephalitis virus | Ebola disease | Ehrlichiosis |
---|---|---|---|---|---|---|---|---|
R2 | R-squared value | 51% | 51% | 44% | 37% | 39% | 26% | 37% |
Q6 | Level of knowledge | 23% | 10% | 18% | 19% | 17% | 15% | 22% |
Q10A | Encountered disease | 59% | 69% | 54% | 59% | 57% | 43% | 52% |
Q1B | Province | 1% | 2% | 2% | 2% | 1% | 4% | 3% |
Q2 | Profession type | 2% | 7% | 3% | 3% | 1% | 3% | 1% |
Q4r2 | Specialty - Family medicine | 1% | 1% | 1% | <1% | 1% | 2% | 1% |
Q7 | Satisfaction with education | 2% | 2% | 4% | 1% | 2% | 2% | 4% |
Q4r6 | Specialty - Community Health | 1% | 1% | 1% | <1% | <1% | <1% | <1% |
Q22_1 | Practice setting - Family medicine clinic | 1% | 1% | 1% | <1% | <1% | 1% | <1% |
Q17Ar1 | Years of practice | <1% | <1% | <1% | 1% | 1% | 1% | <1% |
Q17Cr1 | Years of practice Internationally | 2% | 2% | 6% | 10% | 8% | 6% | 5% |
Q4r1 | Specialty - Infectious disease | 4% | 1% | 3% | 1% | 5% | 4% | 3% |
Q4r3 | Specialty - Public health and preventive medicine | <1% | 1% | <1% | <1% | 1% | <1% | <1% |
Q4r4 | Specialty - Obstetrics/Gynecology | 1% | <1% | <1% | 1% | <1% | 1% | 1% |
Q4r7 | Specialty - Emergency medicine/critical care | <1% | <1% | 1% | <1% | <1% | 2% | 1% |
Q4r8 | Specialty - Internal medicine | <1% | 1% | <1% | <1% | <1% | <1% | <1% |
Q4r91 | Specialty - Surgery | <1% | <1% | <1% | <1% | <1% | <1% | <1% |
Q22_2 | Practice setting - Hospital setting | 1% | <1% | 1% | <1% | 1% | 3% | 1% |
Q22_5 | Practice setting - Community health centre | <1% | <1% | <1% | <1% | <1% | <1% | <1% |
Q22_7 | Practice setting - Public health clinic/setting | <1% | 1% | 1% | <1% | 1% | 1% | 1% |
Q12r1 | Confidence - Patient assessment | <1% | <1% | <1% | <1% | <1% | <1% | <1% |
Q12r2 | Confidence - Diagnosis | <1% | <1% | <1% | <1% | <1% | 1% | <1% |
Q12r3 | Confidence - Infection prevention and control measures | <1% | <1% | <1% | <1% | <1% | 1% | <1% |
Q12r4 | Confidence - Patient management | <1% | <1% | <1% | <1% | <1% | 1% | <1% |
Q12r5 | Confidence - Patient education | <1% | <1% | <1% | <1% | <1% | <1% | <1% |
Q12r6 | Confidence - Contact tracing | <1% | <1% | <1% | <1% | <1% | <1% | <1% |
Q12r7 | Confidence - Public Health Reporting | <1% | <1% | <1% | <1% | <1% | 1% | <1% |
URBAN_RURAL | Urban vs Rural setting | <1% | <1% | <1% | 1% | <1% | 1% | <1% |
Q4r5 | Specialty - Pediatrics | <1% | <1% | <1% | <1% | <1% | <1% | <1% |
Q22_3 | Practice setting - Walk-in clinic or urgent care | <1% | <1% | <1% | <1% | <1% | <1% | <1% |
Q22_4 | Practice setting - Specialized travel health centre/clinic | <1% | <1% | <1% | <1% | <1% | <1% | <1% |
Q22_6 | Practice setting - Long-term care residence | <1% | <1% | 1% | <1% | <1% | 1% | 1% |
Q20 | Northern experience | <1% | <1% | 1% | <1% | <1% | 2% | 1% |
Q26 | Indigenous experience | <1% | <1% | 1% | <1% | 1% | 3% | 1% |
Variable | Variable description | Hantavirus - Pulmonary | Hantavirus - Hemorrhagic | H. granulocytic anaplasm. | Jamestown Canyon virus | Japanese encephalitis virus | La Crosse encephalitis |
---|---|---|---|---|---|---|---|
R2 | R-squared value | 39% | 35% | 35% | 35% | 33% | 31% |
Q6 | Level of knowledge | 13% | 19% | 21% | 18% | 23% | 16% |
Q10A | Encountered disease | 70% | 50% | 53% | 59% | 58% | 55% |
Q1B | Province | 3% | 5% | 3% | 2% | 2% | 2% |
Q2 | Profession type | <1% | 1% | 1% | <1% | 1% | <1% |
Q4r2 | Specialty - Family medicine | 1% | 1% | 2% | <1% | <1% | <1% |
Q7 | Satisfaction with education | 1% | 2% | 3% | 4% | 2% | 7% |
Q4r6 | Specialty - Community Health | <1% | <1% | <1% | <1% | <1% | <1% |
Q22_1 | Practice setting - Family medicine clinic | <1% | 1% | <1% | 1% | 1% | <1% |
Q17Ar1 | Years of practice | 1% | <1% | <1% | <1% | <1% | <1% |
Q17Cr1 | Years of practice Internationally | 2% | 5% | 5% | 4% | 4% | 10% |
Q4r1 | Specialty - Infectious disease | 4% | 6% | 5% | 3% | 2% | 2% |
Q4r3 | Specialty - Public health and preventive medicine | <1% | <1% | <1% | <1% | 1% | 1% |
Q4r4 | Specialty - Obstetrics/Gynecology | 1% | 1% | <1% | 1% | <1% | 1% |
Q4r7 | Specialty - Emergency medicine/critical care | <1% | <1% | <1% | <1% | <1% | <1% |
Q4r8 | Specialty - Internal medicine | <1% | <1% | <1% | <1% | <1% | <1% |
Q4r91 | Specialty - Surgery | <1% | <1% | <1% | <1% | <1% | <1% |
Q22_2 | Practice setting - Hospital setting | <1% | 2% | 1% | 1% | <1% | <1% |
Q22_5 | Practice setting - Community health centre | <1% | <1% | <1% | <1% | 1% | <1% |
Q22_7 | Practice setting - Public health clinic/setting | <1% | 1% | 1% | <1% | 1% | 1% |
Q12r1 | Confidence - Patient assessment | <1% | <1% | <1% | <1% | <1% | <1% |
Q12r2 | Confidence - Diagnosis | <1% | 1% | <1% | <1% | <1% | <1% |
Q12r3 | Confidence - Infection prevention and control measures | <1% | <1% | <1% | <1% | <1% | <1% |
Q12r4 | Confidence - Patient management | <1% | <1% | 1% | <1% | <1% | <1% |
Q12r5 | Confidence - Patient education | <1% | <1% | <1% | <1% | <1% | <1% |
Q12r6 | Confidence - Contact tracing | <1% | <1% | <1% | 1% | <1% | <1% |
Q12r7 | Confidence - Public Health Reporting | <1% | <1% | <1% | <1% | <1% | <1% |
URBAN_RURAL | Urban vs Rural setting | <1% | <1% | <1% | <1% | <1% | <1% |
Q4r5 | Specialty - Pediatrics | <1% | 1% | <1% | <1% | <1% | <1% |
Q22_3 | Practice setting - Walk-in clinic or urgent care | <1% | <1% | <1% | <1% | <1% | <1% |
Q22_4 | Practice setting - Specialized travel health centre/clinic | <1% | <1% | <1% | 2% | <1% | <1% |
Q22_6 | Practice setting - Long-term care residence | <1% | <1% | <1% | 1% | <1% | 2% |
Q20 | Northern experience | <1% | 1% | <1% | <1% | <1% | <1% |
Q26 | Indigenous experience | 2% | 2% | 1% | <1% | <1% | <1% |
Variable | Variable description | Lassa haemorrhagic fever | Leptospirosis | Louse-borne relap. fever | Lyme disease | Marburg virus disease | MERS-CoV | Mpox |
---|---|---|---|---|---|---|---|---|
R2 | R-squared value | 28% | 41% | 25% | 32% | 26% | 51% | 36% |
Q6 | Level of knowledge | 16% | 21% | 30% | 32% | 18% | 6% | 20% |
Q10A | Encountered disease | 42% | 52% | 24% | 24% | 42% | 82% | 55% |
Q1B | Province | 3% | 2% | 5% | 11% | 2% | 1% | 4% |
Q2 | Profession type | 1% | 3% | 1% | 6% | 1% | 1% | <1% |
Q4r2 | Specialty - Family medicine | 1% | <1% | 3% | 5% | 2% | 1% | 1% |
Q7 | Satisfaction with education | 3% | 3% | 5% | 3% | 2% | <1% | 1% |
Q4r6 | Specialty - Community Health | <1% | <1% | <1% | 2% | <1% | <1% | <1% |
Q22_1 | Practice setting - Family medicine clinic | <1% | <1% | 1% | 2% | 1% | 1% | 1% |
Q17Ar1 | Years of practice | 1% | <1% | <1% | 2% | 1% | 1% | <1% |
Q17Cr1 | Years of practice Internationally | 15% | 8% | 9% | 2% | 6% | <1% | <1% |
Q4r1 | Specialty - Infectious disease | 5% | 2% | 9% | 1% | 9% | 1% | 3% |
Q4r3 | Specialty - Public health and preventive medicine | <1% | <1% | 1% | 1% | 1% | <1% | 3% |
Q4r4 | Specialty - Obstetrics/Gynecology | 1% | 1% | 1% | 1% | 1% | <1% | 1% |
Q4r7 | Specialty - Emergency medicine/critical care | <1% | <1% | 1% | 1% | <1% | 2% | 1% |
Q4r8 | Specialty - Internal medicine | <1% | <1% | <1% | 1% | <1% | <1% | 1% |
Q4r91 | Specialty - Surgery | <1% | <1% | <1% | 1% | <1% | <1% | <1% |
Q22_2 | Practice setting - Hospital setting | 1% | 1% | 2% | 1% | 1% | 1% | <1% |
Q22_5 | Practice setting - Community health centre | <1% | <1% | <1% | 1% | <1% | <1% | <1% |
Q22_7 | Practice setting - Public health clinic/setting | <1% | <1% | 1% | 1% | 1% | <1% | 3% |
Q12r1 | Confidence - Patient assessment | <1% | <1% | <1% | <1% | <1% | <1% | 1% |
Q12r2 | Confidence - Diagnosis | <1% | <1% | 1% | <1% | <1% | <1% | <1% |
Q12r3 | Confidence - Infection prevention and control measures | <1% | <1% | 1% | <1% | <1% | <1% | <1% |
Q12r4 | Confidence - Patient management | <1% | <1% | 1% | <1% | 1% | <1% | <1% |
Q12r5 | Confidence - Patient education | <1% | <1% | <1% | <1% | <1% | <1% | <1% |
Q12r6 | Confidence - Contact tracing | <1% | <1% | 1% | <1% | <1% | <1% | <1% |
Q12r7 | Confidence - Public Health Reporting | <1% | <1% | <1% | <1% | <1% | 1% | <1% |
URBAN_RURAL | Urban vs Rural setting | <1% | 1% | <1% | <1% | 1% | <1% | <1% |
Q4r5 | Specialty - Pediatrics | <1% | <1% | 1% | <1% | <1% | <1% | 1% |
Q22_3 | Practice setting - Walk-in clinic or urgent care | 1% | <1% | <1% | <1% | 1% | <1% | 1% |
Q22_4 | Practice setting - Specialized travel health centre/clinic | <1% | <1% | <1% | <1% | <1% | <1% | <1% |
Q22_6 | Practice setting - Long-term care residence | 4% | 1% | 1% | <1% | 2% | 1% | <1% |
Q20 | Northern experience | 1% | 1% | 1% | <1% | 3% | <1% | <1% |
Q26 | Indigenous experience | 2% | 1% | <1% | <1% | 2% | <1% | 1% |
Variable | Variable description | Nipah virus | Plague | Powassan virus disease | Psittacosis | Q Fever | Rabies |
---|---|---|---|---|---|---|---|
R2 | R-squared value | 28% | 21% | 27% | 48% | 54% | 32% |
Q6 | Level of knowledge | 24% | 30% | 25% | 14% | 6% | 18% |
Q10A | Encountered disease | 36% | 27% | 37% | 65% | 83% | 49% |
Q1B | Province | 1% | 3% | 4% | 4% | 1% | 3% |
Q2 | Profession type | <1% | 3% | 2% | 2% | <1% | 1% |
Q4r2 | Specialty - Family medicine | <1% | 1% | 1% | <1% | 1% | <1% |
Q7 | Satisfaction with education | 4% | 7% | 5% | 2% | 1% | 2% |
Q4r6 | Specialty - Community Health | <1% | <1% | <1% | <1% | <1% | 1% |
Q22_1 | Practice setting - Family medicine clinic | 1% | 1% | <1% | <1% | <1% | 1% |
Q17Ar1 | Years of practice | <1% | <1% | 1% | 1% | <1% | 1% |
Q17Cr1 | Years of practice Internationally | 13% | 6% | 9% | 3% | 1% | 2% |
Q4r1 | Specialty - Infectious disease | 7% | 4% | 5% | 4% | 4% | 1% |
Q4r3 | Specialty - Public health and preventive medicine | 2% | <1% | 1% | <1% | <1% | 4% |
Q4r4 | Specialty - Obstetrics/Gynecology | 1% | 1% | 1% | <1% | 1% | 1% |
Q4r7 | Specialty - Emergency medicine/critical care | <1% | <1% | <1% | <1% | <1% | 3% |
Q4r8 | Specialty - Internal medicine | <1% | <1% | <1% | 1% | <1% | 2% |
Q4r91 | Specialty - Surgery | <1% | <1% | <1% | <1% | <1% | 1% |
Q22_2 | Practice setting - Hospital setting | 2% | 3% | 1% | 1% | <1% | <1% |
Q22_5 | Practice setting - Community health centre | <1% | <1% | <1% | <1% | <1% | <1% |
Q22_7 | Practice setting - Public health clinic/setting | 2% | <1% | 1% | <1% | <1% | 5% |
Q12r1 | Confidence - Patient assessment | <1% | <1% | <1% | <1% | <1% | <1% |
Q12r2 | Confidence - Diagnosis | <1% | <1% | <1% | <1% | <1% | <1% |
Q12r3 | Confidence - Infection prevention and control measures | <1% | <1% | <1% | <1% | <1% | 2% |
Q12r4 | Confidence - Patient management | <1% | <1% | 1% | <1% | <1% | <1% |
Q12r5 | Confidence - Patient education | <1% | <1% | <1% | <1% | <1% | <1% |
Q12r6 | Confidence - Contact tracing | 1% | <1% | <1% | <1% | <1% | <1% |
Q12r7 | Confidence - Public Health Reporting | <1% | 1% | <1% | <1% | <1% | <1% |
URBAN_RURAL | Urban vs Rural setting | <1% | <1% | <1% | <1% | <1% | <1% |
Q4r5 | Specialty - Pediatrics | <1% | 1% | <1% | <1% | <1% | <1% |
Q22_3 | Practice setting - Walk-in clinic or urgent care | <1% | 1% | <1% | <1% | <1% | <1% |
Q22_4 | Practice setting - Specialized travel health centre/clinic | 1% | <1% | <1% | <1% | <1% | <1% |
Q22_6 | Practice setting - Long-term care residence | 1% | 2% | 1% | 1% | <1% | <1% |
Q20 | Northern experience | <1% | <1% | 1% | <1% | <1% | 1% |
Q26 | Indigenous experience | 1% | 3% | 2% | <1% | 1% | 1% |
Variable | Variable description | Rift Valley fever | R. mountain spotted fever | Snowshoe hare enceph. | St. Louis encephalitis | Tick-borne encephalitis | Toxocariasis | Toxoplasmosis |
---|---|---|---|---|---|---|---|---|
R2 | R-squared value | 31% | 37% | 33% | 35% | 43% | 36% | 36% |
Q6 | Level of knowledge | 23% | 22% | 24% | 17% | 21% | 19% | 22% |
Q10A | Encountered disease | 52% | 52% | 50% | 63% | 64% | 47% | 51% |
Q1B | Province | 3% | 1% | 2% | 1% | 1% | 2% | 4% |
Q2 | Profession type | 1% | 3% | 1% | 2% | 2% | 3% | 5% |
Q4r2 | Specialty - Family medicine | 1% | <1% | <1% | <1% | <1% | 1% | <1% |
Q7 | Satisfaction with education | 3% | 4% | 4% | 1% | 1% | 4% | 2% |
Q4r6 | Specialty - Community Health | <1% | 1% | <1% | <1% | <1% | <1% | 1% |
Q22_1 | Practice setting - Family medicine clinic | 1% | 1% | 1% | <1% | 1% | <1% | <1% |
Q17Ar1 | Years of practice | <1% | 1% | <1% | <1% | <1% | <1% | <1% |
Q17Cr1 | Years of practice Internationally | 4% | 5% | 7% | 5% | 4% | 8% | 4% |
Q4r1 | Specialty - Infectious disease | 4% | 1% | 3% | 3% | 2% | 6% | 1% |
Q4r3 | Specialty - Public health and preventive medicine | <1% | <1% | 1% | 1% | <1% | <1% | 1% |
Q4r4 | Specialty - Obstetrics/Gynecology | 1% | 1% | <1% | 1% | <1% | <1% | <1% |
Q4r7 | Specialty - Emergency medicine/critical care | 1% | 2% | <1% | <1% | 1% | 1% | <1% |
Q4r8 | Specialty - Internal medicine | 1% | <1% | <1% | <1% | <1% | <1% | <1% |
Q4r91 | Specialty - Surgery | <1% | <1% | <1% | <1% | <1% | <1% | <1% |
Q22_2 | Practice setting - Hospital setting | 1% | 1% | 1% | 1% | 1% | 1% | 2% |
Q22_5 | Practice setting - Community health centre | <1% | <1% | 1% | <1% | <1% | <1% | <1% |
Q22_7 | Practice setting - Public health clinic/setting | <1% | 2% | 1% | 1% | <1% | 1% | <1% |
Q12r1 | Confidence - Patient assessment | <1% | <1% | <1% | <1% | <1% | <1% | <1% |
Q12r2 | Confidence - Diagnosis | <1% | <1% | <1% | <1% | <1% | <1% | <1% |
Q12r3 | Confidence - Infection prevention and control measures | <1% | <1% | <1% | <1% | 1% | <1% | <1% |
Q12r4 | Confidence - Patient management | <1% | 1% | <1% | <1% | <1% | <1% | <1% |
Q12r5 | Confidence - Patient education | <1% | <1% | <1% | <1% | <1% | <1% | <1% |
Q12r6 | Confidence - Contact tracing | <1% | <1% | <1% | <1% | <1% | <1% | <1% |
Q12r7 | Confidence - Public Health Reporting | <1% | <1% | <1% | <1% | <1% | <1% | <1% |
URBAN_RURAL | Urban vs Rural setting | <1% | <1% | <1% | <1% | <1% | 1% | <1% |
Q4r5 | Specialty - Pediatrics | <1% | <1% | <1% | <1% | <1% | 1% | <1% |
Q22_3 | Practice setting - Walk-in clinic or urgent care | <1% | 1% | <1% | <1% | <1% | <1% | <1% |
Q22_4 | Practice setting - Specialized travel health centre/clinic | <1% | <1% | <1% | <1% | <1% | <1% | <1% |
Q22_6 | Practice setting - Long-term care residence | <1% | <1% | 2% | 1% | <1% | 1% | <1% |
Q20 | Northern experience | 1% | <1% | <1% | 1% | <1% | <1% | 1% |
Q26 | Indigenous experience | <1% | 1% | <1% | 1% | 1% | 2% | 2% |
Variable | Variable description | Tularemia | Murine typhus | West Nile virus | W. equine encephalitis | Yellow fever | Zika virus |
---|---|---|---|---|---|---|---|
R2 | R-squared value | 44% | 30% | 39% | 41% | 36% | 32% |
Q6 | Level of knowledge | 17% | 24% | 20% | 19% | 21% | 26% |
Q10A | Encountered disease | 59% | 42% | 56% | 61% | 56% | 55% |
Q1B | Province | 3% | 3% | 6% | <1% | 4% | 4% |
Q2 | Profession type | 4% | 3% | <1% | 1% | <1% | 2% |
Q4r2 | Specialty - Family medicine | <1% | 1% | <1% | <1% | <1% | <1% |
Q7 | Satisfaction with education | 2% | 5% | 2% | 3% | 1% | 1% |
Q4r6 | Specialty - Community Health | 1% | 1% | 1% | <1% | <1% | 1% |
Q22_1 | Practice setting - Family medicine clinic | <1% | 1% | 1% | 1% | <1% | <1% |
Q17Ar1 | Years of practice | <1% | <1% | <1% | <1% | 1% | 2% |
Q17Cr1 | Years of practice Internationally | 4% | 4% | <1% | 5% | 6% | 4% |
Q4r1 | Specialty - Infectious disease | 3% | 4% | 3% | 2% | 1% | 2% |
Q4r3 | Specialty - Public health and preventive medicine | <1% | 1% | 1% | <1% | <1% | <1% |
Q4r4 | Specialty - Obstetrics/Gynecology | <1% | 1% | 2% | 1% | 1% | 1% |
Q4r7 | Specialty - Emergency medicine/critical care | <1% | 1% | 1% | <1% | 1% | <1% |
Q4r8 | Specialty - Internal medicine | <1% | <1% | 1% | <1% | <1% | <1% |
Q4r91 | Specialty - Surgery | <1% | <1% | <1% | <1% | <1% | <1% |
Q22_2 | Practice setting - Hospital setting | 1% | 2% | 1% | 1% | <1% | 1% |
Q22_5 | Practice setting - Community health centre | <1% | <1% | <1% | <1% | <1% | <1% |
Q22_7 | Practice setting - Public health clinic/setting | <1% | 2% | 1% | <1% | <1% | <1% |
Q12r1 | Confidence - Patient assessment | <1% | <1% | <1% | <1% | <1% | <1% |
Q12r2 | Confidence - Diagnosis | <1% | <1% | <1% | <1% | <1% | <1% |
Q12r3 | Confidence - Infection prevention and control measures | <1% | <1% | 1% | <1% | 1% | <1% |
Q12r4 | Confidence - Patient management | <1% | <1% | <1% | <1% | <1% | <1% |
Q12r5 | Confidence - Patient education | <1% | <1% | <1% | <1% | <1% | <1% |
Q12r6 | Confidence - Contact tracing | <1% | <1% | <1% | <1% | <1% | <1% |
Q12r7 | Confidence - Public Health Reporting | <1% | <1% | <1% | <1% | 1% | <1% |
URBAN_RURAL | Urban vs Rural setting | <1% | <1% | 1% | <1% | <1% | <1% |
Q4r5 | Specialty - Pediatrics | <1% | <1% | <1% | <1% | <1% | <1% |
Q22_3 | Practice setting - Walk-in clinic or urgent care | <1% | 1% | <1% | <1% | <1% | <1% |
Q22_4 | Practice setting - Specialized travel health centre/clinic | <1% | <1% | <1% | 1% | <1% | <1% |
Q22_6 | Practice setting - Long-term care residence | 1% | 1% | <1% | 1% | 1% | <1% |
Q20 | Northern experience | 1% | 1% | <1% | <1% | 1% | <1% |
Q26 | Indigenous experience | 1% | <1% | 1% | 1% | 1% | <1% |
The following table lists all 52 diseases, ranked by the % encountered, along with mean self-reported confidence ratings.
Q10A and Q10B. Please indicate which diseases you have encountered in your practice, and rate your level of confidence in managing each zoonotic infectious disease. Base: All respondents (n = 1,023).
Disease | Encountered % | Mean confidence | Disease | Encountered % | Mean confidence | Disease | Encountered % | Mean confidence | Disease | Encountered % | Mean confidence |
---|---|---|---|---|---|---|---|---|---|---|---|
Lyme | 80% | 2.20 | Cryptosporidiosis | 17% | 1.32 | Ebola disease | 7% | 1.31 | Snowshoe hare encephalitis | 3% | 1.12 |
West Nile | 38% | 1.63 | Cutaneous larva migrans | 15% | 1.34 | Western equine encephalitis | 7% | 1.19 | Alveolar echinococcosis | 3% | 1.13 |
Rabies | 37% | 1.96 | Rocky mountain spotted fever | 15% | 1.37 | Babesiosis | 7% | 1.20 | St. Louis encephalitis | 2% | 1.13 |
Toxoplasmosis | 37% | 1.65 | Yellow fever | 13% | 1.42 | Chagas | 6% | 1.20 | Nipah virus | 2% | 1.12 |
H5N1 | 34% | 1.76 | Q fever | 11% | 1.29 | Cystic echinococcosis | 6% | 1.16 | Jamestown Canyon virus | 2% | 1.12 |
Dengue | 30% | 1.55 | Brucellosis | 11% | 1.27 | Ehrlichiosis | 5% | 1.17 | Powassan virus | 2% | 1.13 |
Zika | 30% | 1.60 | Bovine tuberculosis | 10% | 1.27 | Eastern equine encephalitis | 5% | 1.17 | Louse-borne relapsing fever | 2% | 1.12 |
MERS-CoV | 29% | 1.66 | Leptospirosis | 10% | 1.27 | Human granulocytic anaplasmosis | 4% | 1.16 | La Crosse encephalitis | 2% | 1.13 |
Bartonellosis | 29% | 1.52 | Japanese encephalitis | 9% | 1.26 | Anthrax | 4% | 1.21 | Marburg virus | 2% | 1.10 |
H7N9 | 19% | 1.56 | Hantavirus pulmonary | 9% | 1.26 | California encephalitis | 3% | 1.14 | Lassa hemorrhagic fever | 2% | 1.12 |
Mpox | 18% | 1.50 | Tularemia | 8% | 1.23 | Toxocariasis | 3% | 1.15 | Cache valley virus | 2% | 1.11 |
Chikungunya | 17% | 1.36 | Hantavirus -Hemo. fever + renal syndrome | 8% | 1.21 | Plague | 3% | 1.22 | Rift Valley Fever | 2% | 1.13 |
Tick-borne encephalitis | 17% | 1.38 | Psittacosis | 8% | 1.23 | Murine typhus | 3% | 1.15 | Crimean Congo hemorrhagic fever | 1% | 1.09 |
Note: Confidence mean is based on 4-point scale where 1 = "Not at all confident" and 4 = "Very confident." The mean ranges from 1 to 4 and includes all respondents, regardless of encounter. |
Mean Self-Rated Confidence Among Encountered
The table below shows confidence means for diseases among those who had encountered each disease in their practice. Calculated this way, confidence ratings exist in a tight range from 1.80 to 2.59.
Q10A and Q10B. Please indicate which diseases you have encountered in your practice, and rate your level of confidence in managing each zoonotic infectious disease. Base: All respondents (n = 1,023); means calculated based only on those who encountered each disease.
Disease | Encountered % | Mean confidence | Disease | Encountered % | Mean confidence | Disease | Encountered % | Mean confidence | Disease | Encountered % | Mean confidence |
---|---|---|---|---|---|---|---|---|---|---|---|
Lyme | 80% | 2.33 | Cryptosporidiosis | 17% | 2.17 | Ebola disease | 7% | 2.07 | Snowshoe hare encephalitis | 3% | 2.34 |
West Nile | 38% | 2.13 | Cutaneous larva migrans | 15% | 2.41 | Western equine encephalitis | 7% | 2.17 | Alveolar echinococcosis | 3% | 2.55 |
Rabies | 37% | 2.41 | Rocky mountain spotted fever | 15% | 2.06 | Babesiosis | 7% | 2.08 | St. Louis encephalitis | 2% | 2.47 |
Toxoplasmosis | 37% | 2.11 | Yellow fever | 13% | 2.26 | Chagas | 6% | 2.01 | Nipah virus | 2% | 2.11 |
H5N1 | 34% | 2.41 | Q fever | 11% | 2.59 | Cystic echinococcosis | 6% | 2.26 | Jamestown Canyon virus | 2% | 2.49 |
Dengue | 30% | 2.15 | Brucellosis | 11% | 2.19 | Ehrlichiosis | 5% | 2.14 | Powassan virus | 2% | 2.18 |
Zika | 30% | 2.11 | Bovine tuberculosis | 10% | 2.19 | Eastern equine encephalitis | 5% | 2.17 | Louse-borne relapsing fever | 2% | 1.80 |
MERS-CoV | 29% | 2.56 | Leptospirosis | 10% | 2.14 | Human granulocytic anaplasmosis | 4% | 2.19 | La Crosse encephalitis | 2% | 2.39 |
Bartonellosis | 29% | 2.25 | Japanese encephalitis | 9% | 2.06 | Anthrax | 4% | 2.02 | Marburg virus | 2% | 1.99 |
H7N9 | 19% | 2.41 | Hantavirus pulmonary | 9% | 2.22 | California encephalitis | 3% | 2.08 | Lassa hemorrhagic fever | 2% | 2.15 |
Mpox | 18% | 2.27 | Tularemia | 8% | 2.29 | Toxocariasis | 3% | 2.26 | Cache valley virus | 2% | 1.98 |
Chikungunya | 17% | 2.16 | Hantavirus -Hemo. fever + renal syndrome | 8% | 1.94 | Plague | 3% | 1.93 | Rift Valley Fever | 2% | 2.55 |
Tick-borne encephalitis | 17% | 2.11 | Psittacosis | 8% | 2.40 | Murine typhus | 3% | 2.18 | Crimean Congo hemorrhagic fever | 1% | 2.18 |
Note: Confidence mean is based on 4-point scale where 1 = "Not at all confident" and 4 = "Very confident." The mean ranges from 1 to 4 and is calculated based on those who encountered each. |